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ii. Lay Summary 
 
The ribosome is a molecular machine responsible for making all of the 
proteins inside every cell. Its assembly, in turn, requires the action of multiple 
proteins. Nob1, Dim2, and Tsr1 are three proteins out of the ~200 factors involved in 
the process. They are needed in order for the ribosome to become functional. This 
project aimed to explore the mechanism by which these three proteins are able to 
give rise to competent ribosomes. 
Nob1 and Dim2 interact with each other and the immature ribosome. When 
these proteins are removed from cells, the ribosomes produced are unable to make 
proteins. Different parts of the ribosome have been shown to interact with the two 
proteins. However, here we show that Nob1 and Dim2 show an ability to bind to the 
same part. Thus, it is possible that they compete for this site. This could prove to be a 
very important part in regulating the ribosome production. 
Tsr1 function is unknown to date. This protein has also been shown to bind to 
the ribosome and, without it, the cells are unable to make ribosomes capable of 
making proteins. This project aimed to characterise Tsr1 by obtaining its structure. 
The structure of a protein can often give ideas about its function. Some preliminary 
steps have been taken although the structure has not yet been obtained. 
Overall, the research presented here clarifies certain aspects of ribosome 





Ribosome biosynthesis in eukaryotes is a complex process involving over 
200 accessory factors. Nob1, Dim2, and Tsr1 are three conserved factors that are all 
involved in the late processing steps of the small subunit (40S) pre-rRNA. Depletion 
of any of these factors leads to the accumulation of the immature 20S pre-rRNA. 
Nob1, an essential protein in yeast, performs the final cleavage of small 
subunit rRNA giving rise to the mature particle.  It is aided in this process by other 
proteins such as Dim2. Previously, the two proteins have been shown to interact. 
Nob1 function was found to be more efficient in the presence of Dim2. 
Previous studies also indicated that Nob1 binds a site on the pre-40S that is 
distal to the cleavage site while Dim2 binds proximally. Using analytical gel 
filtration, electrophoretic mobility shift assays, and isothermal titration calorimetry 
we show that Nob1 does not interact with the distal binding site in vitro. Instead, a 
stable complex with a micromolar disassociation constant can be formed with a 
sequence derived from the cleavage site. Thus, Nob1 and Dim2 appear to be 
competing for this site. The interaction with both proteins is blocked when this 
sequence is sequestered in a hairpin structure, which has been previously predicted to 
form at this site. By altering individual bases in the RNA sequence, we have 
identified the sequence determinants for Nob1-rRNA recognition. 
Tsr1 function is unknown to date. It shares sequence similarity with certain 
GTPases; however, no GTP binding has been identified in previous studies. The 
depletion of this factor leads to a similar phenotype as the depletion of Nob1 and 
Dim2. By screening various deletion constructs, we have obtained good quality, 
diffracting crystals of yeast Tsr1. However, due to time constraints, the full structure 
has not been solved. Here we present the initial analysis of the crystallographic data 
and the potential for solving the structure in the future. 
Overall, the data presented in this thesis bring insight into the final step of 
small subunit ribosome maturation. 
 
 







1.1 Ribosomal Function and Abnormalities 
 
 
 Ribosome function is essential for life in all organisms. These 
macromolecular machines are needed in every cell in order to synthesize protein 
chains using the peptidyl transferase reaction (Green & Noller, 1997). It has been 
known for a long time that ribosomes are comprised of proteins and RNA and that 
the two components come together to perform the catalytic reaction, thus making 
these molecules ribozymes (Green & Noller, 1997; Nissen et al, 2000; Noller et al, 
1992). 
Understanding how these molecules are made and how they are regulated is 
important for multiple aspects of biological and medical sciences. In the past, it was 
thought that any defect in the ribosome biosynthesis pathway would be lethal. More 
recently, abnormalities in the ribosome have been implicated in the pathogenesis of a 
number of diseases. For example, Diamond-Blackfan anaemia (autosomal dominant) 
and Shwachman-Bodian-Diamond syndrome (autosomal recessive) are rare disorders 
caused by mutations in ribosomal proteins (Narla & Ebert, 2010). Other diseases, 
such as Bowen-Conradi syndrome (autosomal recessive) and Treacher Collins 
syndrome (autosomal dominant), are caused by mutations in the ribosomal RNA 
(rRNA) processing proteins (Freed et al, 2010).  
These disorders are caused by dysregulation of the ribosome biogenesis 
pathway, which, in turn, causes the accumulation of the proteins involved. This leads 
to the activation of the p53 stress response by inhibition of its E3 ubiquitin ligase, 
Mdm2. Haploinsufficiencies are often enough to activate the pathway. The p53 
response can range from arresting the cell cycle to apoptosis depending on the 
severity of the defect. Thus, the cells are forced to evolve to survive and to supress 
the stress response leading to severe phenotypes such as the disorders mentioned. 
Also, it increases the risk of tumourgenesis as the p53 response suppresses 
uncontrolled proliferation. Thus, ribosome dysfunction is also associated with cancer 
(Bursac et al, 2014; Golomb et al, 2014).  
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In cancer, cells need higher levels of protein production during proliferation. 
Recent studies showed that knockdown of a ribosome assembly factor, Nob1, leads 
to decreased proliferation and tumour genesis in ovarian cancer (Lin et al, 2011), 
hepatocellular carcinoma cell lines (Lu et al, 2011), and in in vitro and in vivo 
models of non-small cell lung cancer (Li et al, 2014). The mechanism for this effect 
remains unknown. In malignant glioma, Nob1 has been suggested to potentially be 
an oncogene. Its levels in cell lines and in glioma patients were correlated to the 
severity of the disease (Zhou et al, 2013). All of these findings make Nob1 a 
potential anti-cancer target and thus, make it an important target for study. 
Understanding ribosome biogenesis in organisms other than humans is also 
important. This process in pathogens such a trypanosomatids, (e.g. Trypanosoma 
brucei) requires additional factors (Jensen et al, 2005; Prohaska & Williams, 2009). 
These are not present in metazoa and can potentially be used as drug targets against 
these pathogens. Understanding the pathway in both types of organisms is crucial for 
developing such drugs. 
 
 
1.2 Overview of the Early rRNA Processing in Eukaryotes 
 
 
 Ribosome assembly in eukaryotes is a complicated, multi-step process 
involving over 200 accessory proteins and multiple cellular compartments (Henras et 
al, 2008). It is more fully understood in prokaryotes where it is simpler and involves 
fewer proteins (Connolly & Culver, 2009; Hage & Tollervey, 2004). Also, the 
bacterial ribosome has been fully assembled in vitro (Traub & Nomura, 1968). In 
eukaryotes, the process is largely conserved and has been extensively studied in the 
model yeast, Saccharomyces cerevisiae (Kressler et al, 2010). However, while the 
majority of factors and some processes involved have been uncovered, the 
mechanistic details of how the factors work together to bring about the necessary 
maturation events remain largely unknown. 
 The assembly process starts during rRNA transcription in the nucleolus. The 
5S rRNA is transcribed by RNA polymerase III while the other three out of the four 
rRNAs (18S, 5.8S, and 25S) are produced as a single transcript (35S) by RNA 
polymerase I (Kressler et al, 2010). During transcription, this large rRNA molecule 
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interacts with multiple proteins to give a 90S pre-ribosome (Schafer et al, 2003). 
Then, multiple cleavage steps occur in order to separate and mature the individual 
components (Kressler et al, 2010).  
The cleavages of yeast and human rRNA are summarised in Figure 1.1. In 
yeast, cleavages A0 and A1 remove the 5 external transcribed spacer (ETS). Then, 
cleavage at site A2 in the internal transcribed spacer (ITS) separates the small subunit 
(SSU, pre-40S) and large subunit (LSU, pre-60S) pre-rRNAs. This cleavage occurs 
co-transcriptionally, while the LSU rRNA is still being made (although it can also 
take place after transcription, depending on the metabolic state of the cell) (Kos & 
Tollervey, 2010; Osheim et al, 2004). The processing in the nucleolus involves 
multiple small nucleolar RNAs (snoRNAs) and associated proteins (Dragon et al, 
2002). The pre-40S particle is then released and rapidly transported into the 
cytoplasm for further processing (Kressler et al, 2010).  
After the LSU rRNA is transcribed it is also released. The LSU rRNA travels 
from the nucleolus to the nucleoplasm and eventually to the cytoplasm with different 
processing steps occurring in the different compartments, while the SSU rRNA does 
not appear to undergo processing in the nucleoplasm (Kressler et al, 2010).  
In human cells, the processing steps are very similar but a different 
numbering system for the cleavages is used, as seen in Figure 1.1. The largest 
difference can be seen in the processing of the SSU rRNA. After separation from the 
other RNAs by cleavage at site 2 (A2 in yeast), a further cleavage has to take place 
prior to export into the cytoplasm. This is known as cleavage E. Otherwise, the 
process is very similar although other small differences do exist (Carron et al, 2011; 
Rouquette et al, 2005). For example, while the yeast polycistronic transcript is 
processed co-transcriptionally, the human one is not (Turowski & Tollervey, 2014). 
This is likely due to the relative growth rates of the cells. This research concentrates 
on the late maturation of the 18S rRNA particle. 
 
 
1.3 Overview of the Late 18S rRNA Processing in Eukaryotes 
 
 
The SSU pre-rRNA is rapidly exported from the nucleolus to the cytoplasm 
where two main processing steps occur that allow the mature 18S rRNA to be 
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created. Firstly, the RNA becomes dimethylated at two 3ʹ adenines (1781 and 1782) 
by Dim1 (Campbell & Karbstein, 2011). Although, this modification does not appear 
to be necessary for processing in vivo, cleavage at the D site cannot occur without the 
dimethylation in vitro (Kos & Tollervey, 2010). Finally, cleavage at site D (in yeast) 
is needed to mature the 20S pre-rRNA into the 18S rRNA (Campbell & Karbstein, 
2011; Hage & Tollervey, 2004; Kressler et al, 2010; Lamanna & Karbstein, 2011).  
 
Figure 1.1: Summary of the cleavage steps involved in making the mature rRNAs in S. 
cerevisiae and H. sapiens.  
The small subunit (SSU) rRNA is shown in green while the large subunit (LSU) rRNA is shown in 
blue. Cleavages at sites A0 and A1 (or 01 and 1 for human cells) remove the external transcribed 
spacer at the 5ʹ end. Cleavage A2 (or 2) separates the small and large subunit rRNAs. The LSU rRNA 
undergoes multiple maturation steps in the nucleoplasm and is separated into its constituent parts (by 
cleavage at site C2 or 3’) before export into the cytoplasm. In the cytoplasm, final maturation occurs. 
The yeast SSU rRNA, in contrast, is not processed in the nucleoplasm and is rapidly exported into the 
cytoplasm where it undergoes the final cleavage at site D to give the mature 18S fragment. The human 
SSU rRNA undergoes an additional cleavage in the nucleus at site E before the export and final 
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Multiple factors remain bound to the nucleic acid throughout the transport 
into the cytoplasm. In S. cerevisiae, these include Rio2, Tsr1, Enp1, Ltv1, Dim1, 
Dim2 (also known as Pno1), and Nob1, all of which are involved in the final 
processing steps (Campbell & Karbstein, 2011; Fatica et al, 2003; Schafer et al, 
2003; Vanrobays et al, 2003; Vanrobays et al, 2008). Homologous proteins have 
been shown to bind to the pre-40S particle in human cells (Wild et al, 2010; Zemp et 
al, 2009) implying that late processing steps are conserved. Rio2, Ltv1, and Dim2 
have all been shown to contain functional nuclear export signals (NES) that aid in the 
export of the premature particle (Seiser et al, 2006; Vanrobays et al, 2008; Zemp et 
al, 2009). 
The seven accessory factors appear to make two distinct modules in yeast. 
The first module consists of Enp1 and Ltv1, which have been shown to form a stable 
complex, along with Rps3 (a ribosomal protein), that is resistant to high salt (Schafer 
et al, 2006). The other module consists of Tsr1, Dim1, Dim2, and Nob1, which are 
all connected through their interaction with Rio2 (although the Tsr1 – Rio2 
interaction has not been confirmed) (Campbell & Karbstein, 2011). Interactions 
between Dim2 and Dim1 or Nob1 have also been mapped (Campbell & Karbstein, 
2011; Tone & Toh, 2002; Vanrobays et al, 2004) although the former might require 
an RNA mediator (Campbell & Karbstein, 2011). Previously mapped interaction 
between these late acting accessory factors are shown in Figure 1.2. The interactions 
shown here are strong and appear to be direct (Campbell & Karbstein, 2011).  
The Enp1/Ltv1 module is required for earlier processing (A0, A1, and A2 
cleavages) as well as at the late stages (Chen et al, 2003). In late processing, 
depletion of Ltv1 or mutation of its NES results in 20S pre-rRNA accumulation 
(Fassio et al, 2010; Lebaron et al, 2009). This could be due to interference with the 
Prp43 helicase activity (Lebaron et al, 2009) or due to other unknown effects (Fassio 
et al, 2010). Prp43 is an RNA helicase, which has been shown to be needed for the 
cleavage at site D (Pertschy et al, 2009). Pfa1 is a protein, which stimulates Prp43 
activity. Deletion of Ltv1 and Pfa1 gives a more dramatic inhibition of the 20S pre-
rRNA processing (Lebaron et al, 2009) implying that the two might be connected. 
The second module has a more direct role. As mentioned earlier, Dim1 
methylates the RNA (Campbell & Karbstein, 2011). Nob1 is the endonuclease 
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responsible for cleavage at site D (Pertschy et al, 2009). A mutation that abolishes 
just its nuclease activity (D92N) prevents the cleavage from happening (Fatica et al, 
2003; Fatica et al, 2004). Nob1 has also been shown to bind near the D site 
(Lamanna & Karbstein, 2009). The other proteins in this module are also required for 
the cleavage to occur. Depletion of Dim2 prevents both late steps: the methylation by 
Dim1 and cleavage by Nob1 (Woolls et al, 2011); whereas, the kinase activity of 
Rio2 has been shown to be required for the D site cleavage and for the release of 
Nob1, Dim2, and Ltv1 from the mature particle (Ferreira-Cerca et al, 2012; Zemp et 
al, 2009). Tsr1 is also involved in late 20S rRNA processing although its exact 
function is unknown. Depletion of this protein causes the processing to slow down 




Figure 1.2 (Campbell & Karbstein, 2011): Some main assembly factors involved in SSU rRNA 
processing.  
A) Factors interacting with the SSU rRNA during different stages of maturation. The interactions 
between these factors have been mapped (see below). Multiple factors remain bound to the pre-
40S particle throughout the nuclear export process. For simplicity, no ribosomal proteins are 
shown. 
B) Map of the interactions observed by pull-down experiments (i.e. strong interactions) including the 
interaction between Nob1 and Pno1 (i.e. Dim2). Some ribosomal proteins (light blue) are included. 
A B 
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Dim1 is the most conserved out of all seven co-factors as its homolog can 
even be found in bacteria (known as KsgA) (Lafontaine et al, 1994; O'Farrell et al, 
2006). The structure of KsgA has been solved to 2.1 Å, showing the structural 
mechanism involved in the methylation reaction (O'Farrell et al, 2004). Structural 
information for archaeal (LaRonde-LeBlanc & Wlodawer, 2004) and eukaryotic 
(Ferreira-Cerca et al, 2012) Rio2 has been published and clarified that the protein 
acts as an ATPase as well as a kinase. Finally a crystal structure of archaeal Dim2 
(Jia et al, 2010; Jia et al, 2007) and a limited NMR model of archaeal Nob1 have 
been solved (Veith et al, 2012). Not much is known about the domain organisation of 
the eukaryotic accessory proteins.  
The positioning of the seven late binding accessory factors on the premature 
40S ribosome was determined using cryo-electron microscopy (cryo-EM) in 
combination with sequential depletion of the proteins to identify their densities 
(Strunk et al, 2011). Figure 1.3 shows the results of the study. 
 
Figure 1.3 (Strunk et al, 2011): Positioning of some of 
the assembly factors on the pre-40S ribosome as 
shown by EM at 18 Å resolution. 
Tsr1 is on the other side of the particle. Pno1 (also 
known as Dim2) and Nob1 are shown to be close to each 
other and close to the end of helix 44 where the D site 
cleavage occurs (shown in purple) and to helix 40 
(marked with an arrow). Enp1 and Ltv1 can be seen to 
form the separate module. Solved structure of Rio2 and 





Proteins, which are not structural components of the pre-ribosomes, are also 
important in the D site cleavage. As mentioned earlier, Prp43 activity is required to 
give the mature particles (Lebaron et al, 2009). Rio1 kinase is also needed as its 
activity allows the recycling of Nob1 and Dim2 following the cleavage (Widmann et 
al, 2012). Another example of this can be seen with Fap7. Fap7 adenylate kinase 
depletion leads to accumulation of the 20S pre-rRNA. Its interaction with the pre-
40S particle appears to be transient but important (Granneman et al, 2005). A recent 
 
H40 
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study has shown that its activity is required for positioning of Rps14 and making the 
pre-ribosome a viable substrate for D site cleavage (Loc'h et al, 2014).  
Finally, all of the seven accessory factors also prevent premature activation of 
the pre-40S particle. Tsr1, Rio2, and Dim1 binding sites (as shown by cryo-electron 
microscopy, or cryo-EM) overlap the sites required for binding of translation 
initiation factors eIF1 and eIF1A while Nob1 and Dim2 positioning is incompatible 
with eIF3 binding. The Enp1/Ltv1 module overlaps the hinge region so that the 
mRNA channel cannot open even if a translation initiation factor was to bind (Strunk 
et al, 2011).  
This study aims to clarify the process of the 20S pre-rRNA maturation by 
characterising three biogenesis factors from eukaryotes: Nob1, Dim2, and Tsr1. 
 
 
1.4 Previous Studies Performed on Nob1 
 
 
Nob1 has been shown to be involved in the assembly of the 26S proteasome 
(Tone & Toh, 2002) as well as for the assembly of the 40S ribosome subunit. The 
sequence alignment between yeast and human Nob1 (Figure 1.4) shows moderate 
conservation, especially around the functional domains (PIN and zinc ribbon). Yeast 
Nob1 is seen to localise to the nucleus and the cytoplasm (Fatica et al, 2003) 
although it does not appear to be involved in early rRNA processing. It has been 
suggested that, in ribosome biogenesis, its activity is inhibited until later stages of 
rRNA maturation (Granneman et al, 2010). During 40S ribosome assembly, Nob1 
interacts with multiple proteins including ribosomal proteins Rps5 and Rps14 
(Campbell & Karbstein, 2011), and accessory factors such as Dim2 (Campbell & 
Karbstein, 2011; Tone & Toh, 2002; Woolls et al, 2011).  
There is some evidence that Nob1 can exist as a tetramer although it is 
unclear if this is the case inside the cell. When the yeast protein was purified from 
bacteria as a recombinant construct, it appeared to form larger particles (i.e. 
tetramers) (Lamanna & Karbstein, 2009). However, the EM structure of the pre-40S 
ribosome shown earlier supports a Nob1 monomer binding the particle. A tetramer 
would not fit in the density observed. 
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Nob1 contains a PIN domain, which is required for D site cleavage (Fatica et 
al, 2004; Lamanna & Karbstein, 2009). Normally, this domain is associated with 
Mg
2+
-dependent exonucleases (Arcus et al, 2004). In vitro experiments with the 
yeast protein showed that the nuclease activity of Nob1 is stimulated by manganese 
cations (Lebaron et al, 2012; Pertschy et al, 2009).  
  
Figure 1.4: Sequence alignment of Nob1 from different organisms (obtained using ClustalW and 
Jalview). 
The sequences are coloured using the Clustal colour scheme. Sequences for S. cerevisiae, C. 
thermophilum, and human proteins are shown. The functional domains are marked in boxes with 
outlines (the first blue one corresponds to the PIN domain and the second black box shows the zinc 
ribbon domain). The two fungi show an identity of 34.0%, which is increased to 44.4 and 46.8% in 
the PIN and zinc ribbon domains respectively. Out of the fungal proteins, the C. thermophilum Nob1 
is more similar to the human protein (32.0% vs. 27.5% identity). 
 
A study using DMS probing suggested that the PIN domain binds the 20S 
pre-rRNA close to the D site (Lamanna & Karbstein, 2009). However, another study 
using UV-cross-linking mapped Nob1 to a site that is distant from site D (helix 40) 
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(Granneman et al, 2010). This site is potentially too distant to allow cleavage 
implying that a conformational change is required to bring the D site in contact with 
the Nob1 PIN domain (Granneman et al, 2010; Lamanna & Karbstein, 2011). Studies 
using the archaeal protein showed that the zinc ribbon domain could bind to helix 40 
(Veith et al, 2012). Thus, it is possible that both interactions occur via different 
domains of the protein. This is supported by the EM structure of the pre-40S 
ribosome, which places Nob1 in a position where it would be able to bind to both 
locations (Figure 1.3). Nevertheless, it is unknown how Nob1 is inhibited and why it 
is bound to the rRNA early in the processing pathway.  
Currently, there is one model for D site cleavage that has been supported by 
the Tollervey and Karbstein labs independently (shown in Figure 1.5). In this model, 
there is a ‘translation-like’ cycle that involves interactions of the pre-40S with the 
60S subunit. Both labs have shown that this interaction is mediated by the GTPase 
Fun12 (also known as eIF5B) (Lebaron et al, 2012; Strunk et al, 2012). Once the 
cleavage occurs, the Rli1 ATPase separates the ribosomal subunits in order for the 
accessory factors to dissociate and for a proper translation cycle to occur. Rli1 
performs the same termination function in mature ribosomes (Strunk et al, 2012).  
It was also found that the GTPase activity of Fun12 is needed to stimulate D 
site cleavage. It is possible that GTP hydrolysis causes conformational changes that 
allow Nob1 to perform the cleavage. However, the process is more complicated as D 
site cleavage stimulation also depends on the ability of Fun12 to connect the two 
ribosomal subunits (Lebaron et al, 2012).  
 Interactions between Nob1 and Prp43 (Pertschy et al, 2009), and Dim2 
(Vanrobays et al, 2008; Woolls et al, 2011) have been shown to promote the 
cleavage. The physical interaction between Nob1 and Dim2 has been previously 
demonstrated using a yeast-two-hybrid screen (Tone & Toh, 2002) and pull-down 
experiments (Woolls et al, 2011). It is possible that Dim2 aids in Nob1 making the 
correct contacts.  
Recently, Nob1 has also been shown to interact with Fap7 adenylate kinase in 
vitro (Hellmich et al, 2013). The interaction with Fap7 blocked the cleavage at the D 
site (Hellmich et al, 2013). However, without Fap7 expression, the D site cleavage 
cannot occur in vivo (Granneman et al, 2005). It was also shown, that S. cerevisiae 
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Figure 1.5 (Lebaron et al, 2012): Model for D site cleavage. 
Only the pre-40S subunit is shown for clarity (it is divided into the brown head and green body 
domains). ITS1 is shown in purple, The Nob1 binding site is shown in blue, and the end of the mature 
18S rRNA is shown in dark green. In the lower, structural images, locations of the ribosomal proteins 
Rps5 and Rps14 are shown in black. The ITS1 RNA is positioned inside the mRNA channel (i). 
Fun12 binds to the pre-40S along with the mature 60S subunit (ii). Fun12 hydrolyses GTP causing a 
string of conformational changes. The ITS1 is excluded from the mRNA channel. A potential head 
rotation occurs causing the D site to come into contact with Nob1. Thus, the D site cleavage can now 
proceed (iii). The accessory factors and the 60S subunit are released leaving a mature 40S particle 
(iv). 
 
Finally, an NMR structure of archaeal Nob1 (from Pyrococcus horikoshii) 
has been published. Figure 1.6 shows the structure of the two functional domains. 
The positioning of the domains with respect to each other could not be determined as 
they are connected by a flexible region and appear in different orientations in the 
structures (Veith et al, 2012). However, the data show how each of the domains in 
the protein is folded. Nevertheless, the archaeal protein displays a much shorter 
sequence than its eukaryotic counterpart (Figure 1.7A). While the archaeal protein 
structure gives a significant insight into Nob1 function, structural data on proteins 
from higher organisms are required to better understand its role in the context of the 
more complex eukaryotic ribosome. 




















Figure 1.6 (Veith et al, 2011): The NMR-determined structures of the two functional domains of 
an archaeal (from Pyrococcus horikoshii) Nob1 protein (PDB ID: 2LCQ).  
The top shows the PIN domain and the bottom shows the zinc ribbon domain. Each image is 
comprised of 20 overlaid structures. Alpha helices are shown in orange while the beta-strands are 
purple. The zinc divalent cation is shown as a blue sphere on the lower image. Four cysteine residues 
(sticks with sulphur atoms shown in yellow) coordinate its position. 
 
 
1.5 Previous Studies Performed on Dim2 
 
 
Dim2 is significantly conserved at the sequence level between yeast and 
humans (Figure 1.8), suggesting that its function is also conserved. Transgenic 
homozygous Dim2 knockout mice display early embryonic lethality. However, 
heterozygous knockout mice show normal development and fertility suggesting that 
a small amount of this protein is sufficient but necessary (Wang et al, 2012).  
Like Nob1, Dim2 localises to the nucleus and the cytoplasm. However, 
unlike Nob1, Dim2 is needed for early processing (especially cleavage at site A2) 
(Vanrobays et al, 2004). Crystal structures of an archaeal Dim2 (also from P. 
horikoshii) with (Jia et al, 2010) and without (Jia et al, 2007) rRNA bound to it have 
been published. Archaeal ribosome biogenesis and assembly are similar to 
eukaryotic ones although some key differences exist. For example, archaeal Dim2 
contains two KH domains, which bind rRNA while the eukaryotic protein contains 
only one functional KH domain and a degenerated KH domain (Jia et al, 2010). 
Zinc Ribbon Domain 
PIN Domain 
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Thus, the archaeal structure could differ from the eukaryotic one. An alignment is 
shown in Figure 1.7B to highlight the differences. 
 
 
Figure 1.7: Sequence alignments of Nob1 and Dim2 from yeast and archaea (obtained using 
ClustalW and Jalview). 
A) Nob1 alignment. The sequences are coloured using the Clustal colour scheme. Sequences for S. 
cerevisiae and P. horikoshii proteins are shown. The functional domains are marked in boxes with 
blue and black outlines as before. There is no significant similarity between the sequences except 
in the PIN domain (36.1% identity).  
B) Dim2 alignment. Sequences are coloured in the same manner as the Nob1 alignment. The KH 
domain is shown in a black box. The KH-like domain is marked in a blue box (the first domain in 
the sequence). It forms a functional domain in the archaeal protein unlike in the yeast or human 
proteins. Both domains show some degree of conservation: 26.4% identity in the functional 
domain (black) and 22.6% in the degenerated one (blue). 
A 
B 
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Figure 1.8: Sequence alignment of Dim2 from different organisms (obtained using ClustalW 
and Jalview). 
Sequences are coloured in the same manner as the Nob1 alignment. The non-functional KH-like 
domain is shown in the first blue box and the functional KH domain is shown in the second black box. 
The two sequences from fungi show 49.66% identity, which is raised to 81.13% in the KH domain. In 
this instance, the S. cerevisiae protein is more similar to the human one (48.2% vs. 42.0% identity). 
 
Nevertheless, the structure with rRNA allowed us to map the potential Dim2 
binding site. Figure 1.9 shows the general fold of the protein and the rRNA sequence 
derived from Escherichia coli that was copurified with archaeal Dim2. The binding 
site for the second KH domain (which is the functional domain in eukaryotes) is 
conserved from archaea to human. Thus, this is the predicted binding site in 
eukaryotes even though it has not been experimentally determined. The structure also 
showed that Dim2 interacts with initiation factor 2 (IF2) implying it might play a role 
in translation initiation (Jia et al, 2010).  
Other studies have shown that Dim2 is necessary for the dimethylation 
reaction performed by Dim1 and the two proteins have been shown to co-precipitate 
(Vanrobays et al, 2004). Mutating a single residue in the functional KH-domain 
(G207A) is sufficient to prevent rRNA processing. The equivalent archaeal residue 
(G145) is in the second KH domain in a loop (marked with an arrow in Figure 1.9A) 
involved in making RNA contacts (Vanrobays et al, 2008). Dim2 is also needed for 
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pre-40S export from the nucleus and for efficient D site cleavage by Nob1 
(Vanrobays et al, 2008; Woolls et al, 2011). It had been shown to be one of the last 
proteins to leave the maturing ribosome (Strunk et al, 2012). The release of Nob1 
and Dim2 from the mature 18S particle seems to be dependent on the kinase activity 
of Rio2 (Zemp et al, 2009). 
 
 
                 KH2  KH1 
Archaeal (P. horikoshii) 16S rRNA:    5′-GGAUCACCUCC-3′ 
Yeast (S. cerevisiae) 18S rRNA:    5′-GGAUCAUUA-3′ 
Human 18S rRNA:      5′-GGAUCAUUA-3′ 
Figure 1.9: The general fold of archaeal Dim2 (blue) in complex with bacterial rRNA (black and 
red) (PDB: 3AEV).  
A) The protein and nucleic acid are shown as cartoons. The two KH domains form the interactions 
with the nucleic acid. Both KH domains insert an α-helix into the space between adjacent bases 
forming multiple bonds to the backbone. The bases bend away from the helix and also form 
multiple non-covalent interactions with the protein. The binding appears to be sequence specific 
(CCUCC for KH1 and GGAUCA for KH2) although some changes in the sequence are tolerated 
(Jia et al, 2010). The loop contacting G145 is indicated with the arrow. 
B) The sequences found near the 3ʹ end of SSU rRNA from archaea, yeast, and human. The preferred 
sequence needed for KH2 binding is conserved. Human and yeast Dim2 protein homologs only 
have the KH2 domain and lack the KH-1 domain. The rRNA sequences show that the mode of 
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  Unlike Nob1, Dim2 shows some similarity to a prokaryotic protein, RbfA. In 
bacteria, this protein is required for 5 processing of 16S rRNA. Like Dim2, it has a 
KH domain that is responsible for making the RNA-protein contacts (Datta et al, 
2007; Strunk et al, 2011).  
Figure 1.10 shows the secondary structure of the S. cerevisiae 20S rRNA. 
Cleavage site D is marked (blue circle), as is the mapped Nob1 binding site (red 
circle).  The predicted site for Dim2 is shown in green. The position of these proteins 
on the three-dimensional structure of the ribosome particle was determined by 
electron microscopy (EM), as shown in Figure 1.3 (Strunk et al, 2011).  
The known interaction between Nob1 and Dim2, and the positioning of the 
two proteins on the rRNA molecule indicate that they are functionally related. 
Although Dim2 has been shown to aid in rRNA binding of Nob1 (Woolls et al, 
2011), how the interaction of Nob1 with Dim2 mechanistically affects cleavage is 
unknown. The research described here aims to uncover the functional relationship 
between these proteins and D site cleavage. 
 
 
1.6 Previous Studies Performed on Tsr1 
 
The exact function of Tsr1 is unknown. The human and yeast proteins share 
about 30% sequence identity as seen in the alignment in Figure 1.11. It is highly 
similar to a GTP-binding protein known as Bms1. However, Tsr1 lacks the P-loop 
that is needed for GTP binding and the nuclear localisation signal (both of which are 
present in Bms1) (Gelperin et al, 2001). It also interacts with the pre-rRNA at a site 
very similar to that of the bacterial GTPase, Era (Granneman et al, 2010). In E. coli, 
Era is required for pre-30S maturation (Inoue et al, 2003). In yeast, depletion of Tsr1 
leads to a decrease in 20S rRNA processing and an increase in 80S particles, as seen 
using cryo-electron microscopy (cryo-EM) (Gelperin et al, 2001; Strunk et al, 2011), 
showing that its role might be similar to that of Era in bacteria. 
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Figure 1.10: Secondary structure of the 20S rRNA from S. cerevisiae (obtained from 
http://www.rna.ccbb.utexas.edu/). 
The 20S rRNA, apart from the extra ~200 bases on the 3 end, is shown. Areas of interest for this 
project are marked. Helix 40 where Nob1 has been mapped to bind by cross-linking (red circle) is 
indicated. The D site cleavage takes place at the adenine marked with a blue circle. This site is distant 
from the Nob1 binding region. However, it very close to the Dim2 binding site (green oval) as 
predicted from the experiments performed on the archaeal protein. Helices of interest are marked with 
black numbers. 
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Tsr1 forms its major interactions with the central domain of the rRNA. In the 
folded structure, the protein is in close proximity to helices 44 and 45 and the D site 
although more contacts are made at helices 19 and 26-29 (labelled in Figure 1.10). 
There are 41 nucleotides at this location that are resistant to RNase digestion when 
Tsr1 is present confirming the binding position (Granneman et al, 2010). This 
positioning places the protein in a prime location to block premature ribosome 
assembly and translation initiation (Campbell & Karbstein, 2011; Granneman et al, 
2010; Strunk et al, 2011). For example, the position of helix 28 of the rRNA prevents 
the binding of initiator tRNA. Also, the close proximity to the D site might impede 
premature cleavage by Nob1 (Granneman et al, 2010).  
There is some evidence that Tsr1 prevents degradation of the premature 40S 
allowing the D site time to be cleaved. Also, the Tsr1 binding site overlaps with that 
of Rli1 ATPase. Therefore, its dissociation might be needed to allow Rli1 to bind and 
for the 40S to disassemble from the 80S-like ribosome formed in the ‘translation-
like’ cycle that promotes D site cleavage (Strunk et al, 2012). 
Finally, it has been suggested that Tsr1 is needed for nuclear export of the 
immature particles (Campbell & Karbstein, 2011; Gelperin et al, 2001; Schafer et al, 
2003). However, as stated previously, its precise function and the mechanism by 
which it performs it are largely unknown. An atomic resolution structure of the 
protein might lead to an increased understanding of Tsr1. 
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Figure 1.11: Sequence alignment of Tsr1 from different organisms (obtained using ClustalW 
and Jalview). 
The sequences are coloured using the Clustal colour scheme. Sequences for S. cerevisiae, C. 
thermophilum, and human proteins are shown. The GTPase-like domain is marked in a black box. The 
two fungi show an identity of 37.8%, which is increased to only 38.7% in the GTPase-like domain. 
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1.7 Model Organisms 
 
 
The majority of the ribosome biosynthesis research performed to date utilizes 
S. cerevisiae as a model eukaryote (Kressler et al, 2010). Thus, the research 
undertaken in this study also aims to use this yeast as a model organism. The 
ribosome biogenesis pathway in eukaryotes is well conserved, although some 
differences do exist (Freed et al, 2010; Henras et al, 2008). The majority of total S. 
cerevisiae proteins are known to have orthologs or homologs (58%) in the overall 
human proteome (Karathia et al, 2011). Protein alignments shown in Figures 1.4 and 
1.8 show that Nob1 and Dim2 are reasonably well conserved, especially in the 
functional domains (PIN and zinc ribbon domains, and KH domain respectively). 
Structures of the yeast proteins would also supplement the previously performed 
research with a substantial background of information available. 
The other organism chosen for studying the Nob1/Dim2 complex is 
Chaetomium thermophilum. This is a thermophilic fungus that has been found to 
survive in temperatures of up to 60˚C. Survival at such conditions implies that the 
proteins in the cell should be more stably folded. Thus, they make good candidates 
for structural studies. 73% of all known S. cerevisiae proteins have been found to 
have homologs in the C. thermophilum proteome (Amlacher et al, 2011). Nob1 and 
Dim2 are indeed well conserved as seen in the alignments in Figures 1.4 and 1.8. 
Finally, attempts were also made to use the human proteins, as these are 
useful for understanding the pathology of human disorders. 
 
 
1.8 Aims of Project 
 
 
 The general aim of the research presented in this thesis was to further the 
understanding of the late 20S processing in eukaryotic ribosome biosynthesis. There 
were two main questions that were investigated: how is the D site cleavage 
performed and what is the function of Tsr1 in the premature particle? 
To answer these questions, the goals were to characterise the interaction 
between two eukaryotic proteins needed for D site cleavage, Nob1 and Dim2, and 
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RNA; also, to structurally characterise Tsr1 to increase the understanding of this 
protein’s involvement in late 20S pre-rRNA maturation.  
In order to achieve the first goal, initially, the four components needed for the 
D site cleavage (i.e. Nob1, Dim2, Nob1 RNA binding site, and Dim2 RNA binding 
site/D site) were to be obtained. This was to include expression and purification of S. 
cerevisiae, C. thermophilum, and H. sapiens proteins and transcription of the RNA 
binding sites. Once the proteins were obtained, trials would be performed for Nob1-
Dim2 heterodimer in vitro reconstitution. These dimers and the individual proteins 
were then to undergo structural and biochemical characterisation with and without 
rRNA fragments. The effect of Dim2 on the Nob1-RNA interaction and on the D site 
cleavage was to be investigated. 
For the second goal, a crystallisable, soluble Tsr1 construct was to be 
designed. The yeast protein was to be purified and crystallised. Then, the crystals 
were to be optimised and the structure was to be solved using experimental phasing. 
The research presented in the next chapters shows the results of this 
investigation bringing some insight into the last steps of the small subunit 
maturation. 
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1.1 Preliminary Cloning 
 
 
 Preliminary cloning was performed by Iva Tchasovnikarova and Dr. Atlanta 
Cook. The original yeast Nob1 construct in the pSL6 plasmid was obtained from the 
Tollervey lab. Table 2.1 lists the clones already present prior to the start of this 
project. All the clones, including ones shown later, were tested for expression as 
described later. 
 
Table 2.1: List of cloning performed prior to the start of this project. 
Protein Organism Sequence Plasmids Tag 
Nob1 S. cerevisiae Full-length pSL6 His 
 S. cerevisiae 1-125 (PIN domain) pEC-KHC, pEC-KGC GST or His 
 S. cerevisiae 264-459 (Zn ribbon) pEC-KHC, pEC-KGC GST or His 
Dim2 S. cerevisiae Full-length (FL) pEC-KHC, pEC-KGC GST or His 
 S. cerevisiae ΔN91 pEC-KGC GST 
 
 
1.2 Conventional Cloning 
 
 
Table 2.2 contains a list of plasmids and inserts that were cloned using 
conventional cloning techniques. For this purpose, the gene of interest was amplified 
using PCR with primers containing designed restriction sites on each end. The 
engineered restriction sites can be also seen in Table 2.2. A list of all primers can be 
found in Appendix I while the PCR protocols are shown later, in standard laboratory 
procedures. Specific methods for the different clones can be seen below. 
 
Table 2.2: Constructs created using conventional cloning. 




Nob1 FL S. cerevisiae pET28α NcoI XhoI 
20S rRNA transcription 
sequences 
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1.2.1 ScNob1 cloning 
 
 The ScNob1 gene was amplified using the primers shown in Appendix I 
from a plasmid obtained from the Tollervey laboratory. The Phusion High Fidelity 
PCR Kit (NEB) was used for this purpose, according to manufacturer’s instructions 
for a 50 µl reaction volume. The contents of the reaction were loaded onto a 1% w/v 
agarose gel containing 1 x SYBR Safe DNA Stain (Invitrogen) and run at 80V for 30 
minutes. The band of the correct size (about 1377 bases) was excised and the gene 
was extracted using a Gel Extraction Kit (Qiagen). 
 The ScNob1 gene was then digested with NcoI and XhoI (NEB) in a 10 µl 
volume according to the manufacturer’s instructions (using 10 units of each enzyme 
and 7 µl of the extracted DNA). The enzymes were inactivated by incubation at 80˚C 
for 20 minutes. 150 ng of the pET28α plasmid were also digested with 10 units of 
these enzymes in a 10 µl reaction. Again, the enzymes were inactivated at 80˚C. 
Following digestion, the plasmid was separated on a 1 % w/v agarose gel and 
extracted from the gel, as described previously for the ScNob1 gene. 
 The gene and the plasmid were ligated using T4 DNA ligase (NEB) in a 10 µl 
reaction volume. The manufacturer’s instructions were followed. 2 µl of the gel 
purified vector and 6 µl of gene were used in the reaction. The mixture was 
incubated at room temperature for 30 minutes and transformed into XL-1 E. coli 
strain following a standard transformation protocol for chemically competent cells. 
Selection was performed based on kanamycin resistance.  
Four colonies were picked and grown overnight in 3 ml LB supplemented 
with kanamycin. The plasmid was then extracted using a MiniPrep kit (Qiagen). The 
plasmids were digested with 5 units XhoI and BamHI (an extra site in insert) (NEB) 
according to manufacturer’s instructions (using 3 µl of extracted DNA). Positive 
clones were sent for Sanger sequencing. All of the sequencing was performed by 
GenePool at the University of Edinburgh.  
During the course of this project, Dr. Atlanta Cook also created five ScNob1 
loop-out mutants in the pET28α plasmids. These are shown in Table 2.3. 
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Table 2.3: Loop-out clones created by Dr. Atlanta Cook 
Name Organism Plasmid Deletion 
Nob1∆L1 S. cerevisiae pET28α ∆151-159 
Nob1∆L2 S. cerevisiae pET28α ∆151-169 
Nob1∆L3  S. cerevisiae pET28α ∆151-176 
Nob1∆L4 S. cerevisiae pET28α ∆141-176 
Nob1∆L5 S. cerevisiae pET28α ∆141-159 
 
 
1.2.2 20S rRNA transcription sequence cloning (helix 40 and D site) 
 
Overlapping oligonucleotides were designed, ordered (IDT), and annealed 
prior to cloning to prevent self-annealing during further processing. The fragments 
were designed to prevent hairpin formation prior to cloning. The principle is shown 
in Figure 2.1. 
 
Figure 2.1: Cloning of transcription sequences for RNAs with secondary structures. 
The sequence of the RNA hairpin (purple) has to be cloned as a double stranded DNA (dsDNA in 
black). However, the secondary structure of the RNA would also form in each strand of the DNA. 
Thus, initially, multiple overlapping oligonucleotides (shown at the top in black, blue, and red) are 
annealed with the corresponding oligonucleotides on the other strand (i.e. black-to-black, etc.). Then, 
the three overlapping fragments are annealed to each other to give the full-length dsDNA. This was 
then cloned into the pUC19 plasmid (orange). 
 
 
Annealing reactions were performed in 10 µl containing 250 µM 
oligonucleotides and 1 x T4 polynucleotide kinase (PNK) buffer with ATP. These 
were heated to 90˚C for two minutes and placed directly on ice to remove secondary 
structures. 1 µl of T4 PNK (NEB) was added to each tube followed by incubation at 
37˚C for 1 hour. The enzyme was then inactivated at 70˚C for 20 minutes in a water 
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bath. The samples were slowly cooled to room temperature in the water bath 
overnight. The annealed oligonucleotides were then cloned into the pUC19 plasmid. 
 The pUC19 plasmid was cut with EcoRI and BamHI (NEB) and gel purified 
using a Gel Extraction Kit (Qiagen). Equal volumes of the annealed oligonucleotides 
for each construct were pre-mixed and diluted five-fold. For the ligation reaction, 2 
l of plasmid were mixed with 2 l of diluted mixed oligonucleotides, 1 l (400 
units) of T4 ligase and the T4 ligase buffer (NEB) in 10 l total volume. The 
reactions were incubated at room temperature for 30 minutes and then, transformed 
into XL-1 E. coli strain using a standard transformation protocol for chemically 
competent cells (3 µl of each reaction were used). The transformed cells were 
selected using ampicillin resistance. 
 The pUC19 plasmids were extracted from 4 or 5 colonies for each construct 
using the MiniPrep kit (Qiagen). These were then digested with 2 units KpnI and 
ZraI (NEB) to test for loss of the KpnI site upon ligation with the insert (using 3 µl 
of extracted DNA). Positive clones were sent for Sanger sequencing and then re-
transformed into XL-1 cells and extracted using a MaxiPrep kit (Qiagen) according 
to manufacturer’s instructions. 
 
 
1.3 Ligase-Independent Cloning (LIC) 
 
 
 The plasmids used can be seen in Appendix II. In order to prepare the 
plasmid, the GFP gene was excised using ZraI restriction enzyme (NEB). 2 µg of 
plasmid were incubated with 40 units of ZraI at 37˚C for 2 hours according to 
manufacturer’s instructions. The linearized plasmid was then separated from the GFP 
fragment on 1% w/v agarose containing 1 x SYBR Safe DNA Stain (Invitrogen) for 
visualization in blue light. The plasmid was extracted using a Gel Extraction kit 
(Qiagen) according to the manufacturer’s instructions. 
The gene was amplified from the yeast genome using primers shown in 
Appendix I. The primers were designed to contain sequences that overlap with the 
target plasmid where it was cleaved with ZraI. The amplified fragment was separated 
on a gel and gel-purified in the same manner as the plasmid. 
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An overlap of 17 bases was created using T4 DNA polymerase (Novagen) 
which exhibits an exonuclease (3 to 5) activity. The nuclease is usually balanced by 
the polymerase activity (when a nucleotide is removed, the polymerase adds it back). 
However, this relies on all the nucleotides being available in solution. When only 
one of the nucleotides is present, others preceding the available one will be removed 
as the polymerase will not be able to add them back (Aslanidis & Dejong, 1990). 
This principle is used to create a precise overlap. 
For the insert, 600 ng of DNA were incubated at room temperature for 30 
minutes with 1 x T4 DNA polymerase buffer, 5 mM DTT, 2.5 mM dATP, and 1 unit 
of T4 DNA polymerase in a 20 µl volume. Thus, the overlap was created until the 
first adenine was reached (as dATP was available, this nucleotide was added back 
each time by the polymerase activity). The plasmid was processed in the same 
manner but using 450 ng of DNA, dTTP (instead of dATP to create complementary 
overlaps) and 1.5 units of enzyme. The final volume for these reactions was 30 µl. 
After 30 minutes, the enzyme was inactivated by incubating the reactions at 75˚C for 
20 minutes. 
The annealing reactions were performed by mixing 2 µl of the insert and 1 µl 
of the plasmid. This mix was incubated at room temperature for 10 minutes. Then, 1 
µl of 25 mM EDTA was added and the mixture was incubated for a further 10 
minutes at room temperature. Finally, the annealed plasmid was transformed (2 µl) 
into XL-1 cells using standard laboratory procedures. The overlap was longer than 
normally created with restriction digests. Thus, the insert and vector can stick 
together through the transformation. The breaks are then repaired by host ligases. 
The positive clones were selected for on kanamycin or streptomycin-
containing plates. Single colonies were then picked; the plasmids were extracted and 
tested for the insert using restriction digests. Two clones for each construct were sent 
for Sanger sequencing. Table 2.4 lists all the constructs created this way. As a 
control for re-ligation without the insert, the same protocol was followed for the 
plasmid without adding the insert. 
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Table 2.4: Constructs created using LIC 
Insert Organism Plasmid 
Dim2ΔN91 S. cerevisiae pEC-KHC 
Dim2ΔN51 S. cerevisiae pEC-KHC 
Dim2ΔN61 S. cerevisiae pEC-KHC 
Dim2ΔN99 S. cerevisiae pEC-KHC 
Dim2 FL S. cerevisiae pEC-SHT 
Dim2 FL S. cerevisiae pEC-SGT 
Dim2∆N31 H. sapiens pEC-KHC 
Dim2∆N42 H. sapiens pEC-KHC 
Nob1 FL H. sapiens pEC-KHC 
Nob1 D10N H. sapiens pEC-KHC 
 
 
1.4 Gibson Assembly Cloning 
 
 
 The gene inserts were amplified or (in the case of the tRNA/D site construct) 
ordered from NEB. The appropriate plasmid was amplified as well (primers shown 
in Appendix I). Standard PCR protocol was followed as for the other types of 
cloning. The inserts and plasmids were then separated on a 1% w/v agarose gel and 
extracted using a Gel Extraction kit (Qiagen). 
 The annealing reactions were performed in a 20 µl final volume. The 
amounts of DNA for both, the insert and the plasmid, were between 0.02 and 0.5 
pmol with a 3-fold excess of the shorter fragment (i.e. the insert). This DNA mixture 
was incubated with 10 µl of the Gibson Assembly Master Mix (NEB). The reactions 
were made up to 20 µl using deionized water. Finally, the reactions were incubated 
at 50˚C for 1 hour. 
 The control reaction contained the same reagents apart from the insert, testing 
for any re-ligation of the plasmid. 2 µl of each of the reactions, including the control, 
were transformed into chemically competent XL-1 cells. Positive clones were 
selected using antibiotic resistance (ampicillin for pUC19 and kanamycin for 
pET28α). As with the other methods, several colonies were picked and grown up. 
The plasmids were extracted and tested using restriction digestion for the presence of 
the insert. Finally, two clones from each construct were sent for Sanger sequencing.  
Successful constructs are listed in Table 2.5. 
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Table 2.5: Constructs created using Gibson assembly. 
Insert Organism Plasmid 
tRNA/D site RNA sequence S. cerevisiae pUC19 
Nob1 FL H. sapiens pET28α 
Nob1 D10N H. sapiens pET28α 
 
 
1.5 Expression Trials 
 
 
The lysis buffer formulations used for the pull-downs of tagged proteins were 
as follows: 
For Ni-NTA resin: 
20 mM Tris-HCl pH8.0 at 4ºC 
150 mM NaCl 
0.5 mM β-mercaptoethanol 
10 mM imidazole 
For GSH resin: 
20 mM Tris-HCl pH 7.5 at 4ºC 
200 mM NaCl 
1 mM DTT 
 
 After cloning, each of the constructs was subjected to small-scale expression 
trials. For this purpose, 25 ml of medium were inoculated with a swab of a plate 
containing cells transformed with the plasmid. Different strains were tested, typically 
four out of: BL21 (DE3), BL21 (DE3) pRIPL, BL21 (DE3) pLysS, T7 Express, and 
B834 (DE3). Initially, trials were performed in 2xTY and Superbroth media. 
However, 2xTY showed consistently better expression and was then used for further 
trials. 
 The inoculated culture was grown at 37˚C until an OD of 0.6-1.0 was 
reached. The cells were then cooled to 18˚C for one hour. A 1 ml fraction of the cells 
was then taken as the uninduced fraction. These cells were spun down at 13,000 rpm 
for 10 minutes. The supernatant was removed and 50 µl of sample buffer (100 mM 
Tris-HCl at pH 6.8, 10% v/v β-mercaptoethanol, 4% v/v SDS, 0.2% w/v 
bromophenol blue, 20% v/v glycerol) per 1.0 unit of OD were added to the pellet and 
U. McCaughan  Chapter 2: Materials and Methods 
 29 
the cells were heated to 95˚C for 5 minutes. This fraction was stored at -20˚C until 
needed. 
 The rest of the culture was induced by addition of 0.2 mM IPTG and 
incubation at 18˚C overnight with shaking (250 rpm). The next day, the OD was 
measured and another 1 ml fraction was taken as the induced fraction. This was 
treated in the same way as the uninduced one. The rest of the culture was placed in a 
50 ml Falcon tube and spun down at 4000 rpm for 10 minutes. The pellet was 
weighed and frozen at -20˚C until needed. 
 For the pull-down, an appropriate amount of lysis buffer was added to 
normalise for the cell mass (at least 2 ml) and the pellet was resuspended by 
vortexing. The cells were lysed by sonication using a Soniprep 150 sonicator (MSE) 
at 10 microns for 3 minutes (10 seconds on and 5 seconds off). 2 ml of the sonicated 
sample was centrifuged at 13,000 rpm for 10 minutes. The supernatant was placed in 
a new tube. 2 µl of the supernatant were added to 10 µl of sample buffer as the 
soluble fraction. 100 µl of sample buffer were added to the pellet making the 
insoluble fractions. Both of these were heated to 95˚C for 5 minutes and stored at -
20˚C until needed. 
 The rest of the lysate was incubated for 1 hour at 4˚C (with shaking) with the 
appropriate resin for affinity binding of the protein of interest. Then, the beads were 
spun down at 7,000 rpm for 1 minute. They were washed 3 times with lysis buffer. 
The buffer was then removed and 30 µl of sample buffer was added to give the bead-
bound fraction. It was heated to 95˚C and stored at -20˚C until needed. 
 All 5 fractions were loaded onto a denaturing polyacrylamide gel and 
separated by SDS-PAGE to show if the protein is expressed and if it is soluble. The 
gels were stained with Coomassie to visualise the proteins. 
 
 
1.6 Fungal Protein Expression and Purification  
 
 
1.6.1 ScNob1 – full-length 
 
 ScNob1 was expressed as a C-terminal hexahistidine fusion in the pET28α 
vector in the BL21 (DE3) E. coli strain (selection using kanamycin resistance). Later, 
it was also expressed in a pSL6 vector (also C-terminal hexahistidine fusion) in 
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StabyCodon SE1 (Eurogentec) E. coli strain (selection using ampicillin resistance) 
provided by the Tollervey lab. The cells were grown in 2xTY medium at 37˚C until 
OD of 0.6-1.0 was reached. They were then induced overnight with 0.2 mM IPTG at 
18˚C. The culture was then harvested by centrifugation at 4500 rpm for 15 minutes. 
The pellet was flash frozen in liquid nitrogen until needed. 
 The cells harvested from 2 or 4 litres of culture were lysed in 50 ml of lysis 
buffer supplemented with protease inhibitors (1 ml of 100 mM AEBSF (Fluka) and 
an EDTA-free protease inhibitor tablet (Roche)) and 0.5 ml of 1mg/ml DNase 
(Sigma) in a Constant Systems Cell Disruptor (Constant Systems Limited) according 
to manufacturer’s instructions. The lysis buffer consisted of 50 ml of 20 mM Tris-
HCl (pH 8.0 at 4C), 20 mM imidazole, 500 mM NaCl, 10% v/v glycerol, and 1 mM 
-mercaptoethanol. The cleared lysate was collected by centrifugation at 50,000 g 
for 45 minutes and filtered (0.22 µm filter) prior to purification. All of the above 
steps were the same for all purification protocols although the buffers did change as 
described in the individual circumstances. 
 The cleared lysate was then loaded onto a His-Trap HP 5 ml column (GE 
Healthcare) on an AKTA purifier liquid chromatography system (GE Healthcare) 
pre-equilibrated with the lysis buffer. Absorbance at 280 and 260 nm was measured 
when possible. ScNob1 was eluted with a gradient of imidazole (up to 500 mM over 
100 ml). 2 ml fractions were collected over the gradient. Fractions showing peaks in 
absorbance at 280 nm were examined using SDS-PAGE. Those that contained 
ScNob1 were pooled and loaded onto a HiPrep 26/10 Desalting column (GE-
Healthcare) on the AKTA purifier. The protein was eluted into 20 mM Tris-HCl (pH 
7.5 at 4C), 100 mM NaCl, 10% v/v glycerol, and 1 mM DTT. Fractions displaying 
an absorbance peak at 280 nm were pooled. The same results were obtained when 
the desalting column was replaced with overnight dialysis into the same buffer. 
 Next, the protein sample was loaded onto a manually packed heparin 
sepharose column (GE Healthcare) on an AKTAprime plus system (GE Healthcare). 
It was eluted with a salt gradient (up to 1000 mM). Fractions showing a peak in 
absorbance at 280 nm were, again, examined using SDS-PAGE. ScNob1-containing 
fractions were pooled and concentrated to about 2 ml using a Vivaspin 20 
concentrator (10 kDa cut-off) (Satorius Stedim Biotech). 
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 Finally, the sample was loaded onto a pre-equilibrated (20 mM Tris-HCl pH 
8.0 at 4C, 150 mM NaCl, 5% v/v glycerol, and 1 mM DTT) HiPrep 16/60 S200 HR 
size exclusion chromatography (SEC) column (GE Healthcare) on the AKTA 
purifier system. Fractions encompassing the peak in absorbance at 280 nm were 
examined using SDS-PAGE and pooled. The pure ScNob1 protein was, again, 
concentrated using the Vivaspin 20 concentrator to give a final concentration of 
about 8-10 mg/ml protein. The protein was supplemented with 30% v/v glycerol, 
flash-frozen in liquid nitrogen, and stored at -80˚C. 
 The protocol was adapted to include a cation exchange step: a Mono S 5/50 
GL column (GE Healthcare) or a manually packed SP Sepharose (GE Healthcare) 
column with a higher binding capacity, instead of the heparin step. The HiPrep SEC 
column was replaced with a HiLoad Superdex 200 16/60 column (GE Healthcare). In 
all the following purification protocols, the fractions showing peaks on the 
chromatograms were examined with SDS-PAGE after every purification step. 
 
1.6.2 ScNob1 D15N – Catalytically inactive mutant 
 
 Expression was performed using a construct obtained from the Tollervey lab 
in the same manner as for the wild-type protein. Initially, the lysis was also 
performed in the same manner and in the same buffer. Later, the Tris-HCl 
concentration was raised to 40 mM and a 5-minute sonication step (cycles of 10 
seconds on followed by 5 seconds off) was added after cell disruption to remove 
aggregates. This was performed in a Soniprep 150 sonicator (MSE) at 10 microns.  
The first step of purification was performed in-batch on Nickel resin (GE 
Healthcare). For this purpose, the beads were incubated with the cleared lysate on a 
spinning wheel for 1 hour at 4˚C. An XK 16/20 column (GE Healthcare) was then 
manually packed and connected to an AKTAprime (GE Healthcare) system. The 
protein was eluted in the same manner as the other construct on the pre-packed 
column. 
 The mutant ScNob1 was then dialysed overnight into 20 mM HEPES pH 7.5, 
150 mM NaCl, 5% v/v glycerol, and 1 mM -mercaptoethanol. DTT was not used in 
the buffers as it can chelate metals, such as zinc, which might be required for RNA 
binding via the zinc ribbon domain of Nob1 (Krezel et al, 2001). The sample was 
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injected onto a pre-equilibrated, Resource S column (GE Healthcare). This was later 
changed to a manually packed SP Sepharose (GE Healthcare) column with a higher 
binding capacity. The flowthrough was washed out and ScNob1 D15N was eluted in 
a 100 ml gradient of dialysis buffer supplemented with 1000 mM NaCl. The 
fractions showing a peak on the 280 nm absorbance spectrum were analysed by 
SDS-PAGE. Fractions containing the protein of interest were pooled and 
concentrated to a volume of 2 ml. 
 Next, the sample was injected onto a pre-equilibrated (20 mM HEPES pH 
7.5, 150 mM KCl, 5% v/v glycerol, and 1 mM -mercaptoethanol) HiLoad Superdex 
200 16/60 column (GE Healthcare) column. Again, the fractions obtained were 
examined by SDS-PAGE. The protein was pooled and concentrated to about 2 
mg/ml. Later, the wild-type protein was purified in the same manner to allow easier 
comparisons. 
 
1.6.3 ScNob1 – loop-out mutants 
 
Initially, ScNob1∆L3 and ∆L4 were purified. The same protocol as for the 
D15N mutant was used with the exception that the Resource S column was replaced 
with a Resource Q anion exchange column (GE Healthcare). This change was 
necessary as the removed portion of the protein was highly charged and its deletion 
significantly changed the pI of the constructs. All the buffers were the same. 
Then, with the help of a summer intern (Michal Merdas), the other three 
mutants were also purified using the same protocol. 
 
1.6.4 ScDim2 – full-length and different constructs 
 
 Purification of several different constructs was performed. Table 2.6 
summarises how far each of the protocols was taken and what methods were used.  
 For each of the protocols, the cells were lysed as previously described for 
ScNob1. The lysis buffer consisted of the respective buffer A for the first step of 
purification supplemented with protease inhibitors and DNase as with ScNob1. All 
initial affinity steps were performed in-batch and the columns were packed manually 
prior to connecting them to the AKTAprime system (GE Healthcare). In order to 
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achieve binding, the beads were washed with lysis buffer and then incubated with the 
cleared lysate for at least 1 hour at 4˚C. 
 







Dim2ΔN91 GSH resin  - - 
Dim2 FL GSH resin Mono S / 
Mono Q 
- 
Dim2 FL and 
ScNob1 co-lysis 
GSH resin - - 
Dim2 FL Ni
2+
 NTA - - 
Dim2ΔN51 Ni
2+
 NTA Mono S SEC 
 
 
For the purification of Dim2∆N51 see HsDim2 protocol later. All other 
constructs were purified as follows. For GSH affinity purification, the buffer (A) 
used consisted of 20 mM Tris-HCl (pH 7.5 at 4˚C), 500 mM NaCl, and 1 mM DTT 
and the protein was eluted with 20 mM reduced GSH. For the purification of full-
length His-tagged protein, buffer A consisted of 20 mM Tris-HCl (pH 7.5 at 4˚C), 
500 mM NaCl, 20 mM imidazole, and 1 mM -mercaptoethanol. The bound protein 
was eluted with a gradient of 20-500 mM imidazole over 100 ml.  
 After the affinity step, the respective tags were cleaved overnight using 0.5 
mg of 3C protease during dialysis into low salt buffer. This buffer consisted of 20 
mM Tris-HCl (pH 7.5 at 4˚C), 50 mM NaCl, and 1 mM DTT. 
 The full-length protein purification was then extended into an ion exchange 
step. For the GST-tagged version, a Mono S column was used initially. However, a 
very small amount of the protein bound. Therefore, the Mono Q anion exchange 
column was also used. The protein was eluted with a 100 ml gradient going up to 
1000 mM NaCl. The ScDim2 protein had a lot of RNA contamination so this was not 
continued.  
The His-tagged protein purified was subjected to nuclease digestion to 
remove the RNA. The dialysed protein was supplemented with MnSO4 to a final 
concentration of 6 mM and 10 units of Cyanase nuclease (RiboSolutions, Inc.). 20 µl 
fractions were taken every 30 minutes for 3 hours. The RNA was digested but the 
protein precipitated. Therefore, the purification was discontinued. 
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1.6.5 CtNob1 – full-length 
 
 The expression pRSET-A plasmid containing the CtNob1 gene (Appendix 
III) was ordered as a codon optimized construct from GeneArt. The protein was 
expressed in chemically- or electro-competent BL21 (DE3) cells in 2xTY medium. 
The cells were grown to OD 0.6-1.0 at 37˚C and then cooled to 18˚C for one hour. 
Induction was carried out with 0.2 mM IPTG overnight. 4 litres of culture were used 
for purification. 
The initial protocol was identical to the ScNob1 protocol. Over time this was 
developed to include an anion exchange step (Mono Q 5/50 GL column, GE 
Healthcare). The dialysis buffer contained 50 mM salt but was otherwise the same. 
The HiLoad Superdex 200 16/60 column (GE Healthcare) was used for size 
exclusion chromatography. 
 
1.6.6 CtDim2 – full-length 
 
 As with the CtNob1 plasmid, the construct was ordered from GeneArt 
(Appendix III). Expression trials were performed; however, little or no expression 
was seen in BL21 (DE3), BL21 (DE3) pRIPL, T7 Express, and B834 (DE3) cell 
strains. 
 
1.6.7 ScTsr1 – loop-out constructs 
 
Dr. Uma Jayachandran performed the initial expression and purification of 
the constructs. Once crystals were obtained, the established protocols were used to 
make seleno-methionine labelled protein. For this purpose, the expression plasmid 
containing ScTsr1∆N46∆410-476 was transformed into the B834 (DE3) expression 
cell line. The cells were plated and incubated at 37˚C overnight to obtain colonies. 
The next morning, the colonies were picked and placed in growth media 
supplemented with seleno-methionine. The medium consisted of 2 x M9 medium 
(37.4 mM NH4Cl, 44.1 mM KH2PO4, and 95.8 mM anhydrous Na2HPO4) 
supplemented with 0.4% w/v glucose, 40 µg/ml amino acids (with seleno-L-
methionine instead of methionine), and 1 µg/ml vitamins (riboflavin, niacinamide, 
pyridoxine monohydrochloride, and thiamine). Two litres were grown up to OD 0.6-
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1.0 at 37˚C, cooled to 18˚C, and induced overnight with 0.2 mM IPTG. The pellets 
were then spun down and kept at -80˚C as described for other proteins. 
Cell disruption was performed as described previously. The initial Ni-NTA 
affinity purification step was performed in-batch as described for ScNob1 D15N 
purification. Fractions containing the protein were pooled, mixed with 0.5 mg 3C 
protease, and dialysed into 20 mM Tris pH 8.0 at 4˚C, 600 mM NaCl, 5% v/v 
glycerol, and 1 mM DTT overnight. The protein was then concentrated to 2 ml and 
injected onto a HiLoad Superdex 16/60 S200 column (GE Healthcare) pre-
equilibrated in 20 mM Tris pH 8.0 at 4˚C, 800 mM NaCl, 5% v/v glycerol, and 1 
mM DTT. 
Fractions containing the protein were separated on 15% SDS-PAGE and 
analysed. The fractions not overlapping with 3C protease were pooled and 
concentrated to 10 mg/ml. The protein was divided into 25 µl fractions, flash-frozen 
in liquid nitrogen, and stored at -80˚C until needed. 
 
1.6.8 ScFap7 and ScDim1 
 
ScFap7 was purified by Dr. Uma Jayachandran while Dim1 was purified by 




1.7 Human Protein Expression and Purification 
 
 
 The sequences for the human proteins were obtained from the laboratory of 
Dr. Nick Watkins at the University of Newcastle. The constructs obtained in this 
manner are: HsDim2-FL in pGEX-6P-1 plasmid (GST-tagged) and HsNob1-FL in 
pET100 (His-tagged). These were supplied along with expression protocols and a 
one-step purification protocol used routinely in Dr. Watkins’ laboratory. Details of 
the purification methods are listed below. The HsDim2 construct used for expression 
and purification was not altered. HsNob1 was re-cloned into different vectors for 
easier tag cleavage or to eliminate degradation products. The clones are listed earlier 
in the methods section.  
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1.7.1 HsDim2 – full-length 
 
 The protocol provided by the Watkins lab established the first step of 
purification. BL21 (DE3) cells were grown, induced, harvested, and lysed as 
described for the yeast Nob1. The lysis buffer consisted of 20 mM Tris-HCl (pH 8.0 
at 4C), 300 mM KCl, 10% v/v glycerol, 0.1% v/v Tween20, and 1 mM DTT (GSH 
Buffer A). As previously, it was supplemented with the protease inhibitors and 
DNase. The cleared lysate was bound in batch to GSH resin (GE Healthcare) at 4˚C 
with mixing for two hours. The resin was then spun down at 500 x g for 5 minutes. 
The supernatant was removed and the resin was washed three times with 50 ml of 
lysis buffer (each time it was spun down and the supernatant was removed). 
Then, the GST-tagged HsDim2 was eluted using the above buffer 
supplemented with 50 mM reduced glutathione as recommended by the Watkins lab. 
10 ml of this buffer were added to the resin. The mixture was incubated at 4˚C for 10 
minutes with shaking. Then, the sample was spun down as before and the 
supernatant removed. This was repeated four more times to give five elution 
fractions. These samples were separated on a 12.5% SDS-PAGE gel. Fractions 
containing HsDim2 were pooled and dialysed overnight into Mono S Buffer A (20 
mM HEPES (pH 7.5), 100 mM KCl, 10% v/v glycerol, and 1 mM DTT) in the 
presence of 0.5 mg 3C protease. 
 The dialysed protein was loaded onto a Mono S 5/50 GL column (GE 
Healthcare) and eluted with a gradient of Mono S Buffer B (i.e. Mono S Buffer A 
containing 1000 mM KCl). The gradient lasted 100 ml. The fractions containing the 
resulting peak and surrounding regions were examined on a 12.5% SDS-PAGE gel. 
The appropriate fractions were pooled and concentrated to less than 2.5 ml using the 
Vivaspin 20 (10 kDa cut-off) (Satorius stedim biotech) concentrator for injection 
onto a HiLoad Superdex 200 16/60 SEC column (GE Healthcare).  
 The SEC was carried out in the following buffer: 20 mM Tris-HCl (pH 7.5 at 
4˚C), 150 mM KCl, 5 % v/v glycerol, and 1 mM DTT. A single peak was obtained 
and examined on a 12.5% denaturing gel. The fractions containing HsDim2 were 
pooled and concentrated to give a final concentration of 8.0-10.0 mg/ml. Protein to 
be used within a week was stored at 4˚C while long-term storage was carried out at -
80˚C in 30% v/v glycerol. 
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 His-tagged ScDim2∆N51 was then purified in the same manner with the 
exception that nickel resin in-batch purification (as described earlier for ScNob1 
D15N) was used as the first step. The lysis buffer consisted of 20 mM Tris-HCl (pH 
8.0 at 4C), 300 mM KCl, 20 mM imidazole, 10% v/v glycerol, 0.1% v/v Tween20, 
and 1 mM -mercaptoethanol. The protein was eluted with a 100 ml gradient of 
imidazole reaching 500 mM. The following steps and buffers were the same as for 
the human protein. 
 
1.7.2 HsDim2 – proteolysed fragment 
 
 A truncated version of HsDim2 was purified following preparative 
proteolysis using GluC (Sigma) as the protease. The expression, lysis, and first two 
steps (GSH affinity and ion exchange) of purification were performed as for the full-
length protein. Then, the protein was concentrated to 1.25 ml (3.8 mg) and mixed 
with GluC (0.005 mg GluC per 1 mg of HsDim2) and 400 µl of 20 mM HEPES pH 
7.5, 50 mM NaCl, and 10 mM MgSO4. This was incubated overnight at 4˚C. These 
conditions were established following small-scale limited proteolysis (see standard 
laboratory protocols). The next morning, 110 µl of 100 mM AEBSF protease 
inhibitor (Fluka) was added to the reactions. The sample was immediately injected 
onto a SEC column as for the full-length protein. 
 Two major species were obtained seen as a double peak on the SEC profile. 
These were concentrated separately and used for crystallisation screens.  
 
1.7.3 HsNob1 – full-length 
 
 The human Nob1 was re-cloned into a pEC-KHC plasmid as described 
previously, to allow for easier tag cleavage with the 3C protease. The expression was 
performed in 2xTY medium in BL21 (DE3) cells. The pelleted cells were lysed as 
for the yeast protein. The buffers for the lysis and the first step of purification (nickel 
affinity) were the same as for ScNob1. The protein was bound to the resin in-batch. 
The cleared lysate was incubated with 20 ml nickel affinity resin (GE Healthcare) at 
4˚C for at least 1 hour with mixing. The beads were then spun down and manually 
packed into a XK 16/20 column (GE Healthcare). The eluted HsNob1 was dialysed 
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into 20 mM Tris-HCl (pH 8.0 at 4˚C), 100 mM NaCl, and 1 mM DTT overnight in 
the presence of 0.5 mg of 3C protease to allow tag cleavage. 
 The protein was then subjected to Mono Q anion exchange purification where 
it was eluted off the column with a 100 ml gradient reaching 1000 mM NaCl. The 
protein was found to bind to the column but further purification with this construct 
was not performed due to the presence of degradation products. 
 To prevent the binding of degraded protein to the nickel column, the human 
Nob1 gene sequence was cloned into a pET28α vector to contain a non-cleavable C-
terminal His-tag. The plasmid was transformed into BL21 (DE3) cells and grown up, 
harvested, and lysed in the same manner as previous clones used for purification. 
The binding to the nickel resin and the packing of the column were performed the 
same as for the above construct. 
 The column was attached to an AKTAprime system. The unbound protein 
was washed out and the column was washed with 50 ml lysis buffer supplemented 
with 2 mM ATP and 10 mM MgSO4 to remove any chaperone proteins. The bound 
HsNob1 was then eluted using a 100 ml imidazole gradient going up to 500 mM, as 
for the yeast protein. The column was run at 2 ml/min and 2-5 ml fractions were 
collected. The fractions containing the peaks at 280 nm were separated on a 12.5% 
denaturing SDS/acrylamide gel and fractions containing the HsNob1 were pooled 
and dialysed overnight into 20 mM Tris-HCl at pH 8.0 (at 4˚C), 100 mM NaCl, 10% 
v/v glycerol, and 1 mM DTT. 
 Next the protein was injected onto a pre-equilibrated Mono Q 5/50 GL 
column (GE Healthcare) and eluted as described for the previous proteins. Finally, 
the HsNob1 was concentrated to less than 250 µl and injected onto a HiLoad 
Superdex 200 10/30 column (GE Healthcare) pre-equilibrated in 20 mM Tris-HCl 
pH 7.5 (at 4˚C), 150 mM NaCl, 5% v/v glycerol, and 1 mM DTT. The rest of the 
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1.8 rRNA In Vitro Transcription 
 
 
 In vitro transcription was either performed using the MEGAshortscript kit 
(Ambion) or the T7 polymerase purified in the lab. The details for each of the RNAs 
can be found in the following sections. 
 
1.8.1 Expression and Purification of T7 polymerase 
 
 The His-tagged T7 Polymerase has been previously cloned into an M3 
plasmid and was expressed in Superbroth medium (supplemented with Kanamycin 
and Ampicillin) in M15 cells as described for ScNob1. It was purified using a two-
step protocol: cobalt affinity column followed by a hydroxyapatite (ion exchange) 
step, as previously established (Arts et al, 1997). 
Cell lysis was performed in the same way as for the other proteins described. 
The lysis buffer consisted of 20 mM Tris-HCl (pH 8.0 at 4˚C), 500 mM NaCl, 5 mM 
imidazole, and 1 mM -mercaptoethanol supplemented with DNase and protease 
inhibitors as for the other proteins. The cobalt affinity purification was performed in 
batch using cobalt affinity resin (Sigma). An XK 16/20 column (GE Healthcare) was 
manually packed and attached to the AKTAprime system as described previously. 
The protein was eluted with a 100 ml gradient of imidazole (going up to 500 mM). 
The fractions containing the T7 polymerase were pooled and dialysed into 
hydroxyapatite buffer A (20 mM potassium phosphate buffer at pH 7.5, 50 mM KCl, 
0.3 mM CaCl2, and 3 mM -mercaptoethanol). 
The dialysed protein was filtered to remove any precipitate and injected onto 
a manually packed, pre-equilibrated hydroxyapatite column. The protein was eluted 
with a 100 ml gradient up to 7.5% w/v ammonium sulphate. To remove the salts, the 
T7 polymerase was dialysed again into 20 mM potassium phosphate buffer at pH 
7.5, 150 mM NaCl, and 1 mM DTT. It was then concentrated to 10 mg/ml. A final 
concentration of 50% v/v glycerol was added (to give a T7 polymerase concentration 
of 5 mg/ml) and 1 ml aliquots were frozen in liquid nitrogen and stored at -80˚C until 
needed. 
The activity of the polymerase was tested on a small scale using the same 
protocol as was given by the manufacturer for the MEGAshortscript kit (Ambion). 
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However, all reagents were made in the lab, including the nucleotide solutions and 
the 10 x transcription buffer (400 mM Tris-HCl pH 8.0, 500 mM MgCl2, 10 mM 
spermidine, 0.1% v/v Triton, and 50 mM DTT). 
 
1.8.2 Helix 40 – Small Scale 
 
 The ScNob1 interaction with the 20S rRNA has been previously mapped, 
using crosslinking (Granneman et al, 2010), to a single loop (helix 40). To 
investigate this, three sequences encompassing this loop were transcribed in vitro 
(shown in chapter 4). For this purpose, the sequences were cloned into the pUC19 
plasmid as described earlier. 
 For in vitro transcription, 500 µl of each of the three plasmids were linearized 
using 100 units of SmaI (NEB) overnight in an 800 µl reaction. Linearization was 
tested on a 1% w/v agarose gel where the bands were visualized with SYBR Safe 
Stain (Invitrogen). The linear plasmids were extracted using a standard phenol 
extraction protocol. 
 Test in vitro transcriptions were performed using the MEGAshortscript kit 
(Ambion) in 20 µl reactions using 25 nM of the templates according to 
manufacturer’s instructions. This was then scaled up to 80 µl reactions. 3 µl of the 
reaction contents were examined on a 12% denaturing urea/acrylamide gel (20 x 20 
cm, 0.75 cm thick acrylamide, 1 x TBE, 7 M Urea), which was run at 20W for 30 
minutes. The gel was stained in a 1 x SYBR Safe Stain (Invitrogen) solution for 5 
minutes for visualization. The rest of the RNA was extracted using a standard phenol 
extraction protocol. 
 
1.8.3 D site – Small scale 
 
Several D site sequences were designed, as shown in chapter 4. Some were 
transcribed from oligonucleotides while others from plasmids (see Appendix IV). 
For transcription from oligonucleotides, the two complementary strands were 
ordered from IDT and annealed overnight. This was achieved by mixing equimolar 
amounts and placing them for 10 minutes in a beaker containing water heated to 
95˚C. The heat was then switched off and the samples and beaker were allowed to 
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cool to room temperature overnight. For transcription from a pUC19 plasmid, 
linearization of the DNA was performed as described for Helix 40 RNAs. 
 In vitro transcription was performed using T7 polymerase purified in the lab. 
Each transcription reaction contained 0.5-5 µM template, 25 mM nucleotides, and 5 
µg of polymerase in 20 µl of buffer (40 mM Tris-HCl pH 8.0, 50 mM MgCl2, 1 mM 
spermidine, 0.01% v/v Triton, and 5 mM DTT). The reactions were mixed at room 
temperature and incubated at 37˚C for 3 hours. Often, the concentration of the 
template had to be optimised. 
 To end the reaction, 1 µl of TURBO DNase (Ambion) was added and the 
tubes were incubated at 37˚C for a further 1 hour. The RNA was then analysed by 
denaturing urea/acrylamide gel electrophoresis (acrylamide, 1 x TBE, 7 M Urea) on 
a 12-16% gel. The 20 x 20 cm gel was run at 20 W in 1 x TBE for 45 minutes. 
 The transcription was scaled up accordingly. When required, the RNA was 
gel purified as described for the radioactive labelling protocol in the EMSA section 
of the methods. 
 
1.8.4 D site – Large scale and Purification 
 
 For large-scale transcription, the above protocol was proportionally scaled 
up. For the yeast D site with the short hairpin, 1.25 µM template was used. The rest 
of the reagents were the same, but in a 5 ml volume in a 50 ml Falcon tube. Again, 
the reaction was incubated at 37˚C for 3 hours. The tube was then spun down at 
4,000 rpm at room temperature to remove the precipitated inorganic phosphate. The 
supernatant was filtered with a 0.22 µm filter prior to injection onto a pre-
equilibrated (20 mM HEPES pH 7.5, 150 mM KCl, 5% v/v glycerol, 5 mM MgCl2, 
and 1 mM DTT) HiLoad Superdex S200 16/60 SEC column. The column was run at 
1 ml/min for 1.5 column volumes and 1 ml fractions were collected. This removed 
the spermidine from the sample. 
 The fractions were analysed on a 16% denaturing gel and the ones containing 
the right fragment were pooled. Further purification was achieved using anion 
exchange (Mini Q column, GE Healthcare). The column was pre-equilibrated with 
20 mM HEPES pH 7.5, 150 mM KCl, and 5 mM MgCl2. A small injection of 100 µl 
of RNA was used to establish the best elution conditions (column was run at 0.5 
U. McCaughan  Chapter 2: Materials and Methods 
 42 
ml/min, and 0.25 ml fractions were collected). Initially, the RNA was eluted with a 
20 column volume linear gradient going up to 1000 mM KCl. Absorbance at 260 and 
280 nm was measured during the runs. 
 The optimised elution protocol consisted of binding at 150 mM KCl followed 
by a wash at 350 mM KCl for 3 column volumes. Then, there was a 4-column 
volume gradient from 350 to 450 mM KCl. A wash at 450 mM salt was carried out 
for 3 column volumes. Finally, a gradient from 450 to 700 mM KCl was used to 
elute the last of the RNA over 4 column volumes. To clean the column, a final 1 
column volume of 1000 mM salt was used. The different peaks were examined on a 
16% denaturing gel and pooled separately. Peak 3 was then used for purification of 
the complex (see later). 
 
 
1.9 Primer Extension to Determine rRNA Secondary Structure 
 
 
 In order to determine the fold of the helix 40 in vitro transcribed sequences, 
longer versions were created to enable primer binding. The same protocol as 
described earlier was followed except that the plasmids were linearized with HindIII 
to add an extension. A primer was designed to bind to this extension on the created 
RNA (AGCTTGCATGCCTGC). The primer was labelled with radioactive (
32
P) γ-
ATP. For this purpose, 2.5 µM primer was incubated at 37˚C for 1 hour in the 
presence of 20 units PNK (NEB), 1 x PNK buffer, 10 mM DTT, and 10 uCi 
32
P-ATP 
in a final volume of 20 µl. Then, 30 µl of sterile water were added and the sample 
was spun through a ProbeQuant G-50 Mini column (GE Healthcare). 
 The RNA was diluted (2 µg in 100 µl) in 50 mM Tris-HCl pH8.0, 150 mM 
NaCl, 1.5 mM MgCl2. It was refolded by heating to 65˚C for 10 minutes in a heating 
block and then cooling to room temperature. 15 mM 1-methyl-7-nitroisatoic 
anhydride (1M7) was added to each of the RNA samples and mixed. 1M7 modifies 
the unpaired bases. The nucleic acids were then extracted with a standard 
phenol/chloroform extraction followed by a chloroform extraction and ethanol 
precipitation. The extraction was also performed for control samples, which were set 
up in the same manner but were not refolded or treated with 1M7. These would show 
natural transcription stop points. 
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 The primer (1 pmol) was mixed with the extracted RNA (15 ng) in a 2.75 µl 
volume. This was heated to 85˚C for 3 minutes. Then, 0.5 mM dNTPs, 1 x reverse 
transcriptase buffer, 5 mM DTT, 10 units of RNasin, and 50 units Superscript III 
Reverse Transcriptase (Invitrogen) were added to make up the reaction volume to 5 
µl. This was incubated at 50˚C for 50 minutes to allow primer extension. The 
reactions were stopped by addition of 5 µl of formaldehyde loading dye. The same 
protocol was followed for the control reactions. The transcription should stop more 
frequently before bases modified with 1M7. 
 Sequencing ladders for each transcript were also prepared. 5 µg of plasmid 
DNA were mixed with 0.2 M NaOH and 0.2 mM EDTA. This was incubated at 37˚C 
for 30 minutes. The plasmids were then ethanol precipitated and resuspended in 35 
µl of sterile water. 7 µl of each plasmid were mixed with 1 pmol of the radiolabelled 
primer and 1 x Sequenase buffer. The reactions were incubated at 65˚C for 10 
minutes and allowed to cool to 10˚C in a heating block. 7 mM DTT, 0.4 µl of 
labelling mix, and 26 units Sequenase (Affymetrix) were added to give a final 
volume of 15 µl. Finally, 3.5 µl of these reactions were added to 2.5 µl of each of 4 
termination mixtures that were pre-heated to 37˚C. This was incubated at 37˚C for 10 
minutes and stopped by adding 4 µl of stop solution, as suggested by the 
manufacturer. 
 The primer extension reactions and corresponding ladders were separated on 
a 6% denaturing gel. They were first heated to 95˚C for 2 minutes and then chilled 
on ice. The gel was run at 30W for about 1.5-2 hours. The gel was dried and exposed 
to a phosphor-screen overnight. The screen was then scanned using Fuji BAS-5000 
phosphoimager. 
 An attempt was made to see if ScNob1 could protect the RNA from 
modification by binding to the unpaired regions. For this purpose, after the refolding 
step, the RNA was incubated with ScNob1 for 30 minutes. The rest of the protocol 
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1.10 Complex Formation and Purification 
 
 
1.10.1 Semi-analytical sixe exclusion chromatography (SEC) 
 
Initially, CtNob1 was used with helix 40 RNA (from C. thermophilum or S. 
cerevisiae). 100 µg (1.90 nmol) of protein were mixed with either 1.2 x or 4 x molar 
excess of the corresponding RNA in a 110 µl volume in 20 mM Tris-HCl pH 8.0, 
150 mM NaCl, 4 mM MgCl2, and 1 mM β-mercaptoethanol.  
The samples were incubated at room temperature for 1 hour. Then, 110 µl 
were injected into a 100-µl loop attached to an AKTA purifier system with a pre-
equilibrated Superdex 200 GL 10/300 column (GE Healthcare). The protein and 
RNA were eluted with 1.2 column volumes of the buffer run at 0.5 ml/min (0.5 ml 
fractions were collected). Fractions of interest were separated on gradient SDS-
PAGE (Bio-Rad) and silver-strained (see later for protocol).  
The rest of the semi-analytical SEC experiments described were performed in 
the same manner. However, the amounts of protein used and final volumes changed 
(summarised in Table 2.7). The buffer for the other experiments consisted of 20 mM 
HEPES pH 7.5, 150 mM KCl, 5% v/v glycerol, 5 mM MgCl2, and 1 mM β-
mercaptoethanol. 
 
Table 2.7: Different analytical SEC experiments performed after the first one described above. 
The RNAs used were either at 1.2 or 4 times molar excess relative to the proteins. The relevant 
amounts are shown later with the results. All proteins used were in a one-to-one molar ratio with 
respect to each other. 




Final volume to 
be injected (µl) 
Volume of 
loop (µl) 
ScNob1 and HsDim2 100 (HsDim2) 
186 (ScNob1) 
3.53 60 50 
ScNob1 and helix 40 186 3.53 60 50 
ScNob1 and D site RNAs 50 0.95 60 50 
HsDim2 and D site RNA 50 1.76 60 50 




1.76 60 50 
ScDim2∆N51 and D site RNAs 100 3.65 120 100 
ScNob1 and ScDim2∆N51 100 (ScDim2) 
192 (ScNob1) 
3.65 120 100 
ScNob1 and ScDim1 192 (ScNob1) 
131 (ScDim1) 
3.65 240 200 
ScDim2∆N51 and ScDim1 100 (ScDim2) 
131 (ScDim1) 
3.65 240 200 
ScNob1 and ScFap7 114 (ScNob1) 
50 (ScFap7) 
2.10 60 50 
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1.10.2 ScNob1 and D site RNA complex purification 
 
 In order to purify the complex, the protein was obtained separately first. 
Thus, the affinity step and the ion exchange were performed as described for 
ScNob1. Once pure protein was obtained, it was mixed with 3 times molar excess of 
Peak 3 (see earlier) D site RNA. A 5 x buffer solution was added to the protein first 
to give a final buffer composition of 20 mM HEPES pH 7.5, 150 mM KCl, 5% v/v 
glycerol, 5 mM MgCl2, and 1 mM β-mercaptoethanol in a 2 ml final volume. 
 The sample was incubated at room temperature for 1 hour. Then, it was 
injected onto a pre-equilibrated HiLoad Superdex S200 16/60 column (GE 
Healthcare). It was run at 1 ml/min for 1.5 column volumes while 1 ml fractions 
were collected. Absorbance at 280 and 260 nm was measured and standard SDS-
PAGE was used to analyse the protein content of the peak obtained on the 
chromatogram. The chromatogram was also aligned to that of ScNob1 alone to 
compare the elution volumes of the peaks. The part of the peak that did not overlap 
with the protein alone chromatogram was pooled and concentrated to 8.2 mg/ml. 
 
 
1.11 Biochemical Assays 
 
 
1.11.1 Thermal Denaturation 
 
 Different proteins were subjected to thermal denaturation in different buffers 
in order to examine changes in protein stability. The concentrations used were 
initially optimized based on the best signal-to-noise ratio while using the least 
protein. The concentrations used for the different proteins and the variables tested for 
that sample can be seen in Table 2.8. The assay was performed in plastic, clear 96-
well iQ Real-Time PCR plates (Bio-Rad). Each well contained 5 x Sypro Orange 
(Sigma Aldrich), testing buffer, and the necessary amount of protein in a final 
volume of 50 μl. The proteins were then subjected to incremental increases in 
temperature (0.5˚C every 30 seconds from 20˚C to 80˚C). The change in 
fluorescence was monitored using an iQ5 rtPCR Thermocycler (Bio-Rad). The data 
was then analysed using the iQ5 Optical System Software (BioRad) and re-plotted in 
Microsoft Excel. 
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Table 2.8: Variables tested in thermal denaturation for each protein and the concentration at 




ScNob1 2 pH (8.0-6.5), glycerol (0-10% v/v), NaCl (50-250 mM), zinc acetate 
(0-10 µM) 
CtNob1 2 pH (8.0-6.5), glycerol (0-10% v/v), NaCl (50-250 mM), zinc acetate 
(0-10 µM) 




1.11.2 Electrophoretic mobility shift assays (EMSAs) 
 
1.11.2.1 5 labelling 
 
 300 pmol of each of the RNAs were gel-purified according to standard 
laboratory procedures. The RNA was then resuspended in 15 µl of sterile water. 
After gel purification, the labelling reactions were assembled. 100 pmol of RNA 
were mixed with 20 units of polynucleotide kinase (PNK, NEB), 1 x PNK buffer, 
and 10 uCi of ATP (γ-
32
P) in a final volume of 20 µl. These reactions were incubated 
at 37˚C for 2.5 hours. Then, 180 µl of splicing dilution buffer (100 mM Tris-HCl at 
pH 7.5, 150 mM NaCl, 300 mM NaOAc at pH 5.2, 10 mM EDTA, and 1% w/v SDS) 
were added and the RNA was extracted using a standard phenol/chloroform 
extraction and ethanol precipitation procedure. The samples were dried and 
resuspended in 50 µl of sterile water (2 pmol/µl final concentration). 
 
1.11.2.2 Helix 40 RNA and ScNob1 or CtNob1 
 
Initially, a standard TBE buffer system was used. 2 pmol of RNA were mixed 
with varying amounts of protein (0-400 pmol) in a final volume of 10 µl (in a buffer 
consisting of 20 mM HEPES pH 7.5, 150 mM NaCl, 4 mM MgCl2, and 1 mM β-
mercaptoethanol). These reactions were then incubated at 4˚C, room temperature, or 
37˚C for 30 minutes. 2 µl of non-denaturing dye (0.25% w/v bromophenol blue, 
0.25% w/v xylene cyanole FF, and 50% v/v glycerol) were added and 4 µl were 
loaded onto an 8% native acrylamide gel (0.5 x TBE, 8% acrylamide). The gel was 
run at 200V at 4˚C or at room temperature until the dye was halfway down the gel.  
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Once finished, the gel was wrapped in cling film and taped inside a cassette 
under a phosphoscreen for exposure. The cassette was stored at -80˚C overnight. The 
next day, the gel was removed and the phosphoscreen was scanned using a Storm 
860 Molecular Imager (GE Healthcare).  
 
1.11.2.3 D site and ScNob1 
 
RNA fragments based on the ones found to interact with ScNob1 in the semi-
analytical SEC were obtained from IDT (sequences can be seen in Table 4.6 in the 
results section). Initially, the same EMSA protocol was used as for helix 40. 
However, since the complex could not enter the gel, the percentage of acrylamide 
was reduced to 4%. Also, different running buffers were tested (McLellan, 1982). 
Table 2.9 lists the different buffers used. Once finished running, instead of freezing 
the gel, it was dried according to the manufacturer’s instructions in a GD 2000 Slab 
Gel drier (Hoefer). The phosphoscreen was exposed overnight and then scanned 
using a Typhoon FLA 7000 Imager (GE Healthcare). An EMSA using the ScNob1 
D15N mutant protein was performed in the same manner. All the EMSAs were 
repeated with different batches of purified protein. 
 
Table 2.9: The different buffers used for EMSAs.  
The standard names of the buffers and final concentrations of the components are shown. CAPS is 
also known as 3-(Cyclohexylamino)-1-propanesulfonic acid. 




0.5 x TBE 8.3 45 mM Tris base 45 mM Borate 1 mM EDTA 
1.0 x TC 9.4 60 mM Tris base 40 mM CAPS - 
1.0 x AC 10.2 37 mM Ammonia 20 mM CAPS - 
 
 
1.11.3 Cleavage assays 
 
 Initially, a cleavage assay was set up using 2 pmol of DS5 RNA and 10 pmol 
of ScNob1 in 10 µl. The buffer was the same as for the EMSA with an addition of 5 
mM MnCl2 as was shown to be required by the Tollervey lab (Lebaron et al, 2012). 
The samples were incubated at room temperature for 2 hours with fractions being 
taken every 15 minutes. To stop the reaction, 10 µl of denaturing dye (90% v/v 
formamide, 10 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.05% w/v bromophenol blue, 
and 0.05% w/v xylene cyanole FF) were added. The reactions were then examined 
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on a 14% urea/acrylamide denaturing gel (acrylamide, 1 x TBE, 7 M Urea), which 
was run at 20 W for 50 minutes. 
 As no product was seen, the reactions were repeated with a 3-hour incubation 
at 37˚C. 1% SDS had to be added to the loading dye to denture the complex. The 
MnCl2 concentration was raised to 10 mM and the MgCl2 was removed from the 
buffer. The assay was also used on DS2, DS3, DS4, and DS8 RNAs. Different time 
courses, ranging to overnight, were performed. Finally, the best results were obtained 
using a 6-8 hour incubation at 37˚C with DS5 RNA, 5 mM MnCl2, and no MgCl2. 









) were tested at 50, 500, and 5000 µM concentrations.  
The time course experiment was also performed using the D15N mutant 
ScNob1.  
 
1.11.4 Cleavage assays with potential co-factors 
 
 Dim1 is the protein responsible for di-methylation of the 20S RNA 
(Pulicherla et al, 2009). Initially, 0.5-3.0 µg of ScDim1 (purified by Anees Basha) 
and 160 µM S-Adenosyl methionine (SAM) were added to the above standard 
cleavage assay 2 hours prior to adding ScNob1. However, this yielded inconclusive 
results so the protocol was changed. 2 pmol of DS5 RNA were mixed with 3 µg of 
His- or GST-tagged ScDim1 and 160 µM SAM in buffer 1 (20 mM HEPES pH 7.5, 
150 mM KCl, 4 mM Mg acetate, 5% v/v glycerol, and 1 mM -mercaptoethanol) or 
buffer 2 (as buffer 1 but with 40 mM NH4Cl instead of KCl as the salt) in a 10 µl 
volume. The buffers were designed based on previously published in vitro 
methylation assays (O'Farrell et al, 2006). 
 The reactions were then incubated at 37˚C for 2 hours. Then, 50 pmol of 
ScNob1 were added along with buffer 3 (as buffer 1 but with 5 mM MnCl2 instead of 
Mg Acetate) in a further 10 µl, and incubated for a further 6 hours at 37˚C. The 
reaction was stopped by addition of equal volume (20 µl) denaturing dye (as above). 
As with the standard assay, the reactions were then analysed on a 14% denaturing 
urea/acrylamide gel (acrylamide, 1 x TBE, 7 M Urea). 
 As the results were still inconclusive, the same protocol was repeated but 
ScDim1 was removed from the reactions prior to addition of ScNob1. This was 
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achieved by the addition of 190 µl of splicing dilution buffer to the ScDim1 reaction 
after incubation and standard phenol/chloroform extraction and ethanol precipitation. 
The methylated RNA was resuspended in 5 µl of sterile water. The rest of the 
protocol was the same as previously. 
 
1.11.5 Isothermal titration calorimetry (ITC) 
 
ITC was used to measure the dissociation constants for the Nob1-D site 
interaction and to pinpoint the binding site. The protein for these experiments was 
purified as described previously except that the SEC buffer was changed to 20 mM 
HEPES (pH 7.5), 150 mM KCl, 5% v/v glycerol, 5 mM MgCl2, and 1 mM TCEP 
(tris(2-carboxyethyl)phosphine). The RNAs were ordered from Sigma and were 
already HPLC-purified. Mutated sequences were designed not to have any secondary 
structure. This was tested for using the mfold server (http://mfold.rna.albany.edu). 
These were resuspended to a final 400 µM concentration in the SEC buffer. 
To make sure that the protein and RNA buffers were matched, all binding 
partners were dialysed overnight at 4˚C into the same batch of 1-2 L SEC buffer. 
ScNob1 was dialysed using a Slide-A-Lyzer Dialysis Cassette (Thermo Scientific) 
according to manufacturer’s instructions. The RNAs were dialysed in Micro Float-A-
Lyzer dialysis units (Spectrum labs, molecular weight cut off of 0.1-0.5 kDa, 100-
200 µl volume) also as suggested by the manufacturer. 
The next day, the concentrations of the protein and RNAs were measured, 
using their specific extinction coefficients, on the NanoDrop (Thermo Scientific). 
The protein concentration was re-checked with a JASCO UV/Vis V-550 
spectrometer to ensure accurate results. To obtain the necessary concentrations, the 
samples were diluted with the dialysis buffer. After dilution, the accurate 
concentrations were re-measured and recorded in the ITC200 software. All the 
experiments described below were performed using the MicroCal Auto-iTC200 
system (GE Healthcare). 
In the initial experiment, 10 µM ScNob1 was used in the cell with 150 µM 
DS6 (Table 4.8 in the results section) RNA in the syringe. The samples were 
pipetted into a 96-well MicroCal Auto-iTC200 plate (GE Healthcare) and sealed. 
The plate tray was kept at 15˚C during the experiment. The titration was performed 
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over 16 injections (first one of 0.5 µl and 15 at 2.5 µl) at 25˚C with a reference 
power of 10. A 180 second gap was left between injections.  
Then, the protein and RNA were reversed (10 µM DS6 RNA in the cell and 
150 µM ScNob1 in the syringe); the reference power was reduced to 3 and 
temperatures of 37˚C and 5 ˚C as well as 25˚C were used. The first injection volume 
was reduced to 0.25 µl. The reversed titration at 5˚C with reference power at 3 was 
used for further experiments. The tray temperature was reduced to 10˚C. The stirring 
speed was 1000 rpm for all experiments. The RNA sequences used in the ITC can be 
seen in Table 4.8 in the relevant results section.  
Each set of experiments was accompanied by controls after the experimental 
set-up was chosen. The controls consisted of the same titrations but without one of 
the reactants. One set included buffer being injected into each of the RNAs 
separately and the second was ScNob1 being injected into buffer to eliminate 
dilution and buffer mismatch heat changes. When multiple experiments were 
performed in one run of the machine, the standard DS6 – ScNob1 experiment was 
performed before and after to ensure no changes, such as RNA degradation, 
occurred. 
Once the experiments were finished, the data were processed in the ITC200 
software. The experimental data were plotted together with the relevant controls. The 
baselines were adjusted to make sure all data were included. The peaks were 
integrated and the first point was removed (as the initial small injection is not 
correct). A linear regression was applied to the control data and subtracted from the 
experimental titration. Where possible, a one-site model was fitted to the binding 
curve. The molar ratio was set to 0.25 where required to reduce the dependency of 
the calculated values (i.e. where there was evidence of over-fitting). 
All of the RNAs used were also separated on native PAGE to confirm the 
lack of secondary structures. This was performed on a 10% acrylamide gel in 0.5 x 
TBE. The gel was run at 180V at 4˚C for about 4 hours. The wells contained 2 µl of 
each 400 µM RNA in 50% v/v glycerol. Once finished, the gel was then soaked in 
100 ml of 1x SYBR Safe (Invitrogen) stain solution for 5 minutes. It was then 
scanned using an XR Gel-doc system (Bio-Rad). 
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1.11.6 Surface Plasmon Resonance (SPR) 
 
In order to estimate the dissociation constant for the Dim2-DS1 RNA 
interaction, SPR was performed. The His-tagged ScDim2∆N51 was purified as 
described earlier. However, the size exclusion chromatography utilized a different 
buffer: 20 mM HEPES pH 7.5, 150 mM KCl, 50 µM EDTA, 0.05% v/v Tween20, 
and 1 mM TCEP. This buffer was used throughout the SPR experiments. 
Initially, the experiments were performed at 25˚C. The protein was attached 
to an NTA chip (S Series Sensor chip, GE Healthcare) via nickel ions. The chip was 
placed in the BiaCore T200 machine (GE Healthcare). Channels 1 and 2 were 
washed with 15 µl of 50 mM NaOH and 90 µl of 350 mM EDTA. Channel 1 was 
then left as a reference. Meanwhile, channel 2 was loaded with nickel by a manual 
injection of 10 µl of 500 µM NiSO4. Then, the 7.5-10 µl of 50 nM ScDim2∆N51 
were injected onto the surface of channel 2 (aiming for a response of 500-1000 
units). Both channels were washed with buffer to stabilize the baseline. 
The RNA was dialysed into the SPR buffer prior to the experiments. To 
check the surface activity, initially, 15 µl of 2 µM DS1 RNA were injected into both 
channels. Since the response was not at high as expected, a 75 µl injection was also 
attempted. Then, the RNA concentration was increased to 10 µM. A 60 µl injection 
at this concentration was used. The surface was then stripped with the same NaOH 
and EDTA wash as described earlier. 
These initial experiments were then repeated at 10˚C to increase protein 
stability. Addition of 5 mM MgCl2 made no difference to activity seen. A single 
cycle experiment was then performed at 4, 10, and 25˚C. 
The surface was charged with nickel and protein as described earlier at each 
temperature using fresh protein. Five serial dilution of DS1 RNA were made (30, 15, 
7.5, 3.75, and 1.875 µM). 15 µl of each concentration were injected (starting with the 
lowest concentration) onto the surface, separated by 30 seconds (i.e. 15 µl of buffer). 
The data were then analysed as suggested by the manufacturer. 
 
1.11.7 ScDim2 Solubility screening 
 
Attempts were made to create a soluble ScDim2∆N51 – D site RNA 
complex. For this purpose, a grid screen was set up on two 24-well XtalQuest sitting 
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drop plates (MiTeGen). Each well contained 500 µl of the buffer being tested. Every 
condition had 5 mM MgCl2, 5% v/v glycerol, and 1 mM DTT. On the horizontal 
axis, 12 buffers at different pHs were tested at 100 mM each (sodium citrate pH 5.5, 
sodium citrate pH 6.0, MES pH 6.0, Bis-Tris pH 6.5, HEPES pH 7.0, potassium 
phosphate pH 7.4, HEPES pH 7.5, Tris-HCl pH 7.5, Tris-HCl pH 8.0, Bis-Tris 
propane pH 8.0, Tris-HCl pH 8.5, and Bis-Tris propane pH 9.0). Vertically, different 
KCl concentrations were tested (50, 150, 300, and 600 mM). 
On the pedestal in each of the 48 wells, 1 µl of 8.7 mg/ml (317 µM) 
ScDim2∆N51 was mixed with 2 µl of well buffer and 1 µl of 381 µM (1.2 x protein 
concentration) D site RNA (DS1). The tops were sealed with clear tape and the 
plates were stored at 4˚C overnight. The next day, wells without precipitation were 
noted. These conditions were then tested on semi-analytical size exclusion 
chromatography as described earlier. 
 
 
1.12 Dim2 Modelling 
 
 
The potential structure of the eukaryotic Dim2 was modelled based on the 
solved archaeal structures. For this purpose, the S. cerevisiae protein sequence was 
entered into either the Phyre (http://www.sbg.bio.ic.ac.uk/phyre/ html/), Phyre 2 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index), or Swiss-Model 
(http://swissmodel.expasy.org) server along with a multiple sequence alignment. The 
alignment consisted of some eukaryotic sequences (S. cerevisiae, 
Schizosaccharomyces pombe, C. thermophilum, Caenorhabditis elegans, Wuchereria 
bancrofti, Drosophila melanogaster, Drosophila mojavensis, Acromyremex 
echinatior, Danio rerio, Mus musculus, Rattus norvegicus, and Homo sapiens) and 
some archaeal ones (Pyrococcus horikoshii, Aeropyrum pernix, Pyrolobus fumarii, 
Sulfolobus islandicus, and Methanococcus meripaludis). The top hit for each one 
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1.13 Calculating the Predicted Hydrodynamic Radii 
 
 
The hydrodynamic radii (Rh) and radii of gyration (Rg) were calculated for 
existing solved structures using the HYDROPRO software (Ortega et al, 2011). For 
this purpose, the PDB files were edited to remove duplicate chains and additional 
atoms that were not a part of the protein (e.g. water molecules and ligands). The PDB 
files used were: BSA (ID: 4F5S), carbonic anhydrase (ID: 1V9E), and P. horikoshii 
Dim2 (ID: 2E3U). 
An atomic level model using a shell calculation for each file was employed as 
advised by the creators of the program. The values were kept as the defaults apart 
from experimental variables (e.g. temperature or buffer viscosity), which were 
changed to reflect the conditions used in SEC experiments. 
 
 
1.14 Electron Microscopy (EM) 
 
 
ScNob1 was visualised using EM with and without D site RNA. For this 
purpose, a 5 nm carbon grid was charged in a SC7620 Mini Sputter Coater (Quorum) 
for 15 seconds. 4 µl of 900.0, 90.0, or 9.0 µg/ml ScNob1 were spotted onto the grid 
and left to sit for 2 minutes. Excess liquid was removed by blotting on filter paper 
and the grid was washed 3 times in sterile water. Then, the grid was washed 3 times 
in 2% w/v uranyl acetate. Then, about 5 µl of fresh 2% w/v uranyl acetate were 
spotted on and left for 5 minutes. The stain was removed and the grid was allowed to 
air dry for about 30 seconds. It was then examined using FEI F20 electron 
microscope (Tecnai). The protein with and without glycerol in the buffer was 
visualised. 
For protein-RNA complexes, ScNob1 was first mixed with either 1.2, 4, or 10 
times excess of DS1 RNA. The grids were prepared as described above but with 390 











1.15.1 Crystallisation screening 
 
Crystallisation screens were set up in 96-well MRC plates (Molecular 
Dimensions). The set up was performed by the Gryphon robot (Art Robbins) as 
suggested by the manufacturer. The drops were either made up of 0.1 µl of protein 
and 0.1 µl of well buffer or 0.2 µl of each if more protein was available. The well 
contained 60 µl of solution. Usually, a concentration of about 10 mg/ml of protein 
was used. After the pipetting, the plates were sealed using a XCS-384 pressure sealer 
(FluidX). The majority of plates were then stored at 16˚C (although some were also 
stored at 4˚C) and monitored for crystal growth. For the ScTsr1 constructs, all the 
initial screening was performed by Dr. Uma Jayachandran. 
 The commercial screens used included: PEG/Ion (Qiagen), Index (Hamilton), 
Magic I and II (Xtal Facility, MPI Martinsried), ProPlex (Molecular Dimensions) 
(Radaev et al, 2006), Midas (Molecular Dimensions) (Grimm et al, 2010), Structure 
1 and 2 (Molecular Dimensions) (Jancarik & Kim, 1991), JCSG+ (Molecular 
Dimensions) (Newman et al, 2005), and Morpheus (Molecular Dimensions). 
Different combinations of screens were used for different proteins.  
 




The initial hits occurred in wells A2, A7, and B3 in the Magic I screen using 
8.7 mg/ml protein. Condition A2 consisted of 50 mM MES pH6.0, 10% w/v PEG 
8000, and 0.2 M sodium malonate. A7 had 50 mM MES pH 6.0, 10% w/v PEG 
3350, and 0.2 M sodium chloride while B3 was made up of 50 mM MES pH 6.0, 
18% w/v PEG 8000, and 0.2 M calcium acetate. When these were set up in larger, 
XtalQuest sitting drop plates (MiTeGen), the first two conditions gave the largest 
crystals and were chosen for further optimisation. In the 24-well plates, the drops 
consisted of 1 µl of protein and 1 µl of well solution. The well contained 500 µl of 
the crystallisation mixture. 
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 More 24-well plates were set up testing different variables. Initially, the PEG 
and salt concentrations were optimised using a grid screen. The conditions based on 
well A2 showed the best crystals. Different buffers were tested and Tris-HCl at pH 
8.0 was then chosen. Some trials were also performed at pH 9.0. 
 Seeding was performed. For this purpose, the crystals grown at pH 8.0, 8% 
w/v PEG 8000, and 0.3 M sodium malonate were crushed with a needle. The 
fragments were mixed with 20 µl of well solution and placed in an eppendorf tube. 
The sample was centrifuged at 13000 rpm for 5 minutes. This stock and a 1 in 50 or 
1 in 100 dilution were used to streak (using a cat whisker) drops containing 8.7 
mg/ml protein and the well solution (50 mM Tris-HCl pH 8.0, 4% w/v PEG 8000, 
and 0.22-0.32 M sodium malonate). 
 To prevent the crystals sticking to the plate, a one-minute incubation of the 
plate with 5 µl of Gel Slick (Lonza) on the pedestal was tested. 
 Finally, the effects of additives were also checked. The pH 8.0, 8% w/v PEG 
8000, and 0.3 M sodium malonate condition was used and supplemented with one of 
the following: 5 mM MgSO4, 5 mM magnesium acetate, 5 or 10 mM MnCl2, 5 or 10 
mM CaCl2, 5 mM calcium acetate, 50 µM zinc acetate, 5 or 10 mM glucose, 5 or 10 
mM sucrose, 5 or 10% v/v glycerol, 5 or 10 mM GTP, 5 or 10 mM GDP, and 5 or 10 
mM ATP. Afterwards, additional compounds were tested at pH 8.0 and 9.0. These 
included: 6-16 mM NAD, 6-16 mM TCEP, 6-16 mM DTT, 60-160 mM potassium 
sodium tartrate, 20-45 mM glycyl-glycyl-glycine, and 6-16 mM urea. 
1.15.2.2 ScTsr1∆N46∆410-476 
 
Again, Dr. Uma Jayachandran performed initial screening and some 
optimisation. I carried out optimisation around the best conditions identified, in 24-
well plates using protein at 10 mg/ml in 8-14% w/v PEG 3350 and 0.18-0.30 M 
sodium malonate pH 6.0. Addition of buffers was tested including the following: 50 
mM of MES pH 6.0, MES pH 6.5, HEPES pH 7.0, HEPES pH 7.5, Tris-HCl pH 8.0, 
and Tris-HCl pH 8.5. Conditions without buffer or with HEPES at pH 7.5 were 
further optimised. The protein concentration was lowered to 8 mg/ml. 
The seleno-methionine labelled protein was also crystallised in the optimised 
conditions. As these crystals did not diffract as well, seeding using native crystals 
U. McCaughan  Chapter 2: Materials and Methods 
 56 
was undertaken. For this purpose, the native crystals were treated in the same manner 
as described for the previous construct and the seeding was performed in the same 
manner. The protein was also re-screened at 10 and 5 mg/ml using the Hampton 
Index and Magic I screens as described previously. 
 
1.15.3 Data collection 
 
For data collection, the crystals were first harvested and placed in the well 
solution supplemented with 30% v/v glycerol (which acted as the cryo-protectant) or 
in stabilizing solution with glycerol (see later). They were then immediately 
harvested in nylon loops and flash-cooled in liquid nitrogen in ALS-style pucks 
(MiTeGen). They were stored in the liquid nitrogen until they were shipped to 
Diamond Light Source in Oxford where the data were collected remotely using the 
Generic Data Acquisition (GDA) client software. Initially, the crystals were quickly 
scanned by collecting 4 images 45˚ apart starting at 0 at 30% transmission with a 
0.15 second exposure and 0.15˚ oscillation.  
The data for the best ScTsr1∆N46∆410-476 crystal were then collected on the 
I03 beamline using a strategy calculated by EDNA analysis (Incardona et al, 2009) 
of the initial 4 images. Overall, 270˚ were collected starting at 78˚ with 0.15˚ rotation 
(i.e. over 1800 images). A 0.1 second exposure was used. 
 
1.15.4 Data processing (native) 
 
The 1800 images for the best ScTsr1∆N46∆410-476 crystal were processed 
using XDS software (Kabsch, 2010). All the jobs were run initially using a resolution 
range of 50.0 to 3.4 Å with a space group of 0. Friedel’s law was set to ‘true’ and the 
rest of the settings were taken from the fast data processing files received from the 
Diamond Light Source (e.g. the origin of the beam, etc.). 
The output file from the CORRECT program was examined. Then, the CCP4 
suite of programs was used (Winn et al, 2011) for further processing. The 
XDS_ASCII.HKL file, which contained all of the corrected spot intensities, was 
entered into Combat along with the space group (16) and unit cell dimensions 
provided by XDS. This converted the data into .mtz file, which can be used to run 
SCALA. The intensities were scaled and merged using SCALA with the default 
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settings. Finally, Cad was used to convert the space group in that file from P222 (16) 
to P212121 (19). 
 
1.15.5 ScTsr1∆N46∆410-476 structure solution (phasing) 
 
1.15.5.1 Molecular replacement  
 
Solved structures of eIF5B (PDB ID: 1G7R) and SelB (PDB ID: 4ACA) were 
used as molecular replacement search models to obtain phases for the 
ScTsr1∆N46∆410-476 diffraction data. Initially, this was performed with the 
structures superimposed and the PDB files entered into Phaser (CCP4 suite) (McCoy 
et al, 2007; Winn et al, 2011) as separate ensembles along with the 
ScTsr1∆N46∆410-476 protein sequence and the .mtz file obtained from earlier 
processing. The program was told to search for two copies per asymmetric unit 
(default settings were used for the rest of the parameters). Initial data processing 
suggested that more than one protein molecule is present per asymmetric unit (see 
chapter 6). Thus, searching for 2 copies ensures that a more accurate model is found. 
This is balanced with processing time. Searching for more than two copies can take 
significantly longer as more structural elements need to be fitted.  
The model sequences were then reduced and the side chains were removed 
using Chainsaw (CCP4 suite) (Stein, 2008; Winn et al, 2011) leaving poly-alanine 
sequences within the structures. These simplified models were again entered into 
Phaser (McCoy et al, 2007) with the ScTsr1∆N46∆410-476 data. 
To further simplify the models, several truncations of each model protein 
were made to remove any non-conserved regions. For eIF5B these were at residue 
443, 328, or 225 where anything following these was deleted from the PDB file. For 
SelB, the truncations were at 385, 269, and 178. Again, all six were entered as 
separate ensembles into Phaser (McCoy et al, 2007) with the data to obtain a 
solution. 
Then, some restrictions were lifted to allow faster processing. The second 
truncation for each (328 for eIF5B and 269 for SelB) was rerun looking only for one 
copy per asymmetric unit and increasing the number of clashes allowed from 5 to 10. 
U. McCaughan  Chapter 2: Materials and Methods 
 58 
Truncation 3 (225 for eIF5B and 178 for SelB) for both proteins was then 
used in a single ensemble (to include only the most conserved parts of the proteins). 
Again, only one copy per asymmetric unit was searched for. 
The potential solution files were then examined in Coot (Emsley et al, 2010) 
to see if any structural features could be identified in the electron density maps.  
 
1.15.5.2 Heavy atom soaking 
 
For the heavy atom soaks, a stabilising solution for the crystals was identified 
by harvesting crystals and placing them in higher PEG and sodium malonate 
conditions overnight and making sure no dissolving occurred. 14% w/v PEG 3350 
and 0.3 M sodium malonate were chosen. The heavy compounds used were 
thimerosal, gold (I) potassium cyanide, lead (II) acetate trihydrate, samarium (III) 
acetate hydrate, and potassium tetranitroplatinate (II). These were made up in sterile 
water to a final concentration of 30 mM. The 24-well plate was prepared by placing 
4.5 µl of stabilising solution on each pedestal and 500 µl of the same solution in each 
well. 0.5 µl of each heavy atom stock at 10, 1, or 0.1 mM concentration was added to 
each pedestal to give a final volume of 5 µl. 
Crystals were then harvested from 10-12% w/v PEG 3350 and 0.22-0.30 M 
sodium malonate and placed in the 5 µl drop of the stabilising solution supplemented 
with the heavy atoms. About 3 crystals were placed on each pedestal and sealed. 
They were left to incubate at 16˚C for 3 hours. Then, the crystals were harvested and 
moved to a cryo-protectant solution (back-soaked), which consisted of the stabilising 
solution supplemented with 30% v/v glycerol. They were then immediately picked 
up again and flash-cooled in liquid nitrogen and stored until data collection at the 
Diamond Light Source in Oxford. 
As for the native crystals, data were collected remotely. Initially, to detect if 
any heavy atoms were present and to determine what wavelength to use for data 
collection, a fluorescence scan was performed. Heavy atoms absorb X-rays at 
distinct energies and release them as fluorescence. The required heavy atom was 
selected along with edge L3 and an energy scan was performed, as advised by the 
Diamond Light Source user guidelines. If the heavy atom was present in the crystal, 
the peak and inflection energies at which the fluorescence occurred were recorded. 
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Then, initial crystal scans were collected as normal (4 images as described earlier) 
except that the wavelength was changed to either the peak or inflection energy. 
EDNA (Incardona et al, 2009) was used to calculate a strategy to collect full data 
sets. Table 2.10 lists the different strategies used for anomalous dataset collection. 
Afterwards, the data were processed as described above except that Friedel’s law 
was set to ‘False’ in XDS. 
 
Table 2.10: The strategies used for anomalous data collection.  
The crystal name corresponds to the heavy atom present and whether data were collected at the peak 
or inflection energy. Some data were also collected at high remote energy (hrm), which is reached 

















Hg 1 - peak I03 12298.5 207˚ 0.2˚ 900 0.2 4.0 30 
Hg 2 - peak I03 12298.5 0˚ 0.15˚ 2400 0.15 4.0 30 
Hg 2 - inflection I03 12282.5 0˚ 0.15˚ 2400 0.15 4.0 20 
Hg 3 – peak I24 12311.7 289˚ 0.2˚ 450 0.2 4.0 12 
 I24 12311.7 352˚ 0.2˚ 450 0.2 4.0 20 
 I24 12311.7 352˚ 0.2˚ 450 0.2 4.0 50 
Hg 3 - inflection I24 12293.0 352˚ 0.2˚ 450 0.2 4.0 30 
 I24 12293.0 262˚ 0.2˚ 450 0.2 4.0 30 
Hg 4 - hrm I24 12315.0 289˚ 0.2 550 0.2 4.0 30 
Hg 4 - peak I24 12311.7 289˚ 0.2 550 0.2 4.0 30 
 I24 12311.7 199˚ 0.2 550 0.2 4.0 30 
Pb 1 - peak I03 13050.0 0˚ 0.15˚ 2400 0.15 4.0 20 
Sm 1 - peak I03 6716.0 0˚ 0.15˚ 2400 0.15 4.0 20 
Sm 1 - peak I03 6716.0 0˚ 0.15˚ 2400 0.15 4.0 20 
 
After XDS, SHELXC/D/E (Sheldrick, 2010) was used as recommended by 
the documentation to see if any anomalous signal was present to allow calculation of 
a substructure for phasing. 
 
1.15.5.3 Seleno-Methionine protein 
 
The seleno-methionine ScTsr1∆N46∆410-476 was purified and crystallised 
as described earlier. As for the heavy atom-soaked crystals, initially, a fluorescence 
screen was performed to identify the peak (12662 eV) and inflection (12660 eV) 
energies. Two datasets were collected for the best diffracting crystal (about 10 Å 
resolution) as listed in Table 2.11. 
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Peak I04 12662 0˚ 0.1˚ 1800 0.1 4.0 30 
Inflection I04 12660 0˚ 0.1˚ 1800 0.1 4.0 30 
 
 The datasets were processed in XDS as described for the heavy atom-derived 
crystals. Again, SHELX (Sheldrick, 2010) was used as recommended by the 
documentation to see if sufficient anomalous signal was present to allow for phasing. 
 
 





 Samples were prepared by addition of equal volume of 2 x sample buffer 
(100 mM Tris-HCl at pH 6.8, 10% v/v β-mercaptoethanol, 4% w/v SDS, 0.2% w/v 
bromophenol blue, 20% v/v glycerol). They were then boiled at 95˚C for 5 minutes, 
spun down, and loaded onto a denaturing SDS/acrylamide gel of the appropriate 
percentage. The percentage of acrylamide was chosen based on the size of the 
protein to be visualised. For this project, 10 or 15% gels were utilised. The gels were 
run at 180V for 1 hour. They were then washed with water and stained with diluted 
Coomassie (10% v/v ethanol, 5% v/v acetic acid, 0.001% w/v Coomassie) overnight 




1.16.2.1 Sample Preparation 
 
The samples to be analysed by MALDI-ToF were separated using standard 
SDS-PAGE and stained with diluted Coomassie overnight. The gel was then washed 
for a day with clean water. The bands of interest were excised and incubated in 300 
µl of 200 mM ammonium bicarbonate in 50% v/v acetonitrile (buffer 1) at room 
temperature for 30 minutes. This step was performed twice to remove the SDS. The 
gel fragments were then incubated in 300 µl of buffer 2 (20 mM DTT, and 200 mM 
ammonium bicarbonate in 50% v/v acetonitrile) at 32˚C for 1 hour to reduce the 
protein. 
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 The buffer was removed and the gel was washed 3 times with 300 µl of 
buffer 1. This was followed by a 20-minute incubation in the dark (room 
temperature) in buffer 3 (50 mM iodoacetamide, and 200 mM ammonium 
bicarbonate in 50% v/v acetonitrile) to alkylate the cysteines. The gel pieces were 
then washed 3 times with buffer 4 (20 mM ammonium bicarbonate in 50% v/v 
acetonitrile) and spun down at 13,000 rpm for 2 minutes. 
 Finally, the samples were covered with 200 µl of acetonitrile (until they 
turned white). The solution was decanted and the gel pieces were allowed to air dry. 
30 µl of trypsin (Sigma) at 13.3 µg/ml in 50 mM ammonium bicarbonate were added 
and the gel pieces were allowed to swell in the solution at 4˚C. The tubes were sealed 
with parafilm and incubated at 32˚C for 16-24 hours. They were then stored at -20˚C 
until needed. 
 
1.16.2.2 Matrix Preparation 
 
For peptide analysis, 10 mg of a-cyano-4-hydroxyconnamic acid (CHCA) 
were weighed out and mixed with 400 µl of sterile water. 100 µl of 3% v/v 
trifluoroacetic acid (TFA) were added and the sample was mixed. Then, 500 µl of 
acetonitrile were added followed by more mixing. This was spun down at 5,000 rpm 
for 1 minute. The supernatant was used for spotting onto the plate. 
 
1.16.2.3 Sample analysis  
 
0.5 µl of peptide sample and 0.5 µl of CHCA matrix were spotted unto a gold 
or a stainless steel 100-sample plate (Applied Biosystems). The plate was allowed to 
air dry and then it was inserted into the Voyager DE-STR (Applied Biosystems) 
machine. Data were collected as advised by the manufacturer. 
 Once the peaks were obtained, they were processed in Data Explorer 
(Applied Biosystems), again, according to manufacturer’s recommendations. The 
size of the fragments was calibrated based on visible trypsin peaks. Finally, the 
Mascot search engine (http://www.matrixscience.com) was used to identify the 
protein fragments based on known protein sequences. 
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1.16.3 Silver staining 
 
 Pre-cast 4-20% gradient gels (Bio-Rad) or standard gels were loaded and run 
at 180V for 35 minutes.  They were then fixed in 50 ml 50% v/v methanol three 
times (10 minutes each). This was followed by at least 10 minutes of rehydration in 
5% v/v methanol. The gels were then rinsed 3 times with water and soaked in DTT at 
5 µg/ml for 20 minutes. The DTT was removed and the gels were soaked in 0.1% 
w/v silver nitrate for 20 minutes. This was followed by a quick rinse with 100 ml 
water and a change into a clean container.  
The gels were rinsed twice with 50 ml developer solution (7.5 g Na2CO3 and 
0.02% v/v formaldehyde in 250 ml water). Then, 50 ml of fresh developer was added 
to each gel and the exposure was carefully monitored. Once satisfactorily exposed, 5 
ml of 2.3 M citric acid were added to stop the reaction. The gels were left to mix for 
10 further minutes and then rinsed with water.  
 
1.16.4 RNA native gels 
 
Native gels were used for EMSAs and secondary structure analysis of RNAs. 
The 20 x 20 cm gels consisted of the appropriate percentage of acrylamide and 0.5 x 
TBE buffer. The samples to be loaded onto the gel were mixed with 6 x non-
denaturing dye (0.25% w/v bromophenol blue, 0.25% w/v xylene cyanole FF, and 
50% v/v glycerol) and kept on ice or at room temperature. After loading, the gel was 
run in 0.5 x TBE buffer at 200V at 4˚C or at room temperature until the dye was 
halfway down the gel (usually between 2 and 4 hours depending on the percentage of 
acrylamide). 
 
1.16.5 RNA gel purification 
 
RNAs were separated on a 12-16% denaturing urea/acrylamide gel 
(acrylamide, 1 x TBE, 7 M Urea). The 20 x 20 cm gel was run in 1 x TBE at 20 W 
for 45 minutes to separate the RNAs. The gel was then wrapped in cling film and 
placed on a Fluor-coated TLC plate (Ambion). The RNAs were visualised using UV 
shadowing under short wave (254 nm) light and marked on the cling film. The bands 
were excised and incubated in 400 µl of elution buffer (300 mM NaCl, 60 mM 
NaOAc at pH 5.2, and 0.2% w/v SDS) overnight. The following day, they were 
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phenol/chloroform extracted and ethanol precipitated as described below. The RNA 
was resuspended in the required amount of sterile water. 
 
 
1.16.6 Phenol/Chloroform extraction 
 
 An equal volume of phenol/chloroform/IAA (25:24:1, Ambion) was added to 
the sample. The tube was vortexed twice. The samples were spun down at 13,000 
rpm for 1 minute at room temperature. The aqueous phase (top layer) was carefully 
collected (without touching the bottom phase) and placed in a clean tube. 
 
1.16.7 Ethanol Precipitation 
 
 Ethanol (100%) was added to the tubes (usually 1 ml to give a final 
concentration of about 70% v/v ethanol). These were vortexed and placed at -20˚C 
for 1 hour. They were then centrifuged at 13,000 rpm at 4 ˚C for 15 minutes. The 
liquid was discarded and the pellet was washed with 300 µl of 80% v/v ethanol. The 
tubes were spun again at 13,000 rpm at 4˚C for 1 minute. The liquid was discarded 
and the pellets were allowed to dry. They were then resuspended in the appropriate 
amount of buffer or water. 
 
1.16.8 Limited Proteolysis 
 
 For limited proteolysis, 10 µl of the protein of interest (at a concentration of 
0.6 mg/ml) were mixed with 3 µl of a dilution of a protease. The proteases used were 
trypsin, elastase, chymotrypsin, GluC, and subtilisin (Sigma). There were 3 dilutions 
used for each (0.1, 0.01, and 0.001 mg/ml) in 20 mM HEPES pH 7.5, 50 mM NaCl, 
and 10 mM MgSO4. The reactions were incubated on ice for 30 minutes and then 2 
µl of SDS-loading dye were added to stop the cleavage. The samples were analysed 
on 12.5% gels using standard SDS-PAGE. 
 
1.16.9 PCR protocols 
 
The following PCR protocols were used throughout the project: 
Gene/plasmid amplification: 
Initial denaturation:  95°C for 3 minutes 
38 cycles:    95°C for 30 seconds 
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65°C for 30 seconds 
72°C for 15–30 seconds/kb  
Final extension:  72°C for 5 minutes 
 
RT-PCR protocol: 
First strand synthesis:  58˚C for 15 minutes 
Initial denaturation:  95°C for 4 minutes 
40 cycles:    95°C for 30 seconds 
60°C for 30 seconds 
68°C for 10 seconds 
Final extension:  68°C for 5 minutes 
 
 
1.16.10 Transformation protocols 
 
1.16.10.1 Chemically-competent cells 
 
The appropriate volume of DNA (usually between 1-3 µl of plasmid extracted 
using the MiniPrep kit) was added to 50 µl of aliquoted cells. The mixture was stored 
on ice for 30 minutes. Then, heat shock was applied by moving the cells to 37˚C for 
30 seconds and immediately following placing them back on ice for a further 5 
minutes. 200 µl of SOC medium were added and the cells were shaken at 37˚C for 1 
hour. They were then plated on agar supplemented with the appropriate antibiotics. 
 
1.16.10.2 Electro-competent cells 
 
Again, DNA was added (up to 2µl) to the aliquoted cells. The mixture was 
placed on ice in a 0.2 cm gap Gene Pulser cuvette (Bio-Rad). Electroporation was 
performed in MicroPulser Electroporator (Bio-Rad) according to the manufacturer’s 
instructions. 200 µl of SOC medium were added and the cells were shaken at 37˚C 
for 1 hour in the same manner as the chemically-competent cells. Again, these were 
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As previously mentioned, Nob1 is the nuclease responsible for D site 
cleavage and is conserved in yeast and humans. This protein consists of two 
domains: a PIN domain and a zinc ribbon. The PIN domain is normally associated 
with magnesium-dependent exonucleases (Arcus et al, 2004). A single mutation in 
this domain (D15N in the yeast or D10N in the human protein) was shown to abolish 
the nuclease activity of Nob1 (Lebaron et al, 2012). The zinc ribbon domain is 
thought to be necessary for RNA interactions (Granneman et al, 2010). 
During ribosome assembly, Nob1 localises to the nucleus and the cytoplasm 
(Fatica et al, 2003). Its activity appears to be inhibited until the final stages of pre-
18S maturation are reached (Granneman et al, 2010). It is possible that it forms a 
functional tetramer in vitro (Lamanna & Karbstein, 2009) although no conclusive 
evidence is available to date that this is the case in vivo. 
Nob1 has been shown to interact with multiple proteins, including Prp43, 
Dim2, and Fap7 (Hellmich et al, 2013; Vanrobays et al, 2008; Woolls et al, 2011). In 
archaea, the interaction with Fap7 blocks D site cleavage in vitro (Hellmich et al, 
2013). However, the cleavage cannot occur in yeast in vivo without Fap7 expression 
(Granneman et al, 2005). 
An NMR structure of the individual domains of the P. horikoshii Nob1 
protein is available. The domains are linked by a flexible region that could not be 
mapped in a single conformation (Veith et al, 2012). Also, the archaeal protein is 
much shorter than its eukaryotic counterpart. Due to the complexity of the ribosome 
biogenesis in eukaryotes, Nob1 has to be separated from the other components in the 
pathway in order to understand its specific function and the mechanism by which it is 
performed. 
During the course of this project, eukaryotic recombinant Nob1 from C. 
thermophilum (Ct), S. cerevisiae (Sc), and H. sapiens (Hs) was expressed, purified, 
and characterised. The results of the characterisation are presented in this chapter.  
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3.2 Cloning and Expression Trials 
 
 
In order to study Nob1 function, different constructs for protein expression 
were created. These included yeast and human versions of the protein, as shown in 
Table 3.1. The ScNob1 full-length and the D15N mutant sequences in the pSL6 
plasmid were obtained from the Tollervey lab. The expression trials for these 
constructs were repeated and can be seen in Figure 3.1. Two media were tested 
(Superbroth and 2xTY) and 2xTY was chosen for all following experiments. The 
expression for the D15N mutant seemed to be as good as for the wild type (WT) 
protein. However, its ability to interact with nickel beads was decreased. 
 
Table 3.1: List of Nob1 constructs. 
The top four constructs were present prior to the start of the project while the rest were created during. 
Insert Organism Plasmid Comments 
Nob1 Full-length (FL) S. cerevisiae pSL6 Expressed, soluble – only in SE1 cells 
Nob1 1-125 (PIN 
domain) 
S. cerevisiae pEC-KHC, 
pEC-KGC 
Expressed, Majority insoluble 
Nob1 264-459 (Zn 
ribbon) 
S. cerevisiae pEC-KHC, 
pEC-KGC 
Expressed, Majority insoluble 
Nob1 D15N S. cerevisiae pSL6 Expressed, soluble 
Nob1 Full-length (FL) S. cerevisiae pET28α Expressed, Soluble 
Nob1 FL H. sapiens pEC-KHC Expressed, Soluble; Degradation seen 
Nob1 D10N H. sapiens pEC-KHC Expressed, Soluble; Degradation seen 
Nob1 FL H. sapiens pET28α Expressed, Soluble; No degradation 
Nob1 D10N H. sapiens pET28α Expressed, Soluble; No degradation 
 
 
 Other constructs were successfully cloned and the sequences were confirmed 
to be correct by Sanger sequencing prior to further use. The human protein sequence 
was originally obtained in the pET100 plasmid from Dr. Nick Watkins (University of 
Newcastle) and then re-cloned into pEC-KHC (see Appendix II) and pET28α. 
Figure 3.2 shows the results of the expression tests for these constructs. These 
results are also summarised in the table. The expression of the full-length yeast 
protein was not as good as using the original clone in the pSL6 vector so it was not 
used after optimisation of purification. 
 The expression of HsNob1 was good. However, putative degradation 
products could be seen with the His-tag on the N-terminus, suggesting that 
truncations were occurring on the C-terminus. These were not seen when the His-tag 
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was moved to the C-terminus as the degradation products now lacked the tag and did 
not bind to the nickel resin. The D10N mutant (like the D15N yeast mutant) showed 
a decreased ability to bind to nickel beads, although moving the tag to the C-




Figure 3.1: Expression trials for His-tagged wild type (WT) ScNob1 and the D15N mutant 
obtained from the Tollervey lab. 
The two proteins were in the pSL6 plasmid (with a non-cleavable C-terminal His-tag) and were 
expressed in SE1 cells in either Superbroth or 2xTY medium. The different lanes correspond to the 
different fractions: uninduced (U), induced (I), soluble (S), insoluble/pellet (P), and the nickel bead-
bound (B) fraction. The molecular weight markers (M) are also shown on each gel. The band 
corresponding to the correct size is indicated with an arrow. The same labels are used in all following 
expression trials. 
A) Expression of the WT ScNob1 in the two media. Both show large amounts of soluble protein. 
However, a larger portion of the soluble protein in 2xTY bound to the beads so this medium was 
chosen for further preparations. 
B) Expression of the D15N mutant version of the ScNob1 protein in the different media. Again, 
expression levels between the media are comparable. Like the WT, all following cultures were 
grown in 2xTY. The mutant protein shows a reduced ability to bind to the nickel beads compared 
to the WT even though the expression level is good. 
 
 
 During the project, Dr. Atlanta Cook also cloned ScNob1 “loop-out” mutants. 
These lacked different regions of the large flexible loop connecting the PIN domain 
to the zinc ribbon. These clones are listed in Table 3.2. As for the other constructs, 
expression tests were performed and the results can be seen in Figure 3.3. All the 
mutants were expressed in BL21 (DE3) cells and showed better enrichment on nickel 
beads than the WT protein. 
 




Figure 3.2: Expression trials for the different Nob1 constructs created during this project. 
The lane labelling is the same as for the previous figure. 
A) Expression of ScNob1 cloned into the pET28α vector in different cells lines. The cell line used is 
shown under each set of fractions. Faint bands at the correct size can be seen in bead-bound 
fractions using BL21 (DE3) and B834 (DE3) strains. The BL21 (DE3) pRIPL cell line shows a 
much higher level of expression. No protein can be observed in any of the lanes for the BL21 
(DE3) pLysS sample. In following experiments, either the pRIPL or the BL21 (DE3) cell lines 
were used for expression. After the purification conditions were established, the pSL6 construct 
was used instead. 
B) Expression of HsNob1 (and the D10N mutant) cloned into the pEC-KHC plasmid. These clones 
have a cleavable His-tag on the N-terminus. The tests were performed in the BL21 (DE3) cell line. 
The WT protein (left) shows some soluble expression, which is enriched in the bead-bound 
fraction. The D10N mutant (right) shows a similar level in the induced fraction as the WT but it 
does not bind to the nickel resin as efficiently, as shown by the lack of enrichment in the bead-
bound fraction. The WT protein shows what might be degradation products in the bead-bound lane 
as there are multiple bands, below the full-length protein, which bound to the nickel beads. 
C) Expression of HsNob1 (and the D10N mutant) cloned into the pET28α plasmid where the His-tag 
is on the C-terminus and is non-cleavable. The level of WT protein in the induced fraction is less 
than for the other construct. However, the level is still enriched on nickel beads and fewer 
degradation products are seen. The D10N mutant shows better enrichment on the beads. The N- 
and C-terminally tagged proteins were tested in purification as shown later. 
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Table 3.2: List of “loop-out” mutants cloned by Dr. Atlanta Cook. 
Insert Organism Plasmid Comments 
Nob1∆L1 (∆151-159) S. cerevisiae pET28α Expressed, Soluble 
Nob1∆L2 (∆151-169) S. cerevisiae pET28α Expressed, Soluble 
Nob1∆L3 (∆151-176) S. cerevisiae pET28α Expressed, Soluble 
Nob1∆L4 (∆141-176) S. cerevisiae pET28α Expressed, Soluble 






Figure 3.3: Alignment and expression of the ScNob1 loop-out mutants created by Dr. Atlanta 
Cook. 
A)  A local sequence alignment (showing residues 135-180) of the full-length ScNob1 and the loop-
out mutants. 
B) The lanes are labelled as before and the construct being tested is shown below each set of samples. 
All the mutants and the WT protein were in the pET28α plasmid containing a non-cleavable C-
terminal His-tag. The expression was performed in BL21 (DE3) cells. As seen before with this 
construct, the WT protein shows a weak band in the bead-bound fraction. All of the mutants 
(ScNob1∆L1-L5) show an increased level of protein in the bead-bound fraction compared to the 
WT suggesting that ScNob1 is stable and soluble without parts of the flexible loop. 
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Finally, Nob1 from C. thermophilum was ordered as a codon optimised 
construct in the pMK-RQ plasmid from GeneArt. The expression was good as shown 





Figure 3.4: Expression trials for CtNob1 in different cell lines. 
Again, the labels are the same as before and the cell lines are shown below each set of samples. The 
protein was expressed and soluble in every cell line tested. The T7 Express cells show the least 
enrichment on the beads. The BL21 (DE3) cell line appears to have the highest expression level and 




3.3 Protein Purification 
 
 
3.3.1 ScNob1 – full-length  
 
 A three-step purification protocol for ScNob1 had been previously 
established involving affinity capture (nickel resin binding the His-tagged protein) 
followed by heparin sepharose and size exclusion chromatography (SEC). All steps 
included buffers supplemented with glycerol (10% for the first two steps and 5% for 
the third). Relatively pure protein was obtained (Figure 3.5). However, as seen in 
Figure 3.5C, contaminants, including RNases, were still present at the SEC step. 
The protocol was further optimized by removing glycerol from the buffers and using 
a cation exchange step instead of heparin sepharose, which improved the quality of 
the protein, especially at the SEC step (Figure 3.6). The protein was predicted to 
bind to the cation exchange column based on its calculated isoelectric point (pI of 
8.5). After optimisation, about 15 mg of protein were obtained from 2 litres of 
bacterial culture. 
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Figure 3.5: Initial purification of ScNob1.  
All chromatograms show absorbance at 280 nm and 260 nm (when available) in blue and red respectively. The pink dotted line corresponds to the injection of the 
sample. The appropriate elution gradient 
is shown as a green line. The protein of 
interest is indicated on the gels with an 
arrow. 
A) Nickel resin purification. The 
green line shows the imidazole gradient 
(20-500 mM) used for elution. On the 
right, an SDS-PAGE gel of the different 
fractions is shown. ScNob1 runs just 
below 66 kDa and is the most visible 
band. Anything that came off the column 
prior to the gradient was considered to be 
flowthrough (FT). 
B) Heparin sepharose column 
purification. The green line shows the 
salt gradient (200-1000 mM). Again, 
SDS-PAGE gels of the fractions are 
shown with the band corresponding to 
ScNob1 marked with an arrow. 
C) SEC of the ScNob1 sample. The 
first peak corresponds to the void volume 
(i.e. FT) and shows that some 
contamination is present (possibly RNA 
contamination as it displays relatively 
high absorbance at 260 nm compared to 
280 nm). 
 
U. McCaughan  Chapter 3: Characterisation of Nob1 
 72 
Figure 3.6: Optimised purification 
of ScNob1.  
All the labelling and colour schemes 
are the same as on the previous 
figure. No glycerol was used in the 
buffers and the second step was 
changed.  
A) As before, the first step 
consisted of nickel affinity 
purification. The profile appears 
different, as the buffers used this 
time did not contain glycerol.  
B) The second step was 
changed to cation exchange i.e. 
Mono S column. The elution profile 
can be seen. The gradient ranged 
from 100 to 1000 mM salt. The 
majority of the contaminants 
precipitated out of solution during 
dialysis into 100 mM NaCl prior to 
this step. The gel on the right shows 
that the protein coming off during 
the gradient is relatively clean. 
C) The final step was, again, 
SEC. No FT in the void volume is 
seen since the input is cleaner. The 
extra bands seen on the gel appear to 
be degradation products and not 
contamination. 
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3.3.2 CtNob1 – full-length  
 
 CtNob1 was first purified using the same starting protocol as ScNob1. 
However, as with ScNob1, contaminants were still present after size exclusion 
chromatography (Figure 3.7). Also as with ScNob1, a similar improvement in purity 
was observed when an anion exchange step was included after initial affinity capture 
(Figure 3.8). An anion exchange step, instead of cation exchange, was used due to 
the predicted pI (6.1). About 11 mg of protein could be obtained from 4 litres of 
culture. 
 
3.3.3 HsNob1 – full-length 
 
Initially, the N-terminally tagged protein (expressed from the pEC-KHC 
plasmid) was subjected to purification. As with the protein from the other two 
organisms, nickel affinity was used as the first step. Then, the tag was cleaved and 
the protein was loaded onto an anion exchange column (pI of 6.6). However, as 
shown in Figure 3.9, there were many degradation products present that could not be 
separated using these two steps. Therefore, no further attempts were made using this 
construct. 
The protein was re-cloned to contain a non-cleavable C-terminal His-tag to 
prevent the binding of degradation products to nickel resin. The purification was 
performed as above but an ATP wash was included in the first step to remove any 
associated chaperones. After the anion exchange, a SEC step was performed (Figure 
3.10). The HsNob1 obtained was not completely pure and only about 30 µg of 
protein were obtained from 4 litres of bacterial culture. 
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Figure 3.7: Initial purification of 
CtNob1.  
All the labelling and colour 
schemes are the same as on 
previous figures. The protocol is 
the same as, initially, for the S. 
cerevisiae protein. However, 
unlike for ScNob1, the His-tag 
was cleaved with 3C protease after 
the first step. All buffers contained 
glycerol. 
A) Initially, nickel affinity 
was used as for ScNob1.  
B) Heparin sepharose 
purification. Again, similar to 
results seen for ScNob1. 
C) As with the other Nob1 
protein, contaminants are still seen 
at the SEC step with likely RNA 
contamination coming out in the 
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Figure 3.8: Optimised purification of 
CtNob1.  
All the labelling and colour schemes are 
the same as on previous figures. No 
glycerol was used in the buffers and the 
second step was changed. 
A) The nickel affinity column 
elution profile is similar to before. The 
first spikes in absorbance seen after the 
start of the gradient were artefacts due to 
pump malfunction during the run. The gel 
shows that, at this stage, more 
contamination is present without glycerol 
in the buffers. 
B) A Mono Q anion exchange 
column was used to replace the heparin 
sepharose step. This gave very good 
separation with many contaminants 
coming off the column later in the 
gradient. The gradient ranged from 50 to 
1000 mM salt. 
C) The SEC shows only one peak, 
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Figure 3.9: Purification of N-
terminally tagged HsNob1. 
The labelling is the same as 
before. 
A) The nickel affinity elution 
profile shows a single peak. 
However, when the fractions are 
examined on the gel, many 
degradation products can be seen. 
B) Elution from the anion 
exchange column (over a 100-
1000 mM salt gradient). Due to 
technical issues during the run, 
fraction numbers are overlaid over 
the chromatogram in red. Multiple 
peaks were seen, most of them 
containing HsNob1, as shown on 
the gel. Also, a potential 
chaperone was pulled out and none 











U. McCaughan  Chapter 3: Characterisation of Nob1 
 77 
Figure 3.10: Purification of C-terminally 
tagged HsNob1. 
A) An ATP wash was included in the 
nickel affinity step to remove the potential 
chaperone. A small peak containing 
HsNob1 was eluted. The gel on the right 
shows a much cleaner product than 
obtained with the N-terminally tagged 
construct. 
B) The anion exchange profile, again, 
shows multiple peaks most of which 
contain HsNob1. However, most of the 
protein of interest is in peak 1. Therefore, 
fractions containing this peak were pooled 
and used in SEC. 
C) Results of the SEC. Two peaks 
could be observed. One corresponded to the 
potential chaperone and the other to 
HsNob1. Although it is not completely 









3.3.4 ScNob1 – D15N mutant 
 
After the WT protein was purified, the catalytic mutant (ScNob1 D15N) was 
subjected to the same purification protocol. Some of the protein did bind to the 
nickel beads but the majority was left in the flowthrough, supporting the results from 
the expression test. The protein that did bind was then dialysed into 100 mM salt in 
preparation for the cation exchange column. However, unlike the WT ScNob1, the 
mutant precipitated and it could not be rescued with higher salt. Therefore, the 
concentration of salt during dialysis was changed to 150 mM, which prevented the 
precipitation. 
The mutant ScNob1 was then separated on a cation exchange column 
followed by SEC. During SEC, the protein came out in the void volume suggesting 
that it was aggregated. Also, the absorbance at 260 nm was higher than at 280 nm 
showing that RNA contamination was present (Figure 3.11). 
In order to prevent the aggregation, the purification was performed again but 
with a sonication step added following cell lysis. As seen in Figure 3.12, this was 
successful in giving some non-aggregated protein. However, only 90 µg of the 
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Figure 3.11: Initial purification of the 
ScNob1 D15N mutant. 
A) The elution from the nickel 
column shows a single peak. When the 
fractions were separated on SDS-PAGE, 
a protein of the correct size could be seen. 
However, the majority still remained in 
the flowthrough (FT). Also, many 
contaminants were still present after this 
step. 
B) Cation exchange was used as the 
second step. All of the protein bound to 
the column and was eluted late in the 
150-1000 mM salt gradient. Some of the 
contaminants were removed using this 
step. 
C) Again, SEC was used as the 
final purification step. However, all of the 
protein was eluted in the void (i.e. FT). 









Figure 3.12: SEC results for the ScNob1 D15N mutant when sonication is used after cell lysis. 
The first two steps were identical and no difference was seen in the chromatograms or on the gels. The 
SEC chromatogram still shows a lot of protein in the FT and this was confirmed on the gel. However, 




3.3.5 ScNob1 – Loop-out mutants 
 
Initially, only two of the loop-out mutants were purified. ScNob1∆L4 (∆141-
176), the mutant with the largest deletion, was purified first using the protocol 
established for the WT protein, with the exception that anion exchange was used 
instead of cation exchange. This change was necessary because the flexible loop that 
was removed by the mutation contained multiple positively charged residues. Thus, 
the new construct had a significantly reduced pI (6.1). The mutant did not bind to the 
anion exchange column as seen in Figure 3.13. However, the contaminants did bind, 
giving relatively pure protein by a subtractive purification step. After the SEC step, 2 
mg of protein were obtained from 2 litres of culture. 
ScNob1∆L3 (∆151-176) was then purified in the same manner (pI of 6.5). 
Again, relatively pure protein was obtained (Figure 3.14). In the end, 0.4 mg of 
protein were obtained from 2 litres of culture. The SEC profile showed some low 
molecular weight contaminants, likely nucleic acids.  
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Figure 3.13: Purification results for the 
ScNob1 ∆L4 mutant. 
A) A single peak is eluted from the 
nickel affinity column. This peak 
corresponds to the right protein and shows 
a relatively clean elution on the gel. 
B) The sample was then injected 
onto an anion exchange column to which 
it did not bind. It could be that the starting 
salt (150mM) concentration was too high. 
The gel confirms that the majority of the 
protein remained in the FT. This was 
concentrated for SEC. 
C) A single peak was obtained in the 
SEC that corresponded to the ScNob1∆4 
mutant on the gel. The protein appears to 
be relatively pure. 
 
 




Figure 3.14: SEC profile for the ScNob1∆L3 mutant. 
The first two steps looked the same as for the ∆L4 mutant. In the last step, the protein was eluted in a 
single peak. However, there was a contaminant present, which gave rise to a tail. Also, low molecular 
weight contaminants were seen (peaks 2-5). These came out towards the end of the column volume 
(120 ml). Nothing is seen in these fractions on the Coomassie stained gel. The absorbance at 260 nm 




Finally, with the help of a summer intern (Michal Merdas), the other loop-out 
mutants were also purified using the same protocol. The protein parameters and 
yields from 2 litres of culture are listed in Table 3.3. All of the constructs behaved in 
the same manner throughout the purification. ScNob1∆L1 showed some aggregation 
in the SEC step performed by Michal Merdas (data not shown). However, a peak of 
the right size was still seen. 
 
 
Table 3.3: Summary of loop-out protein parameters and the yield obtained from 2 litres of 
bacterial culture. 
Construct Molecular Weight (kDa) Isoelectric point Yield from 2L (mg) 
Nob1∆L1 (∆151-159) 52.0 6.8 2.4 
Nob1∆L2 (∆151-169) 50.9 6.3 1.2 
Nob1∆L3 (∆151-176) 50.2 6.5 0.4 
Nob1∆L4 (∆141-176) 49.1 6.7 2.0 
Nob1∆L5 (∆141-159) 50.8 7.0 2.3 
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3.4 The ScNob1 Protein is Unlikely to be Monomeric 
 
 
ScNob1 was purified and eluted as a single peak in SEC. However, the size 
appeared to be larger than predicted for the monomer (53 kDa). Figure 3.15A shows 
a comparison of the ScNob1 SEC profile with some known size standards. However, 
as SEC depends on the shape of the molecule as well as the size, the oligomeric state 
of ScNob1 cannot be obtained from this result.  
Thus, a sample of ScNob1 was sent to Dr. Andrew Leech at the University of 
York for size exclusion chromatography coupled with multi-angle light scattering 
(SEC-MALS) analysis, which can give absolute molecular mass. The resulting 
calculations showed a size of about 120 kDa. However, this was an overestimate, as 
there seemed to be a mixture of high and low molecular weight material (Figure 
3.16). Overall, it appears that ScNob1 might form a dimer in solution. 
 
 
Figure 3.15: ScNob1 and 
ScNob1∆L4 SEC results 
compared to size standards.  
The protein standards are 
labelled under the 
chromatogram. Their sizes 
(in kDa) are shown in orange 
next to each peak with the 
corresponding elution 
volumes shown above these 
in blue or green. 
A) Comparison of 
ScNob1 with the size 
standards. ScNob1 appears 
larger than the BSA 
monomer but smaller than 
the dimer. As the proteins get 
larger, the space between 
peaks gets smaller. 
B) SEC results for 
ScNob1∆L4 compared to the 
standards. The protein is now 
smaller than the BSA 
monomer (66.5 kDa). Thus, 
it is either significantly 
smaller than the WT or it has 
changed its shape. 
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The loop-out version (∆L4) of ScNob1, however, shows a relatively large shift 
to a later elution volume in the SEC (Figure 3.15B) suggesting that the size had 
significantly changed. The deletion in ∆L4 should correspond to a decrease in size of 
about 3.3 kDa. However, the difference seen in SEC suggests a larger change, 
possibly a monomerisation. The elution volume of the ∆L3 mutant was almost the 
same as for ∆L4 (less than 0.6 ml difference), suggesting that the decrease in size 
between the mutants and the WT protein (5.4 ml to ∆L4) is significant. The ∆L3 






Figure 3.16: ScNob1 molar mass plot obtained from SEC-MALS analysis. 
The plot shows the calculated molar mass as the overlaid dark red line and the SEC peak. The 
absorbance at 280 nm (top red trace) and the amount of light scattering (bottom red trace) is shown as 
the protein is eluted from the SEC column (x-axis shows the elution time). The y-axis displayed is 
associated with the molar mass line and is shown on an exponential scale. The y-axes for the 
absorbance and light scattering are not shown for simplicity. The flat portion of the molar mass line at 
about 29.5 min corresponds to about 120 kDa. However, the line then goes up exponentially 
suggesting the presence of high molecular weight particles along with the smaller molecules. This is 
supported by the presence of a tail following the peak in the chromatogram. 
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3.5 Determination of Protein Stability by Thermal Denaturation 
 
 
3.5.1 ScNob1  
 
The stability of the purified ScNob1 was tested using thermal denaturation in 
different buffer conditions. In this assay, Sypro Orange is used as a dye that increases 
in fluorescence when it is in a hydrophobic environment. Thus, when a protein 
denatures at higher temperatures and exposes its hydrophobic core, an increase in 
fluorescence is seen. This allows the temperature at which the protein is denatured 
(melting temperature or Tm) to be obtained, giving a measure of its stability in 
different conditions. 
Initially, it was found that the Tm of the protein decreased from 48.5˚C to 
45.7˚C with increasing concentration. Also, the melting temperature decreased with 
lower pH or lower glycerol concentrations. However, salt and zinc concentrations 
had no effect on protein stability (Figure 3.17).  
 
3.5.2 CtNob1  
 
As expected, the C. thermophilum protein was more stable than the yeast 
protein (Tm = 61.0˚C vs. 48.0˚C). Protein concentration did not have as significant an 
effect on stability as for ScNob1. Increasing salt concentration changed the stability 
by a modest amount (60.7˚C to 61.7˚C over 50 to 250 mM NaCl). Also, CtNob1 
showed a decreased melting temperature in the presence of 10 µM zinc (61.0˚C went 
down to 60.2 ˚C). Like the yeast protein, decreasing pH and glycerol also decreased 
the melting temperature of CtNob1 (Figure 3.18). 
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Figure 3.17: Thermal denaturation results for ScNob1. 
The experiments were performed in triplicate. The error bars represent the standard deviations. 
A) An example of the raw thermal melt obtained. The increase in relative fluorescence units (RFU) 
was recorded over changes in temperature. SYPRO Orange fluorescence increases as it comes in 
contact with hydrophobic residues. Therefore, the increase in RFU corresponds to protein 
denaturation. For ScNob1, a single melt curve is seen. 
B) An example derivative of the thermal melt. The bottom of the peak corresponds to the melting 
temperature (Tm). This value was taken for each of the experiments and averaged over the three 
repeats to obtain the summarised results. 
C) Summary of the effect of protein concentration on protein stability. Higher ScNob1 concentrations 
led to a lower melting temperature suggesting decreased stability.  
D) 2 µM protein was used for all the following experiments. Summary of the effect of pH on the 
melting temperature. The protein appears to be more stable at higher pH. 
E) Effects of glycerol concentration on ScNob1 stability. The Tm increases with glycerol. 
F) NaCl concentration has no effect on protein stability. 
G) Zinc has no effect on ScNob1 stability.  
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Figure 3.18: Thermal denaturation results for CtNob1. 
The experiments were performed in triplicate. The error bars represent the standard deviations. 
A) An example of the raw thermal melt obtained. As for ScNob1, a single melt curve is seen for 
CtNob1. 
B) An example derivative of the thermal melt. The Tm is higher than that of ScNob1. 
C) Summary of the effect of protein concentration on protein stability. As for ScNob1 concentrations 
led to a lower melting temperature but the effect is less pronounced. 
D) 2 µM protein was used for all the following experiments. Summary of the effect of pH on the 
melting temperature. This protein also appears to be more stable at higher pH. 
E) Effects of glycerol concentration on CtNob1 stability. The Tm again increases with glycerol. 
F) NaCl concentration slightly increases CtNob1 stability (unlike for ScNob1). 
G) Zinc has no clear effect on CtNob1 stability. However, a lower Tm is observed at 10 µM zinc 
concentration.
U. McCaughan  Chapter 3: Characterisation of Nob1 
 88 
3.6 Identification of Stable Domains by Limited Proteolysis 
 
 
3.6.1 CtNob1  
 
 CtNob1 was digested with a series of dilutions of different proteases (Figure 
3.19) in order to determine if any stable domains are present. The low concentrations 
of proteases should allow cleavage only in exposed flexible regions, whereas stable 
folded domains would be protected. These would then be identified as abundant 
bands on Coomassie-stained SDS-PAGE gels. 
Chymotrypsin gave one relatively stable fragment. MALDI-ToF analysis of 
the band identified peptides that primarily map to the N-terminus, suggesting a C-
terminal truncation. However, due to time constraints, this was not explored any 
further. The same experiment had previously been performed with ScNob1 by Dr. 
Atlanta Cook without any promising results and was, therefore, not repeated. 
 
 
3.7 Crystallisation Trials 
 
 
 Crystallization trials of ScNob1 and CtNob1 were performed using several 
commercial screens in 96-well plates (Magic I, Magic II, Hampton Index, Morpheus, 
JCSG+, and Structure screen 1 and 2). However, none of them yielded any promising 
crystal hits. This is likely due to the proteins’ flexibility.  
All of the loop-out mutants were also tested (using at least the Hampton 
Index and Magic I screens for each) with the help of Michal Merdas. The initial 
results looked more promising than for the full-length constructs. Over half of the 
wells for the mutants showed granular precipitation, which suggests that nucleation 
events could be happening. About a week after screening, crystals were observed in 
one condition for ScNob1∆L2 and ∆L3. These are shown in Figure 3.20. The 
condition contained BIS-TRIS at pH 6.5 and 5.5 respectively and 25% (w/v) PEG 
3350. 
The crystals seen were very small and needle shaped. These need to be 
further optimised in the future. Due to time constraints and their size, they have not 
yet been tested for diffraction. 





Figure 3.19: Limited proteolysis and mass spectrometry analysis of CtNob1.  
A) Results of limited proteolysis performed on CtNob1. The enzymes used are shown above. Three 
dilutions per enzyme (of 1 mg/ml stocks) were used. Limited proteolysis allowed mapping of 
stable regions. The band of interest in the 1:100 chymotrypsin lane is marked with an arrow.  
B) Mass spectrometry analysis of the band of interest. The band was excised from the gel and 
subjected to trypsin digestion. The predicted cleavage sites are marked with blue arrows. Then, the 
resulting peptides were analysed using MALDI-ToF mass spectrometry. The identified fragment is 
likely a C-terminal truncation. Most of the N-terminal portion is covered by the identified peptides 
(shown in red). Only one C-terminal peptide is seen suggesting that this part of the protein is 
underrepresented in the sample, even though some of the predicted fragments would be long 
enough to be seen. The experiment can be potentially scaled up in order to obtain a large amount 
of the truncated protein. 





Figure 3.20: Initial crystal hits obtained with ScNob1∆L2 and ∆L3. 
A) The small needles obtained using ScNob1∆L2 in the Hampton Index screen. The crystals are very 
small and attached to each other. 
B) Crystals obtained with ScNob1∆L3 in the same screen but at a different pH. The needles are larger 







3.8.1 Protein expression and purification 
 
Nob1 from three organisms was successfully expressed and purified. 
However, the level of success varied between the different constructs. The yeast 
Nob1 was over-expressed in SE1 cells from the pSL6 vector. However, when the 
same protein was re-cloned into the pET28α plasmid, the expression level dropped. 
A similar expression level to the pSL6 construct was observed in the expression tests 
using the RIPL cell line. However, this still equated to significantly less protein per 
unit biomass. 
Successful purification protocols were established for both constructs. DTT 
was replaced by -mercaptoethanol in all Nob1 purifications, as it has been shown to 
be able to chelate zinc in the past (Krezel et al, 2001). The protocols were optimised 
so that the SEC acted as final quality control. After the cation exchange, all the 
visible contaminants were removed. However, some low molecular weight bands 
could still be seen on the gel. The fact that they all came out in a single peak in SEC 
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suggests that they were degradation products. Their amount was minimised in later 
preparations by always keeping the sample at 4˚C during purification and performing 
the first two steps as quickly as possible. 
Human Nob1 was clearly over-expressed when it was cloned into the pEC-
KHC vector. However, there were multiple degradation products eluted after the first 
step and purification led to a mixture of differently sized fragments that could not be 
separated. Therefore, the protein was cloned into a pET28α plasmid with a C-
terminal His-tag. This helped to decrease the amount of degradation products. 
However, while the protein was still enriched on nickel beads, it was less well 
expressed than the other construct.  
Nevertheless, the C-terminally tagged HsNob1 was purified. Due to the low 
level of expression and the presence of multiple contaminants, a very small amount 
of protein (30 µg from 4 litres of culture) was obtained. Thus, this protein was not 
used for any assays or for crystallisation. 
Nob1 from the thermophilic fungus, C. thermophilum, was ordered as a 
codon optimised construct. Thus, it was used directly in expression trials where it 
was shown to be over-expressed in all the strains used. The purification protocol 
used was the same as for ScNob1 and it was optimised in the same fashion. As with 
the yeast protein, some degradation was seen but it was reduced over time by 
performing the purification fast and keeping the protein on ice. 
For human and yeast Nob1, the catalytic mutants were expressed (D10N and 
D15N respectively). Surprisingly, the N-terminal mutation decreased the ability of 
the C-terminal His-tag on ScNob1 to bind to nickel beads. The D15N mutant was 
clearly over-expressed and soluble, but it was not enriched on the beads. During 
purification trials, after the nickel affinity step, most of the protein was still in the 
flowthrough. It was later shown in the SEC that the mutant formed an aggregate. 
Thus, it could be that the C-terminal His-tag was sequestered in the aggregate and 
could, therefore, not bind to the resin. 
With the human D10N mutant, the same trend was seen with the N-
terminally tagged protein. However, as the mutation is on the N-terminus, there are 
potential changes in conformation that could not have been predicted and perhaps 
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sequestered the His-tag. Purification of this construct was not undertaken due to the 
problem with degradation products mentioned earlier. 
The C-terminally His-tagged D10N mutant showed an ability to bind to 
nickel beads that was comparable to the WT HsNob1 protein. However, the over-
expression was low as for the WT. Therefore, no further attempts were made to 
purify this construct either. 
Finally, five yeast loop-out mutants were tested. All five mutants showed 
more over-expression in the pET28α vector than the WT ScNob1. All of these were 
purified. The first one used, ∆L4, had the longest truncation. A single peak 
corresponding to the relevant protein was seen for each mutant in SEC. This suggests 
that the mutant proteins still folded properly. The elution profile for the ∆L3 mutant 
showed a tail and substantial low molecular weight contaminants (likely RNA). 
However, the SEC peak still contained relatively pure protein. ∆L1 showed some 
aggregation in the void volume. However, a peak for the non-aggregated protein was 
also seen and contained the pure product. The other two mutants behaved well, 
giving single peaks in SEC containing pure protein.  
 
3.8.2 Oligomerisation state of Nob1 
 
Initially, when the full-length Nob1 was purified, its size (predicted on the 
elution volume from the SEC column) appeared to be larger than expected. However, 
the separation in SEC depends on the shape of the molecule and its interactions with 
the matrix as well as its size (Wen et al, 1996). Therefore, it is possible that the Nob1 
protein is a monomer, but it is extended in one direction giving the appearance of a 
larger molecule. The archaeal structure showed that the two domains move with 
respect to each other due to the flexible linker. Thus, at any time, they might be 
relatively far apart from each other creating an elongated molecule. 
SEC-MALS was performed in order to obtain a definite size of the particles. 
This method relies on light scattering immediately following the SEC. The scattering 
of the laser is measured at different angles and is dependent on the properties of the 
particles in the solution. Unlike with just SEC, the absolute molecular weight can 
then be calculated from the scattering behaviour (Oliva et al, 2001).  
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Results from the SEC-MALS performed at the University of York were 
inconclusive as well, as the sample appeared heterogeneous. The presence of the tail 
following the peak suggests that there are some interactions between the protein and 
the matrix. The experiment was performed at room temperature, which could also 
have caused additional changes in the protein-protein and protein-matrix interactions 
compared to the purification performed at 4˚C. Nevertheless, it appears as though the 
particle is around 120 kDa, although this is likely an overestimation. The results 
would be consistent with ScNob1 being a dimer in solution. 
In the future, if possible, SEC-MALS should be repeated with fresh protein 
immediately from purification. Also, to complement the method, the same sample 
(once retrieved from SEC-MALS) should be tested with dynamic light scattering 
(DLS). This technique measures the dynamic properties of the particles in the 
sample, such as the hydrodynamic radius. Like with MALS, scattered light is 
measured. However, the information is obtained from the effect of the neighbouring 
particles and Brownian motion of the protein on the scattered light. This would give 
an idea about whether the protein is monodispersed and about how many other 
species are present in the sample (Berne & Pecora, 2000). This would then allow 
clarification of ambiguous SEC-MALS results where more than one species appears 
to exist. 
The thermal denaturation experiments showed that ScNob1 stability is 
concentration dependent. For all of the SEC experiments, the protein concentrations 
were relatively high (about 38 µM). Therefore, it is possible that this caused some 
protein to be improperly folded giving an asymmetric peak in SEC. 
Additionally, the SDS-PAGE gels from SEC showed the presence of smaller 
species, which are likely to be degradation products. This would be supported by the 
fact that a single elution peak is seen suggesting that the smaller species are 
associated with each other making a complex of a similar size/shape as the full-
length protein. For example, if the proteolysis occurred in the flexible linker, the two 
functional domains could stick together through protein-protein interactions in SEC 
but be separated in denaturing gels. These types of species could also cause the tail 
seen in SEC. The identity of the fragments could be confirmed by mass spectrometry 
analysis of the bands. 
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Conversely, the two loop-out mutants purified showed elution volumes in 
SEC that would be consistent with the protein being monomeric. Thus, it is possible 
that the flexible loop region is responsible for dimerization and removing it prevents 
this from happening. This is unlikely as this part is not well conserved and it does not 
appear to be folded. Nevertheless, SEC-MALS will have to be performed on these 
mutant proteins in order to obtain the absolute size. 
 
3.8.3 Potential for crystallisation 
 
All of the purified constructs were used for crystallisation screening where 
possible. The full-length proteins did not give any hits. These proteins have a long 
flexible region between the two functional domains. In archaea, this region was 
shown to be very flexible in NMR (Veith et al, 2012). Thus, it is likely that the 
protein is too dynamic for crystallisation. 
To negate this issue, the loop-out mutants were created. If the two domains 
interact with each other, these mutations would help by removing the flexible region 
(Figure 3.21A). This arrangement is supported by the fact that when the domains 
were cloned separately (by Iva Tchasovnikarova), they were found to be insoluble. 
However, it is also possible that the two domains do not form any interactions and 
rotate independently of each other. In this situation, the deletion of the linker would 
only bring the domains closer together without making the protein less flexible 
(Figure 3.21B). 
All of the mutant proteins were purified and two of them gave a hit in the 
Hampton Index screen. Also, all of the constructs behaved well in purification, 
implying that the folding of the domains was not significantly changed. No 
aggregates were present (apart from ∆L1) and the crystallisation screens showed the 
presence of globular precipitation. In the future, the initial crystals obtained should 
be optimised and grown on a larger scale. 
Once they are large enough, the crystals can be tested for diffraction at the 
Diamond Light Source synchrotron (Oxford, UK). It is possible that the species 
forming are salt crystals but this is unlikely, as the crystallisation conditions did not 
contain additional salts. Nevertheless, this cannot be ruled out at this stage and 
further testing needs to be undertaken. If the initial crystals do not diffract, the 
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species can be identified by dissolving the crystals, separating them on SDS-PAGE, 
and silver-staining the gel. 
The CtNob1 protein showed a promising stable fragment in limited 
proteolysis. Mass spectrometry analysis of the protein fragment showed large 
coverage of the N-terminus and only a single peptide at the C-terminus. Thus, this 
band could represent a C-terminal truncation. The last N-terminal peptide identified 
ends at residue 274. The flexible loop spans residues 163-321. Therefore, it is 
possible that the proteolysis occurs within the loop. 
Large scale limited proteolysis coupled with SEC purification would lead to 
enrichment of this fragment and electrospray mass spectrometry could be used to 
obtain a total mass in order to identify the cleavage site. As it appears to be 
proteolytically stable, it might represent a single domain that could prove easier to 
crystallize.  
Previously, Iva Tchasovnikarova has tried to express the individual domains 
(PIN and zinc ribbon) separately. However, they were found to be insoluble. Using 
the limited proteolysis, a better map for the domains could be obtained and soluble 
fragments might be able to be cloned. Due to time constrains, this has not been 




Figure 3.21: The two possibilities for 
domain organisation of Nob1. 
The PIN (blue) and zinc ribbon (ZnR, grey) 
domains are shown to be connected by the 
flexible loop (black line). 
A) If the two domains interact with 
each other, the deletion of the loop removes 
the flexible region of the protein particle 
B) If the two domains do not interact, 
the deletion of the loop still allows them to 
rotate with respect to each other. Thus, the 
flexibility is still present. 
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3.9 Concluding remarks 
 
 
Overall, the expression and purification of Nob1 were successful. The protein 
appeared to be folded and stable at room temperature. The oligomerisation state of 
each of the constructs remains in question. Crystallisation of the loop-out mutants 
has shown a promising hit with a lot of potential for optimisation in the future. The 
two domains could also be cloned separately in order to solve the individual 
structures. This was unsuccessful in the past but potential for optimisation still exists. 
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In order for Nob1 to perform its function, it needs to form the necessary 
contacts with RNA. This is especially important as its nuclease activity has to be 
specific to the D site (Pertschy et al, 2009). The interaction between Nob1 and RNA 
has been debated for a long time. Some studies have shown it binding near to the D 
site (Lamanna & Karbstein, 2009). However, initial cross-linking studies placed it at 
a more distant site (helix 40) that would require a conformational change to occur in 
order for the cleavage to take place (Granneman et al, 2010). Otherwise, the zinc 
ribbon domain could be binding to helix 40 while the PIN domain interacts with the 
D site. 
More recent cross-linking experiments in growing cells, performed by the 
Tollervey lab, (unpublished results) support that Nob1 does interact with the D site. 
Also, a sequence upstream of the cleavage site, in the first internal transcribed spacer 
(ITS1), was identified using these conditions. Again, it is possible that all these 
interactions occur at different stages of pre-18S maturation and/or via different 
domains of the protein. Additionally, the predicted Dim2 binding sequence 
(GGAUCA) is proximal to the cleavage site, potentially obscuring or aiding Nob1 
binding. 
It is also unclear which domain of the Nob1 protein is more important for the 
RNA interactions. It has been shown that the PIN domain is required for the cleavage 
at site D (Fatica et al, 2004; Lamanna & Karbstein, 2009). The activity of this 
domain is stimulated by manganese cations (Lebaron et al, 2012). However, it is 
unclear if the domain is bound to the D site prior to the cleavage or if it only makes 
the necessary contacts immediately preceding cleavage. 
Finally, although Nob1 has been shown to bind to the D site and some 
different sequences (Granneman et al, 2010; Lamanna & Karbstein, 2009), no 
consensus recognition sequence for Nob1 has been identified. Thus, it is unclear how 
it is properly placed on the RNA to perform its high fidelity function. In this chapter, 
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recombinant eukaryotic Nob1 is used to identify the potential short RNA sequences 
recognised by this protein. 
 
 
4.2 Nob1 Does Not Interact with Helix 40 RNA in vitro 
 
 
In order to investigate whether recombinant Nob1 can bind to the initially 
identified cross-linked site, short RNAs containing the helix 40 (H40) sequence were 
designed. Three RNAs of different lengths were used, as the exact recognition 
sequence is unknown. To transcribe the individual RNAs, the T7 polymerase was 
purified as described in the next section. 
 
 
4.2.1 Expression and Purification of the T7 Polymerase 
 
 
The T7 polymerase was used for the large and small scale in vitro 
transcription of different RNAs during this project. The protein expression was 
initially tested in M15 cells in two media: Superbroth and 2xTY. The expression was 
very good, as shown in Figure 4.1. Thus, 2 litres of culture were used to purify the 
polymerase according to a previously established protocol (Arts et al, 1997). 
 
 
Figure 4.1: Expression trial of T7 polymerase in M15 cells in Superbroth and 2xTY media. 
The different lanes correspond to the different fractions: uninduced (U), induced (I), soluble (S), 
insoluble/pellet (P), and the nickel bead-bound (B) fraction. The molecular weight markers (M) are 
also shown on each gel. The band corresponding to the correct size is indicated with an arrow. The 
protein is highly over-expressed in both media and enriched on the beads as expected. Superbroth was 
chosen as the medium for large-scale expression. 
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The first step of purification used affinity chromatography. The His-tagged 
protein was bound to cobalt beads and eluted with an increasing concentration of 
imidazole. As seen in Figure 4.2, a single large peak containing the polymerase was 
eluted. The protein was pooled and dialysed into a low salt buffer. Then, it was 
injected onto a hydroxyapatite column and eluted with an ammonium sulphate 
gradient. Again, a single peak was obtained containing pure T7 polymerase. 
The protein was concentrated to 10 mg/ml and then diluted to 5 mg/ml with 
100% glycerol (to obtain a mixture containing 50% glycerol). It was flash frozen in 
liquid nitrogen and stored at -80˚C until needed. About 140 mg of protein were 
obtained from the 2 litres of culture. 
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Figure 4.2: Purification of the T7 polymerase using a previously established protocol.  
All chromatograms show absorbance at 280 nm in blue. The pink dotted line corresponds to the injection of the sample. The appropriate elution gradient is shown as a 
green line. The protein of interest is indicated on the gels with an arrow. 
A) Affinity purification using cobalt resin. The protein bound to the column via its His tag and was eluted using an imidazole gradient (from 5 to 500 mM over 100 
ml). A single peak that saturated the UV lamp was eluted. SDS-PAGE of the fractions showed that the peak contained the correctly sized protein and that most of 
the input bound to the column. 
B) Hydroxyapatite purification of the T7 polymerase eluted from the cobalt column. The vast majority of the protein bound to the column and was eluted in a single 
peak over a 0 to 7.5% ammonium sulphate gradient. The peak contained pure full-length and nicked T7 polymerase as shown on the gel. 
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The activity of the purified T7 polymerase was immediately tested alongside 
the MEGAshortscript kit (Ambion). The results (Figure 4.3) showed that the 
transcription was very similar using the two protocols. 
 
 
Figure 4.3: An in vitro transcription test using the commercial 
MEGAshortscript kit and the purified T7 polymerase. 
Both methods show a high level of transcription in the same time. The 
commercial kit shows a slightly larger amount of the full-length RNA 
but the levels are comparable. Some degradation products are seen in 

















4.2.2 Successfully transcribed helix 40 RNAs 
 
The RNAs that were successfully transcribed are listed in Table 4.1. The 
DNA sequences were cloned into the pUC19 plasmid and linearized with restriction 
enzymes. This allowed the polymerase to reach the end of the template and fall off, 
terminating transcription. Alternative restriction sites were also present to allow the 
creation of a 3 extension for primer extension (see section 4.3.2). The RNA was then 
transcribed using the MEGAshortscript kit (Ambion). Figure 4.4 shows different 
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Table 4.1: RNA sequences obtained from in vitro transcription and the structures predicted to 
form.  
The helix 40 sequences from S. cerevisiae (ScH40) were successfully transcribed. Black letters in the 
sequences mark the regions that correspond to actual rRNA. Extra bases were added for more efficient 
cloning, transcription, and/or loop formation. These are shown in blue on the structure images and in 
the sequences. The structures shown are predicted to form in vivo. 
Organism  RNA Name Predicted Secondary 
Structure 
RNA Sequence 























 Additional S. cerevisiae and C. thermophilum short H40 RNAs were 
synthesized by IDT. These are shown in Table 4.2. They did not contain the extra 
bases (denoted in blue in Table 4.1) and were tested in some assays. 
 
Table 4.2: Helix 40 RNA sequences from the two organisms synthesized by IDT.  
They form the structure shown for the short H40 in Table 4.1 but without the extra blue bases. The 
sequences differ from each other by two nucleotides (marked in red). These lie in the single-stranded 
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Figure 4.4: In vitro transcription of the different 
H40 RNAs cloned. 
Two marker RNAs (marked with an M) were run 
on the gel as size standards (14 and 42 bases long). 
The transcribed RNAs ran at the appropriate sizes 
although some products were stuck in the wells. 
This could be due to secondary structures not being 
fully denatured or due to the plasmid not being 
completely digested and some long RNAs being 
made. Either way, the gel shows that the H40 









4.2.3 Determination of helix 40 RNA secondary structure by chemical 
modification and primer extension  
 
The structure of the RNA likely plays a role in its ability to bind to Nob1. 
Since the RNA is taken out of the ribosomal environment, its structure could be 
affected. Thus, the secondary structure of the short constructs was probed using 
chemical modification followed by primer extension. 
RNAs were transcribed with an extended 3 vector sequence to allow the 
binding of the primer. They were then subjected to treatment with 1M7, which 
modifies flexible nucleotides usually indicating non-base pairing. Reverse 
transcription was used to identify the modified (i.e. single-stranded) regions as the 
enzyme stopped transcribing more often at these bases. The different DNA fragments 
were then separated on a denaturing gel along with sequencing ladders. This allowed 
the mapping of the modified regions and the secondary structure of the RNAs to be 
confirmed. 
Figure 4.5 shows the results of the primer extension. The two shorter RNAs 
were confirmed to have the expected structure. The 5 end of the long RNA could not 
be clearly visualised on the gel. A second, internal primer would be needed to clarify 
this region. However, the parts that could be analysed confirmed the predicted 
structure of the important helix 40.  
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Figure 4.5: Primer extension results using the three different H40 RNAs. 
Each of the transcribed fragments was subjected to 1M7 (1-methyl-7-nitroisatoic anhydride) 
modification. This reagent only reacts with ‘open’ regions (i.e. single-stranded regions). When a base 
shows this modification, it causes polymerases to stop prior to replicating it. Thus, when the 
fragments were then subjected to reverse transcription using a radioactively labelled (5 
32
P label) 
primer, fragments of certain lengths were found to be more abundant (i.e. when the reverse 
transcriptase paused due to the modification). This allowed mapping of the single-stranded regions. 
Each refolded and modified fragment (rf / 1M7 lane) was separated on a 6% denaturing gel along with 
the corresponding sequencing ladder and a sample without refolding or 1M7 modification (-/- lane) to 
allow mapping of natural stops. A phosphoscreen was exposed to the gel and then scanned. The result 
can be seen here and are summarised on the picture to the right (predicted structures). Blue letters 
represent bases that were added to aid in hairpin formation but are not found in the rRNA sequence. 
Pink shows the bases that were shown to be single-stranded during primer extension. The green region 
on the long RNA could not be accurately mapped as the bases are too close together at the top of the 
gel. Overall, the structures appear to be correct, especially around helix 40 (the helix pointing down). 
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The assay was repeated with ScNob1 in the mixture to observe whether 
protein binding caused helix 40 RNA to be protected from modification. However, 
there was no change in the observed pattern. 
 
4.2.4 Neither CtNob1 nor ScNob1 interact with Helix 40 RNA  
 
The interaction between the short H40 RNA hairpin and CtNob1 or ScNob1 
was tested in semi-analytical SEC and EMSAs. Upon complex formation, a larger 
species is expected to form. This would correspond to a shift to the left in SEC (i.e. 
an earlier elution volume). Also, the shifted peak would be expected to have a higher 
absorbance, as it would correspond to protein and RNA. In the EMSAs, the larger 
complex would migrate more slowly through a native gel and, thus, appear as a 
higher band. 
In SEC, the transcribed short hairpin and the synthetic C. Thermophilum 
(CtH40) RNAs were used. Figure 4.6 shows that the ScNob1 does not interact with 
ScH40 in these conditions. The same was seen using CtNob1 and CtH40 (Figure 
4.7) or ScH40 (Figure 4.8).  
Finally, the CtNob1 protein and the intermediate ScH40 RNA were tested. 
However, as shown in Figure 4.9, the elution profile for the RNA alone was very 
complex and could not be easily analysed. Nevertheless, no major changes were seen 
when the protein was added. Therefore, it is unlikely that there was an interaction. 
This was confirmed by analysing the fractions on a silver stained SDS-PAGE gel. 
The two species did not co-elute and remained separate. 
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Figure 4.6: Semi-analytical SEC of ScNob1 and ScH40. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only. A single peak is seen. 
B) The chromatogram for ScH40 RNA alone. Two overlapping peaks are seen, likely due to the 
presence of some RNA dimers as well as the hairpin. 
C) The SEC result when ScNob1 is mixed with ScH40 in a 1:1.2 ratio. The peaks remain separate and 
look like an additive effect. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The tops of the peaks 
are in the same positions on the elution profile suggesting that there is no interaction. A slight 
increase in absorbance can be seen. This is likely due to pipetting or injection variation. 
 
 




Figure 4.7: Semi-analytical SEC of CtNob1 and CtH40. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for CtNob1 only. A small single peak is observed. 
B) The chromatogram for CtH40 RNA alone. A single peak is seen suggesting that no RNA dimers 
are formed with this RNA. 
C) The SEC result when CtNob1 is mixed with CtH40 in a 1:1.2 ratio. The peaks remain separate like 
in the previous chromatograms. 
D) Results for CtNob1 and CtH40 mixed in a 1:4 ratio to verify that there are no interactions. The 
peaks still remain separate although a ‘bump’ is seen in the RNA peak suggesting that at higher 
concentrations, RNA dimers are formed. 
E) An overlay of the four previous results showing absorbance only at 280 nm. The tops of the peaks 
are, again, in the same positions on the elution profile suggesting that there is no interaction. Some 
changes in the height of the peaks are seen due to experimental variations. 
 




Figure 4.8: Semi-analytical SEC of CtNob1 and ScH40. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for CtNob1 only. A small single peak is observed. 
B) The chromatogram for ScH40 RNA alone. A single peak is seen suggesting that no RNA dimers 
are formed this time. 
C) The SEC result when CtNob1 is mixed with ScH40 in a 1:1.2 ratio. The peaks remain separate and 
look like the individual chromatograms. The slight changes in sequence appear to have no effect. 
D) Results for CtNob1 and ScH40 mixed in a 1:4 ratio. The peaks still remain separate. Again, a 
bump is seen on the RNA peak suggesting dimer formation at higher concentrations.  
E) An overlay of the four previous results showing absorbance only at 280 nm. The tops of the peaks 
are, as with the other experiments, in the same positions on the elution profile suggesting that there 
is no interaction. The sequence differences between ScH40 and CtH40 do not give any changes in 
the results. 
 




Figure 4.9: Semi-analytical SEC of CtNob1 and ScH40 intermediate RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for CtNob1 only. A small single peak is observed. 
B) The chromatogram for ScH40 intermediate RNA alone. Multiple peaks are seen suggesting that 
many different conformations of the RNA exist in the same sample. 
C) The SEC result when CtNob1 is mixed with ScH40 intermediate RNA in a 1:1.2 ratio. The peaks 
remain in the same positions although the heights of some of them do change. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The tops of the peaks 
are in the same positions on the elution profile suggesting that there is no interaction. Some 
changes in the height of the peaks are seen. These could be caused by an interaction. However, 
this is unlikely as the positions (i.e. sizes/shapes of the molecules) stay the same. 
E) Silver stained gel of the fractions covering the peaks labelled in image C). The lanes include the 
input (In), markers (M), numbered peaks (1-5), and just RNA (R). The position and distribution of 
the RNA and protein do not change suggesting that there is no interaction. 
U. McCaughan  Chapter 4: Investigating Nob1-RNA Interactions 
 110 
For the EMSAs, the synthetic H40 sequences from IDT without any extra 
bases were used. The lack of any strong protein-RNA interactions was also observed 
in these experiments (Figure 4.10), confirming the observations obtained with in 
vitro transcribed sequences (which contained extra bases to stabilise the hairpin) 
used in SEC. For the ScNob1, the EMSA was repeated after the protocol was 
optimised (optimisation shown later). Therefore, the band for the complex appears in 




Figure 4.10: EMSA results for ScNob1 and CtNob1 binding to ScH40 and CtH40. 
A) ScNob1 binding to ScH40 and CtH40. The amount of protein added to 0.2 µM RNA was varied as 
seen on top of the image. The amount of free ScH40 RNA is not seen to decrease significantly. 
However, some complex formation is seen at 10-40 µM protein. The CtH40 experiment shows 
slightly less complex forming suggesting that the sequence might be important. However, the 
interaction is very weak in both cases. Thus, it is potentially completely non-specific.  
B) CtNob1 binding to CtH40 and ScH40. In the last reaction, 30% glycerol was added to see if it 
would affect binding (as glycerol was present in the analytical gel filtration experiment). No 
difference was seen in amount of free CtH40 or ScH40 present when glycerol is added. Again, 
some complex is seen to form. However, this is extremely inefficient and could be due to non-
specific interactions. This is supported by the fact that both sequences behave in the same manner.  
 
U. McCaughan  Chapter 4: Investigating Nob1-RNA Interactions 
 111 
4.3 Nob1 Does Interact with D-site Derived Sequences 
 
 
4.3.1 In vitro transcribed D site RNAs 
 
In order to test whether the Nob1 protein can interact with the D site RNA 
sequence, several constructs were created for in vitro transcription. Some of the 
RNAs were directly transcribed from DNA sequences, while others were synthesized 
by IDT. Table 4.3 lists some of the different RNAs transcribed using the purified T7 
polymerase. Other RNAs used are shown later in the relevant sections. 
 
Table 4.3: Some of the different D site RNAs transcribed.  
Black letters in the sequences mark the regions that correspond to actual rRNA. Extra bases were 
added for more efficient cloning, transcription, and/or loop formation. These are shown in blue on the 
structure images and in the sequences. The red adenine is where the D site cleavage occurs. This site 
is also shown on the structure images in a blue circle. The first two sequences were cloned into the 
pUC19 plasmid for transcription while the lower two were transcribed from annealed DNA 
oligonucleotides. The structures shown are predicted to form in vivo, although there is still some 
debate about whether the D site is double- or single- stranded. 
Organism RNA Name Predicted Secondary 
Structure 
RNA Sequence 
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4.3.2 ScNob1 does not interact with DS0 but does with DS1 
 
Initially, the yeast DS0 and DS1 RNAs from Table 4.3 were tested with 
ScNob1 to see if an interaction could be observed. Semi-analytical SEC was 
performed and showed that the ScNob1 did not bind to DS0 in these conditions 
(Figure 4.11). However, as seen in Figure 4.12, when DS1 (which is predicted to 
form a partial hairpin) was used, a complex was formed, suggesting that a single-
stranded substrate is required for binding. 
 
 
Figure 4.11: Semi-analytical SEC of ScNob1 and DS0 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only. A single peak is seen. 
B) The chromatogram for DS0 RNA alone. A single large peak is seen showing that a single RNA 
species is present. 
C) The SEC result when ScNob1 is mixed with DS0 in a 1:1.2 ratio. The peaks remain separate and 
look like the individual profiles, suggesting an additive effect. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The peaks are in the 
same positions on the elution profile suggesting that there is no interaction. A slight increase in 
absorbance can be seen. This is likely due to pipetting or injection variation. 
 




Figure 4.12: Semi-analytical SEC of ScNob1 and DS1. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only. A small single peak is observed. 
B) The chromatogram for DS1 RNA alone. Multiple peaks are seen showing that different 
conformations exist. 
C) The SEC result when ScNob1 is mixed with DS1 in a 1:1.2 ratio. There is a slight shift in the 
position of the peak and an increase in absorbance at 260 nm suggesting complex formation. 
D) Results for ScNob1 and DS1 mixed in a 1:4 ratio. A much larger shift to an earlier elution volume 
is seen, again, supporting that a complex is formed.  
E) An overlay of the four previous results showing absorbance only at 280 nm. The increase in size 
and absorbance when the DS1 RNA is added is clearly seen. 
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These results were then confirmed with an EMSA. However, when a standard 
EMSA protocol based on a TBE buffer system (described in Table 4.4) was used 
(Figure 4.13), the complex would not enter the gel, possibly due to the pH of the 
TBE buffer (8.3) being below the pI of the protein (8.5). Thus, the protein was not 
negatively charged and was retained in the well. 
 
Figure 4.13: Initial standard 
EMSA using ScNob1 and DS0 or 
DS1 RNA. 
 0.2 µM RNA was used with 
increasing amounts of protein. The 
free RNA can be seen at the bottom 
of the gel while the complex gets 
stuck in the well. Both RNAs are 
seen to form a complex although 
more of the free DS1 RNA is absent 







To optimise the protocol, several buffer systems were tested. Most showed no 
improvement. The best two buffers (at pH 9.4 and 10.2 shown in Table 4.4), 
described by McLellan (1982), were used on non-radioactive non-denaturing PAGE 
gels with ScNob1 and the DS0 RNA (as it showed retention of protein in the wells 
using the standard EMSA protocol). As shown in Figure 4.14, both allowed the 
protein to enter the gel. However, some protein was still present in the wells on the 
pH 9.4 gel. Thus, the ammonia/CAPS buffer at pH 10.2 was chosen. Figure 4.15 
shows the results of the EMSA using this system. 
 
Table 4.4: The different buffers used for EMSAs.  
The standard names of the buffers and final concentrations of the components are shown. CAPS is 
also known as 3-(Cyclohexylamino)-1-propanesulfonic acid. The first entry is the standard buffer 
used for EMSAs. Other buffers were also tested but showed no improvement. 
Buffer name pH Basic component Acidic component Additional 
component 
0.5 x TBE 8.3 45 mM Tris base 45 mM Borate 1 mM EDTA 
1.0 x TC 9.4 60 mM Tris base 40 mM CAPS - 
1.0 x AC 10.2 37 mM Ammonia 20 mM CAPS - 
 




Figure 4.14: PAGE analysis of ScNob1 without and with DS0 RNA using different EMSA buffer 
systems. 
A non-denaturing acrylamide gel containing the tested buffer was run for each system. It was then 
stained with Coomassie dye to detect the ScNob1. At pH 9.4 the protein is able to enter the gel 
although some is still staining at the well. At pH 10.2 all of the protein is seen to enter the gel in a 





Figure 4.15: Optimised EMSA using ScNob1 and DS0 or DS1. 
Again, 0.2 µM RNA was used with increasing protein concentrations. As before, both RNAs are seen 
to form a complex. Free DS0 RNA is still seen using a 100 times excess of protein. DS1 RNA starts to 
disappear at a 1:1 ratio and is completely absent at 5.0 µM ScNob1. With higher protein 
concentrations, higher order structures are seen (i.e. multiple bands for the complex are present). 
U. McCaughan  Chapter 4: Investigating Nob1-RNA Interactions 
 116 
Some complex formation with DS0 at high ScNob1 concentrations is seen. 
However, there is also free RNA present at these concentrations. Thus, it seems that 
the hairpin RNA is not able to bind to the ScNob1 protein efficiently. All of the free 
DS1 RNA is retarded at 10-50 µM ScNob1 suggesting much stronger binding than 
that observed with DS0. 
 
4.3.3 ScNob1 binding site overlaps with the predicted ScDim2 site 
 
In order to narrow down the ScNob1 binding site on the D site RNA, 
extensive EMSA experiments using different sequences (listed in Table 4.5) were 
performed. The optimised protocol was used with each of the RNAs. The EMSAs 
were later repeated with a new protein preparation and the results remained the same. 
Figure 4.16 shows all the EMSAs performed and the results are summarised in 
Table 4.6. 
 
Table 4.5: RNAs synthesized by IDT for EMSA experiments.  
The first nucleotide removed by D-site cleavage is shown in red. The predicted Dim2 binding site is 
shown in green and extra bases are shown in blue. DS0 and DS1 are the same as the previously 
described in vitro transcribed sequences. 
Name Sequence (5 - 3) 
DS0                                                                       GGGAUCAUUAAAGAAAUUUAAUAAUCCC 
DS1                                                            GGGAAGGAUCAUUAAAGAAAUUUA 
DS2                                                                  GAAGGAUCAUUAAAGAAAUUUAAUAAU 
DS3                                                                  GAAGGAUCAUUAAAGAAAUUUA 
DS4                                         GAACCUGCGGAAGGAUCAUUAAAGAAAUUUA 
DS5 GGGUUUCCGUAGGUGAACCUGCGGAAGGAUCAUUAAAGAAAUUUAAUAAU 
DS6   GGGAAGGAUCAUUAAAGAAA 
DS7                                                            GGGAAGGAUCAUUAAAG 
DS8                                                                           GGAUCAUUAAAGAAAUUUAAUAAU 
DS9                       GGAUCAUUAAAGAAAUUUA 
DS10                                                                                         AUUAAAGAAAUUUAAUAAU 
 
 The results suggest that binding to the D site is most strongly affected when 
the predicted Dim2 binding site (see Chapters 1 and 5 for details) is removed. Thus, 
it is possible that the binding sites for the two proteins overlap and that only one 
protein can bind at any time. 
 





Figure 4.16: EMSA results for DS0-DS10 RNAs with ScNob1. 
The relative amounts of complex formed using each of the RNAs (at 0.2 µM) can be seen. The RNAs 
that do interact with ScNob1 show increased levels of higher order structures as the protein 
concentration is increased. All of the RNAs are seen to bind apart from DS10, which shows no 
decrease in free RNA levels. A small amount of complex is still seen at a 100 times excess of protein 
but that is likely due to non-specific interactions. 
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Table 4.6: Summary of EMSA results using DS0-DS10 with ScNob1. 
The colouring is the same as in the previous table. The Dim2 binding site is marked with a green text 
in the sequences and a green oval in the structure images. The binding to ScNob1 is scored based on 
the amount of complex observed in the EMSAs. DS0 was assigned a score of 1 while DS1 was 
assigned a score of 3. All other RNAs were scored based how the complex formation compared to 
these two RNAs. 
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4.3.4 The AGGA sequence is the binding determinant 
 
From the EMSA experiments, it seemed that ScNob1 interacted with the D 
site in the same location as Dim2. To further verify the location of the interaction, 
ITC experiments were performed using RNAs with point mutations. During a 
binding event, heat is released or absorbed (depending on whether the reaction is 
exo- or endothermic respectively). In ITC, these heat changes are measured during 
consecutive injections of one reactant into the other. The data is integrated and 
thermodynamic values and dissociation constants are calculated from the resulting 
binding curve. 
Although DS0 and DS1 were tested in the ITC (Figure 4.17), the mutant 
RNAs were based on DS6. This RNA still binds to the protein but lacks any 
predicted secondary structures that might cause heat changes in the ITC. The 
different mutations tested can be seen in Table 4.7.  
 
 
Table 4.7: RNAs synthesized by IDT for ITC experiments.  
The first nucleotide removed by D-site cleavage is shown in red. The predicted Dim2 binding site is 
shown in green and extra bases are shown in blue. Mutated nucleotides are shown in orange.  
Name Sequence (5 - 3) 
DS0             GGGAUCAUUAAAGAAAUUUAAUAAUCCC 
DS1 GGGAAGGAUCAUUAAAGAAAUUUA 














DS12            GGGAUCAUUAAAGAAA 
DScram1 GAAAGGAGAGGAUUACAAUA 
DScram2 GAAAAAAGCGGUAGUAAUAG 









Figure 4.17: ITC results for DS0 and DS1 RNAs binding to ScNob1. 
The raw data for the protein control (black), RNA control (blue), and the experiment (green) are 
shown in the top panel. The protein and RNA controls were subtracted from the experimental data to 
give the lower graph. The peaks were integrated and plotted as a binding curve for each of the RNAs 
(shown as the bottom panel). As seen above, the DS0 RNA does not bind to ScNob1 and, thus, no 
significant heat changes are seen. The integrated binding curve looks like a straight line supporting 
that there is no binding. Conversely, the DS1 RNA is able to bind and shows a clear binding curve. 
The thermodynamic values obtained from the curve can be seen in Table 4.9. The molar ratio (0.25) 
shows that four RNA molecules were able to bind one ScNob1 molecule.  
 
 
The WT DS6 was tested along with 11 mutants (DS6.1-11). Then, an RNA 
that mimics the cleaved product (DS11) was used. DS12 has the same starting 
sequence as DS0 but lacks the 3 end, which creates the hairpin in DS0. A human 
version of the DS6 was also tested as it only differs in the 3 end after the cleavage 
site. Finally, two scrambled RNAs were also included as controls (DScram1 and 2). 
Figures 4.18-20 show the ITC results for the RNAs. The dissociation 
constant (Kd) values obtained from the experiments are shown in Table 4.8. It 
appears that the AGGA sequence that overlaps the predicted Dim2 binding site is the 
only part that affects ScNob1 binding. Point mutations in the AGGA sequence did 
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not completely abolish binding. However, the protein binding sites were not 
saturated suggesting a weaker interaction. Also, the binding event with the mutants 
appears more complex as there is a kink in the curves. A double mutant was tested 
(DS6.4) and that showed an additive effect: a small heat change was seen, but the 
binding was much weaker than for the individual point mutations. 
DS11 binds better than DS6 suggesting that the RNA is not efficiently 
released after the cleavage and might require additional factors. The first scrambled 
RNA did bind to the protein. However, this RNA was found to contain an AGGA 
sequence. When this was removed in DScram2, the RNA was no longer able to bind. 
Additional thermodynamic values were also obtained and are listed in Table 
4.8. However, these values varied using different RNAs. This can also be observed 
in the binding titrations as the magnitudes of the heat changes observed changed 
significantly with different sequences due to unknown factors. For example, the 
changes in heat and enthalpy (∆H) observed depended on the heat of folding of 
RNA/protein as well as the binding event (Feig, 2007). These different contributions 
made it impossible to distinguish differences in enthalpy caused by binding alone. 
Thus, these values were not used for more specific analysis.  
 




Figure 4.18: ITC results for the DS6 RNA and the 6.1-5 mutants. 
All binding curves are shown on the same scale as for DS1 in the previous figure. The WT DS6 RNA 
shows a full binding curve that comes to saturation at the end. The molar ratio corresponds to 0.25 as 
with DS1. Again, all thermodynamic values can be seen in Table 4.8. The values for all of the 
mutants shown in this image could not be determined. Mutants 6.1, 2, 3, and 5 showed incomplete 
curves due to a lower affinity for the substrate. Also, they showed a kink in the curve suggesting a 
more complex reaction. Mutant 6.4 showed a small dip in the binding curve. However, this was too 
small to allow a curve to be fitted implying that no significant interaction is seen. 
 




Figure 4.19: ITC results for mutants DS6.6-11. 
All of the mutants shown here were able to bind to the ScNob1 protein showing similar binding 
curves to the WT DS6. The magnitude of the heat changes does vary even though the dissociation 
constants are similar. As with the others, the thermodynamic values can be found in Table 4.8. 
 




Figure 4.20: ITC results for DS11, DS12, DScram1-2, and the human DS6 sequence with 
ScNob1. 
DS11 mimics the product of the D site cleavage and is able to bind to Nob1 as shown here. DS12 has 
the same sequence as DS0 but does not have any predicted secondary structures. It shows small heat 
changes. However, these changes are too small to fit a curve. DScram1 is a scrambled sequence that 
contains AGGA within it. It shows binding which is comparable to DS6. Conversely, DScram2 lacks 
the AGGA and does not appear to interact with the ScNob1 protein to any significant extent. Finally, 
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Table 4.8: Summary of the thermodynamic values obtained from the ITC experiments for each 
of the RNAs tested.  
The RNAs without any values could not be fitted with a simple one-site binding model and/or did not 
come to completion. 











DS0 No fit - - - - - 
DS1 1.0 -36580 -104.0 -28912 -7668 -7.7 
DS6 1.9 -13240 -21.4 -5949 -7291 -7.3 
DS6.1 No fit - - - - - 
DS6.2 No fit - - - - - 
DS6.3 No fit - - - - - 
DS6.4 No fit - - - - - 
DS6.5 No fit - - - - - 
DS6.5.2 1.1 -23930 -58.7 -16319 -7611 -7.6 
DS6.6 1.9 -33540 -94.3 -26215 -7325 -7.3 
DS6.7 1.3 -19500 -43.2 -12010 -7490 -7.5 
DS6.8 1.7 -42430 -126.0 -35028 -7402 -7.4 
DS6.9 1.1 -34350 -96.1 -26716 -7634 -7.6 
DS6.10 1.5 -28100 -74.2 -20628 -7472 -7.5 
DS6.11 3.1 -60420 -192.0 -53376 -7044 -7.0 
DS11 0.6 -12120 -14.8 -4114 -8006 -8.0 
DS12 No fit - - - - - 
DScram1 1.3 -30210 -81.1 -22546 -7664 -7.7 
DScram2 No fit - - - - - 




          
 The RNAs used in the ITC had no predicted secondary structures. However, a 
native gel was run to see if any structures did form. Figure 4.21 shows that some of 
the RNAs did indeed have more complex conformations. Thus, it is possible that 
some of the variation in the ability of ScNob1 to bind to the RNA and in enthalpy 
stemmed from the secondary structures. Breaking base interactions within hairpins 
and double strands consumes and releases a lot of energy causing large heat changes 
in the cell during the ITC run. These can mask changes caused by the protein-RNA 
interaction. It is noteworthy that the higher the concentration of the RNA, the more 
secondary structures are present. The concentrations in ITC were much lower than 
on the gel. Thus, it is likely that fewer structures existed in the ITC. 
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Figure 4.21: Native gels of the RNAs used in ITC. 
A) A native gel stained with SYBR Safe showing all of the RNAs used for ITC. Most of the RNAs 
contain some secondary structures even though none were predicted. All of the RNAs showing 
changes in binding (DS6.1-5) show some amount of complex formation. The WT DS6 also shows 
a small amount of a species that runs higher on the gel. 
B) A native gel without DS6.1 and ITS1 as they were overloaded in the previous gel preventing 
analysis of some of the other RNAs. Again, most of the RNAs show a mix of secondary structures. 
The amount of DS0 was increased to see if there is a concentration effect on the secondary 
structures. As shown here, the higher the concentration, the more secondary structures are present. 
 
 
In order to test the effect of different conformations, mutant DS6.5.2 was 
created. This RNA has a mutation in the same site as DS6.5 but the adenine is 
changed to a uracil instead of a guanine. This mutation, as shown in Figure 4.22, 
rescues the ScNob1 binding. On the native gel, the RNA does not appear to have any 
secondary structures unlike DS6.5. Thus, it is possible that the RNA conformation 
plays a big role in ScNob1 binding. However, it is also possible that a smaller base is 
tolerated in this position. 
Finally, all of the RNAs for which the binding curve could be determined 
showed a molar ratio of 0.25. This means that four RNA molecules were able to bind 
to one molecule of protein. This result was obtained with multiple protein batches. 
Repetition of the DS6-ScNob1 titration yielded the same results every time (average 
Kd of 1.8 ± 0.4 µM from four repeats). 
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Figure 4.22: ITC results for DS6.5.2 binding to ScNob1. 
This mutant shows the same binding curve as WT DS6. Thus, it appears that this mutation is able to 
rescue ScNob1 binding. 
 
 
4.3.5 The stoichiometry of the interaction remains unclear 
 
From previous experiments, it is clear that ScNob1 interacts with the D site 
RNA. However, it is unclear what the stoichiometry is. The semi-analytical gel 
filtration and EMSAs show an increase in size and ITC suggests a four RNAs to one 
protein ratio. The particles were then visualised with EM. However, as seen in 
Figure 4.23, the addition of RNA causes the formation of very large complexes. 
A sample of protein with the DS1 RNA was sent to Dr. Leech in York to run 
on SEC-MALS. However, the sample eluted in the void suggesting a size of several 
MDa (data not shown). Again, this supports the formation of large complexes. 
Finally, the same result could be observed in semi-analytical SEC of ScNob1 
with higher concentrations of human DS1. The complex was seen to elute in many 
fractions including the void volume (Figure 4.24). 
 




Figure 4.23: Example EM images of ScNob1 alone and with a 2 times excess of DS1 RNA. 
The ScNob1 by itself shows well-distributed small particles in the negative stain. The addition of DS1 
RNA causes the formation of larger, more distinct species. This suggests that multiple proteins and 
RNAs interact to make complex structures. 
 
 




Figure 4.24: Semi-analytical SEC of ScNob1 and human DS1 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only. A small single peak is observed. 
B) The chromatogram for human DS1 RNA alone.  
C) The SEC result when ScNob1 is mixed with DS1 in a 1:1.2 ratio. The main peaks remain in the 
same positions. However, some of the protein and RNA make a complex and elute in the void. 
D) Results for ScNob1 and DS1 mixed in a 1:4 ratio. A much larger shift to an earlier elution volume 
is seen, again, supporting that a complex is formed. The complex shows a variety of sizes and 
elution volumes, including the void volume. 
E) An overlay of the four previous results showing absorbance only at 280 nm. The increase in size 
when the DS1 RNA is added is clearly seen. Again, the size increase appears to be very 
significant. 
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4.4 Nob1 binds to an ITS1 loop sequence 
 
 
The Tollervey lab has recently shown, using cross-linking in vivo in growing 
cells, that Nob1 interacts with a fragment of the internal transcribed spacer (ITS1) 
(unpublished data). The same site was identified in vitro by the Karbstein lab using 
chemical modification in the presence and absence of the protein (Lamanna & 
Karbstein, 2009). However, only a single base showed the lack of modification when 
Nob1 was present suggesting that this effect could be due to Nob1 proximity and not 
binding. Also, both studies utilised long, folded RNAs, which made data analysis 
more complex. 
To test this theory using a short RNA, an ITS1 hairpin fragment 
(GGGCCUGCGCUUAAGUGCGCGGUCU, bases +96 to +120) was tested in ITC 
and semi-analytical SEC. The results in Figures 4.25-26 show that the interaction 
can be seen in vitro. In ITC, the binding is a complex process and a simple one-site 
model could not be fitted to the binding curve. In SEC, all of the ScNob1 protein is 
saturated using a 1.2 times excess of RNA (unlike with DS1) suggesting that this 
interaction is stronger than the one with the D site and/or that only one binding site is 
present (unlike for the D site RNAs). 
 
Figure 4.25: ITC results for the ITS1 
fragment with ScNob1. 
The predicted secondary structure of the 
RNA fragment is shown under the 
legend. A clear binding even can be seen. 
However, the curve does not show a 
simple one-site binding interaction and a 
model could not be fitted. 
 




Figure 4.26: Semi-analytical SEC of ScNob1 and ITS1 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only. A small single peak is observed. 
B) The chromatogram for ITS1 RNA alone.  
C) The SEC result when ScNob1 is mixed with ITS1 in a 1:1.2 ratio. The protein peak is seen to shift 
to an earlier elution volume and the absorbance at both wavelengths is significantly increased 
suggesting complex formation. 
D) Results for ScNob1 and ITS1 mixed in a 1:4 ratio. Again, a shift and increase in absorbance are 
seen. However, the changes appear the same as in the previous experiment.  
E) An overlay of the four previous results showing absorbance only at 280 nm. The increase in size 
and absorbance when the ITS1 RNA is added is clearly seen. The protein appears to be saturated 
at a 1.2 times excess of RNA as no significant further shifts are seen using a 4 times excess. 
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4.5 Nob1 can Cleave the D-site in vitro 
 
 
Since ScNob1 can bind the D site in vitro, the next step was to check if it 
could perform the cleavage. DS5 was used for this purpose as it shows a large 
change in size when the cleavage occurs. It was found that the cleavage could 
happen in vitro. However, this process is manganese dependent (as expected) and is 
extremely inefficient (Figure 4.27). It also requires very high concentration of the 
metal in order to be observed. 
The assay was repeated with a supplementary methylation step. The RNA 
was first incubated with purified Dim1 and S-Adenosyl methionine prior to 
incubation with ScNob1. However, no improvement in D site cleavage was observed 
(data not shown). 
Finally, to confirm that the observed RNA is indeed the product of cleavage 
mediated by ScNob1 and not a contaminant, the nuclease dead mutant (D15N) 
protein was used in the assay. Due to purification issues, the protein was not 
completely pure and RNase contamination was seen. Nevertheless, the cleavage 
product was not present. Figure 4.28 shows that the mutant is able to bind the RNA 
but does not appear to cleave it. The results are not conclusive due to the RNA 
digestion observed in the D15N mutant lanes. 
 




Figure 4.27: Cleavage assays using ScNob1 and DS5 RNA. 
A) Time trial using manganese as the metal (5 mM). 0.2 µM RNA was incubated with 5 µM ScNob1. 
A cleavage product can be seen to appear after 2 hours of incubation at 37˚C. The amount of 
product increases at 6-8 hours. Overnight incubation, however, does not give an increased amount. 
Thus, a 6-hour incubation was chosen for the next experiment. 
B) Cleavage assay using different metals at 50, 500, or 5000 µM. The RNA and protein 
concentrations are the same as before. The cleavage product is only seen when 5000 µM 
manganese is added to the reaction. 




Figure 4.28: EMSA (top) and cleavage assay (bottom) comparing the WT ScNob1 and the D15N 
mutant. 
The EMSA, in the top panel, shows that both proteins are able to bind to the DS5 RNA. Complex 
formation and higher order structures are seen earlier with the D15N mutant. This could mean that the 
mutant binds more strongly. Below, the cleavage assay using 5 µM of each protein is shown. A very 
small amount of product is seen using the WT protein. The D15N mutant shows various digestion 
products, especially at longer incubations. This suggests that there is RNase contamination present. 
However, the 35-base cleavage product cannot be seen at all. This could be obscured by the RNase 
digestion but is also likely to not be there at all, as this mutant was shown before to have no nuclease 
activity (Lebaron et al, 2012). 
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4.6 Crystallisation Trials using Protein-RNA Mixtures 
 
 
As with the protein alone, crystallisation screens were performed with 
mixtures of ScNob1 and DS1, DS6, or ITS1. However, no hits were observed. 
Mixing the protein with any of the RNAs caused precipitation that disappeared upon 
incubation at room temperature. Since ITS1 appears to bind more strongly than D 
site RNAs (only a 1.2 times excess is needed to saturate the complex), this RNA was 
also used with ScNob1∆L4. However, when the two components were mixed, 
precipitation was observed and it could not be dissipated by incubations at higher 
temperatures or in higher salt.  
In the future, further screens should be performed using the loop-out mutants 
of ScNob1 with different RNAs, particularly with ScNob1∆L2 and ∆L3 as they can 
definitely form crystals. Shorter ITS1 RNAs that do not form a hairpin might prevent 
precipitation. The recognition site in this RNA needs to be identified to define the 
minimal binding requirements. Also, tests with the mutant proteins and D site RNAs 
should be performed. 
 
 
4.7 Purification of ScNob1-D site RNA complex 
 
 
For further crystallisation trials, the ScNob1 and DS1 RNA were co-purified 
as a complex. This required large scale in vitro transcription followed by RNA 
purification. Initially, SEC was followed by anion exchange. Figure 4.29 shows the 
results of this purification. Multiple peaks were obtained in the anion exchange. To 
determine which peak was best for binding to ScNob1, semi-analytical SEC was 
performed. It was found that peak 3 was best (Figure 2.30) and this was chosen for 
the next step. 
The ScNob1 protein was partially purified (affinity chromatography followed 
by cation exchange). Then, the transcribed and purified peak 3 RNA was added and a 
SEC step was performed. Figure 4.31 shows the results of the co-purification. 
The obtained complex was used in crystallisation screens. However, no hits 
were obtained. The same experiment should be repeated with the ITS1 RNA in the 
future. 





Figure 4.29: Mini Q anion exchange purification of in vitro transcribed DS1. 
A single peak was obtained in SEC, which was then injected onto the anion exchange column. The 
gradient included 3 steps, which were optimised prior to the large scale run shown here. The first step 
consisted of a wash with 35% buffer B (buffer A: 20 mM HEPES pH 7.5 and 5 mM MgCl2, buffer B: 
20 mM HEPES pH 7.5, 5 mM MgCl2 and 1000 mM KCl). Then, a gradient from 35 to 45% over 4 
column volumes was used and the column was washed at 45%. Finally, a gradient from 45 to 70% 
buffer B eluted the last peak. The three peaks were analysed on denaturing and non-denaturing gels. 
They all contained RNA of the right size (denaturing gel). However, the RNA showed different 
conformations (native gel). 
 




Figure 4.30: Semi-analytical SEC results using ScNob1 with each of the DS1 peaks obtained 
from the Mini Q column. 
The legend is shown in the top right corner. As before, the absorbance at 260 nm is shown as a dashed 
line while absorbance at 280 nm is shown as a solid line. Peak 1 showed the smallest species in SEC. 
However, it failed to show significant binding to ScNob1. Peak 2 showed the presence of two species. 
The larger one was depleted upon addition of ScNob1 suggesting an interaction. Peak 3 had the most 
complex elution profile. However, it also showed the largest shift upon ScNob1 addition and was 
therefore used for the large-scale complex formation. 
 




Figure 4.31: Co-purification SEC results for ScNob1 and DS1. 
Absorbance at 280 nm is shown in blue and at 260 nm in red. 
A) The elution profile for the complex. Three peaks were seen. The void and the first peak contained 
the ScNob1 protein. Thus, the excess RNA was likely in the other two peaks. The absorbance at 
260 nm in the first peak suggests that a complex was formed. 
B) An overlay of the complex elution profile (solid lines) and the profile for ScNob1 on its own 
(dashed lines). The fractions in peak 1 that did not overlap the free protein peak were pooled and 







4.8.1 ScNob1 binds to D site and ITS1 but not helix 40 RNAs 
 
EMSAs, semi-analytical SEC, and ITC have shown that the recombinant 
ScNob1 is able to bind certain D site and ITS1 sequences. However, it does not show 
any interaction with the H40 RNA that was previously found in in vivo cross-linking 
studies (Granneman et al, 2010). Most of the experiments involving the H40 RNA 
used the short hairpin stabilised by extra bases. Thus, it is possible that, if ScNob1 
only interacts with single-stranded RNA at this site, this caused the lack of 
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interaction. However, a specific interaction with H40 is unlikely as the binding mode 
would not be the same as for the D site (no AGGA sequence is present in H40). It 
would also be distinct from binding seen at ITS1 as this RNA fragment likely forms 
a hairpin but is still able to interact with the protein. 
This is supported by the EMSAs, which were performed with wild-type RNA 
fragments (no extra bases were included), as these also showed no significant 
binding. The same was observed in SEC with the intermediate H40 RNA fragment, 
which contained further sequences that could have influenced binding. Nevertheless, 
all of the H40 sequences tested would have formed stable hairpins. If Nob1 requires 
single-stranded regions (like the ends of the ITS1 fragment), no interaction would be 
observed with the H40 fragments. Otherwise, H40 could have been cross-linked to 
Nob1 due to proximity and not due to complex formation, or other factors might be 
needed to stabilise the interaction. 
The secondary structures of the H40 fragments were confirmed using primer 
extension assays. However, as seen with the intermediate fragment in SEC, multiple 
conformations still exist. If two separate RNA molecules were to hybridise, the loop 
structures would still appear in the same places in primer extension, as it is not 
sensitive to changes that do not affect secondary structure. The amount of alternative 
structures observed is exacerbated because the SEC was performed at 4˚C while the 
primer extension was at room temperature. Finally, the concentration of RNA used 
might have a large effect on the dimerization of the RNA molecules. At higher 
concentrations (as in SEC), there is a higher chance of dimer formation.  
The long H40 RNA was not used because data analysis would be very 
complex with such a complex fragment and its full structure was not determined. A 
second primer could have been used to determine the structure as the 5 end. 
However, this was not performed, as there was no evidence of Nob1-H40 interaction 
found. The lack of binding was supported by the primer extension protection 
experiment with all three H40 RNAs. The pattern of 1M7 modification did not 
change when ScNob1 was included in the reactions suggesting that there were no 
interactions, even with the longest H40 fragment. 
Conversely, most D site fragments used in the different experiments were 
able to interact with ScNob1. The AGGA sequence was found to be needed for the 
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interaction. Changing the guanines into adenines and vice versa made the interaction 
weaker. However, changing the last adenine to a uracil had no effect. The reason for 
this remains unclear. It could be that the binding site is able to accommodate a 
change into a smaller base or that the effect of the mutation on the secondary 
structure of the RNA is smaller in this case. Further experiments would be needed. 
Either way, it appears that Dim2 and Nob1 are likely to compete for this site. 
It is possible that Dim2 prevents Nob1 binding at early stages and cleaving before all 
the other maturation steps have been completed. 
Finally, an ITS1 fragment was tested in the ITC and SEC. This fragment was 
chosen as some previous studies have shown that it can interact with Nob1 (Lamanna 
& Karbstein, 2009). However, the data suggesting this interaction were not 
conclusive as only a single base showed changes in modification when Nob1 was 
added. The ITC performed here with a short RNA fragment showed that it binds but 
the curve was too complex to fit a one-site binding model. EMSAs and further ITC 
experiments should be performed to further explore the recognition sequence within 
the ITS1 RNA.  
ITC competition experiments should also be performed to determine if the D 
site and ITS1 RNAs could bind to the protein at the same time. For this purpose, 
ScNob1 would initially be saturated with one RNA. Then, the other one would be 
titrated in. If the Kd remains the same as without the competing RNA, the two 
fragments bind independently. A lower Kd would suggest co-operative binding while 
a higher one would show competition for a binding site. 
It is possible that the D site is bound by the PIN domain while the ITS1 is 
bound by the zinc ribbon domain. New CRAC data in growing cells support that 
ScNob1 binds to both, the D site and ITS1. The H40 site is also still present in these 
results (personal communications with Prof. Tollervey) adding more complexity. 
The SEC results using ITS1 show complex saturation at a 1.2 times excess of RNA. 
With the D site, a four times excess is needed suggesting that the ITS1 binds more 
strongly or that fewer sites are present. Since the ITS1 fragment does not contain an 
AGGA sequence and has a significantly different structure (tight hairpin), it is likely 
that different binding mechanisms and/or sites are involved.  
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In the future, the loop-out mutants of ScNob1 should also be tested to see if 
they bind the same RNAs with the same affinity. The experiments could also be used 
with CtNob1 to see if the binding sites are conserved between the two organisms.  
 
4.8.2 Large complexes are formed with the D site RNA and ScNob1 
 
Multiple results suggest that ScNob1 forms large, heterogeneous complexes 
when the D site is added. The EMSAs showed multiple bands, which suggest that 
multiple proteins/RNAs were able to assemble together. The bands were well-
defined (not a smear of variable size) suggesting a distinct, modular behaviour. The 
amount of these higher weight bands correlates to protein concentrations used, 
further suggesting that multiple proteins come together to make these. This could be 
biologically relevant if a multimer of the protein is required to perform the cleavage. 
This is unlikely, as the previous EM studies do not support a multimer binding to the 
pre-40S (Strunk et al, 2011). However, it could potentially provide another level of 
control for the final step of maturation. 
In the EM, addition of D site RNA caused the formation of long structures. 
Analysis of the structures was not undertaken due to time constraints. However, 
these are unlikely to form inside the cell, as there would not be enough space in the 
busy environment around the premature ribosomes. The local concentrations would 
be too low and the rest of the ribosomal structure would prevent the particles coming 
close together. 
In SEC-MALS, ScNob1 and DS1 were seen to elute in the void volume 
supporting the formation of a mega-Dalton species. This was not seen in the semi-
analytical SEC performed locally, likely because the sample was fresh and kept at 
4˚C. For the SEC-MALS, the mixture of protein and RNA had to be shipped and was 
only tested a day later. Also, the SEC-MALS was run at room temperature while our 
SEC was at 4˚C. 
The molar ratio obtained from ITC suggested that four molecules of RNA 
were able to bind to one molecule of protein. This, again, implies that complex 
structures can be formed when the two particles come together. As before, the 
biological significance for this remains unclear. Although the modular behaviour 
could form a part of the control mechanism for the cleavage, the complexes seen in 
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EM would not be able to form inside the cell. Overall, further studies are needed to 
determine if the cleavage efficiency is affected when the multimerisation is 
prevented. Also, tests to see whether the loop-out mutants behave in the same 
manner should be performed. 
Finally, semi-analytical SEC with the human DS1 showed elution of a 
spectrum of species. They ranged in elution volume from the void to the normal 
ScNob1 volume. This was not seen with the yeast RNA sequence although the two 
only differ in the 3 end. The effect could be partially explained by the fact that the 
human sequence shows a higher propensity for secondary structure formation (ΔG = 
-2.60 kcal/mol vs. -0.30 kcal/mol predicted by mFold - http://mfold.rna.albany.edu) 
and dimerization than the yeast. Thus, the RNA-RNA interactions could be causing 
different species to form. 
 
4.8.3 Binding is likely affected by secondary structures 
 
Initially, it appeared that DS0 could not bind to ScNob1 (while DS1 RNA 
could) because of the hairpin formation. However, once the binding site was 
identified with ITC, it became apparent that DS0 contains a point mutation in this 
site (GGGA instead of AGGA). Thus, the lack of binding could have been caused by 
the mutation and not the secondary structure. DS12 was designed to distinguish 
between the two possibilities. It contained the same mutation as DS0 but lacked the 
3 end, which allowed hairpin formation. This RNA was seen to give a very small 
heat change in ITC suggesting that no significant interactions were occurring. DS0 
shows no heat change at all suggesting that both the structure and sequence are 
causing the effect. 
The RNAs used for ITC were checked with mFold and showed no predicted 
secondary structures. Nevertheless, the native gel of the RNAs showed that most of 
the mutants that impaired ScNob1 binding (DS6.1-DS6.5: AGGA to GGGA, AAGA, 
AGAA, AAAA, or AGGG) showed an increased amount of secondary structures. 
When a mutation that did not cause secondary structure formation was introduced 
(DS6.5.2), the binding was rescued. However, this mutation only included the last 
nucleotide (AGGA to AGGU). Thus, it is possible that this base is less important 
than the middle ones. Also, the adenine-to-uracil substitution reduces the size of the 
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base (unlike the adenine-to-guanine experiment) and could, therefore, be more 
tolerated. Additionally, DS6.4, the double mutant (AAAA sequence), did not have 
additional structures but showed less binding than the single mutants. Thus, the 
sequence is definitely important. Further point mutations, particularly 
adenine/guanine to uracil, need to be tested. 
The native gel also showed that the RNA concentration had a large effect on 
the structure. When the same total amount of DS0 was separated on the gel but in a 
smaller volume (i.e. higher concentration), structures previously not seen were 
observed. The concentration used in ITC was relatively low (10 µM). Thus, it is less 
likely that the structures observed on the gel actually occurred in ITC. Again, this 
means that the effect of RNA structure on ScNob1 binding could not be fully 
determined. 
In contrast to the DS0 hairpin, the ITS1 hairpin was able to bind to ScNob1 in 
the ITC. However, as mentioned earlier, it is possible that the two RNAs interact 
with different domains of the protein. Thus, their interactions are not directly 
comparable. 
In the future, longer D site RNAs with further mutations could be tested in 
ITC. Their structures could be probed with primer extension at the concentrations 
that they would be used at in the experiments. The DS6-based RNAs used here were 
too short for primer extension. However, others (like DS5) could be utilised. In vivo, 
the secondary structure of the D site RNA remains in question, although there is 
some evidence to suggest that the predicted hairpin is not formed and the D site is 
single-stranded (Lamanna & Karbstein, 2009). 
 
4.8.4 In vitro cleavage is very inefficient 
 
The recombinant ScNob1 protein was able to perform the D site cleavage. As 
previously observed with longer substrates (Lebaron et al, 2012), this cleavage was 
very inefficient and required large amounts of manganese. However, this result was 
obtained when Nob1 was taken out of the context of the ribosome. It is possible that 
some other factors are needed for the cleavage to occur efficiently. For example, the 
RNA was pre-incubated with Dim1, potentially methylating it. However, the 
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methylation state was not confirmed and the pre-incubation did not help with the 
cleavage. 
A methylation assay would need to be developed in the future to see if the 
Dim1 protein is active in vitro. Other factors, such as Rio2, might also be required 
for Nob1 to perform its function. Additionally, the high levels of manganese required 
in vitro suggest that a cellular mechanism must exist that compensates for the low 
levels inside the cell. Whatever this mechanism is, it might be required for cleavage. 
For example, Nob1 might have to be phosphorylated in order to bind manganese or 
cleave RNA. 
Finally, a D site cleavage product mimic was used in ITC (DS11). This RNA 
was able to bind to the ScNob1 protein as well as fragments containing the 3 end. 
Thus, additional factors may be needed to release the substrate. These might also be 
needed for the cleavage to occur efficiently. Since Nob1 must cleave with high 
fidelity in order to maintain the ribosomal function, it is likely that all these factors 
are there to make sure that the cleavage only occurs in particles that are otherwise 
correctly processed and at the right time.  
The cleavage assay was then performed with a nuclease dead mutant protein 
(D15N) to confirm that the observed band was created by ScNob1 activity. The 
mutant protein, however, was difficult to purify and contained RNase contamination. 
Thus, it remains unclear whether the predicted cleavage product seen on the gel is 
definitely created by Nob1, although it is the correct size and only appears when 
Nob1 is included in the reaction suggesting that it is likely to be the product. In the 
future, if clean ScNob1 D15N can be obtained, the EMSA and cleavage assay should 
be repeated to show that the binding to the D site is not affected while the cleavage is 
inhibited.  
Mutant RNAs that do not bind to the wild-type protein (e.g. AAAA sequence 
instead of AGGA) should also be tested in the cleavage assay to see if binding is 
required for cleavage. The existing loop-out mutants could also be used, to test if the 
loop is necessary for nuclease activity. ITC would be used to see if the same 
deletions affect the protein-RNA interactions. 
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4.8.5 Crystallisation trials were unsuccessful 
 
All crystallisation trials with ScNob1 and different RNAs were unsuccessful. 
The Kd for the D site RNAs appears to be around 1.0 µM. Thus, when the excess of 
RNA is removed or the sample is diluted, the complex can separate again. Also, as 
seen in some of the experiments, the RNA and protein complex can form larger 
structures at high concentrations. This might be impeding the formation of crystals, 
as it would introduce heterogeneity. 
Finally, if the RNAs interact with only one domain, the two domains could 
still be too flexible with respect to each other. More likely, the flexibility of the loop 
between the domains is preventing crystal formation (as the loop-out mutants were 
seen to form crystals). Therefore, in the future, the loop-out mutants in complex with 
RNA should be tested.  
Additionally, separating the two domains might prove to be successful in the 
future, although initial attempts did not work. If this is the case, they should be used 
with the D site and ITS1 RNA fragments separately to see which domain interacts 
with which RNA fragment. The other option is to make a D site RNA that is 
connected (through an RNA sequence with no secondary structures) to the ITS1 
RNA. Thus, if the two fragments interact with different domains, this long RNA 
could ‘lock’ the protein in a single conformation. Different lengths of connecting 
sequences could be used to see what gives the strongest interaction. 
 
 
4.9 Concluding Remarks 
 
 
The ScNob1 D site RNA binding site was successfully identified. Co-
crystallisation trials were unsuccessful to date and the molar ratio remains in 
question. However, these results are a good start for further experiments and RNA 
binding partner optimisation. The ITS1 fragment also looks like a promising RNA 
species that could be used in the future. 
The D site binding sequence appears to be only four nucleotides long. Thus, 
other mechanisms would have to be involved in positioning the protein correctly and 
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ensuring the cleavage occurs in the right place. The binding to ITS1 could potentially 
be more specific and be a part of this mechanism. 
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 Dim2 is a highly conserved RNA binding protein that, in eukaryotes, consists 
of a degenerated (KH1) and a canonical (KH2) KH domain. It is required for the A2 
and the D site cleavages and, thus, localises to both the nucleus and the cytoplasm 
(Vanrobays et al, 2004). It has been shown to interact with Nob1 through in vitro co-
precipitation (Woolls et al, 2011) and yeast-2-hybrid assays (Tone & Toh, 2002). 
The interaction appears to be regulatory, as Dim2 does not exhibit any enzymatic 
activity. 
 The regulatory role of Dim2 is also important for the dimethylation reaction 
performed by Dim1. These two proteins have also been shown to interact through co-
precipitation in cell extracts (Vanrobays et al, 2004). Dim2 is also involved in the 
pre-ribosome export from the nucleus (Vanrobays et al, 2008). As with Nob1, a 
single mutation in Dim2 (G207A) can prevent 20S processing (Vanrobays et al, 
2008). This mutation is in the RNA binding loop of the conserved KH domain and is 
predicted to prevent the protein from binding to the pre-ribosome. 
 An RNA recognition site for Dim2 can be predicted from an X-ray crystal 
structure of the archaeal protein from P. horikoshii (Jia et al, 2010), as shown in 
Figure 1.8 in the first chapter. This site appears to be very close to the D site, 
supporting the protein’s role in the final stages of maturation. However, unlike the 
eukaryotic protein, the archaeal protein contains two canonical KH domains. Thus, 
the RNA recognition site in eukaryotes requires further exploration to determine 
whether it is the same as in archaea. This chapter examines the interaction between 
recombinant Nob1 and Dim2, and the D site RNA in the eukaryotic system, 
providing insight into how the final D site cleavage might be regulated.  
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5.2 ScDim2 Modelling Based on the Archaeal Structure 
 
 
Initially, a model for the yeast protein was created using crystal structures of 
the archaeal Dim2. A multiple sequence alignment using Dim2 from eukaryotes and 
archaea was entered into Phyre, Phyre 2, and Swiss-Model. All three programs used 
archaeal structures (PDB IDs: 2E3U, 1TUA, and 3AEV respectively) to create a 
model for the yeast protein based on the predicted similarity to the solved structures. 
Both, Phyre and Swiss-Model, used the P. horikoshii structure (without and 
with RNA respectively). Phyre 2 used a structure of a protein of unknown function 
from Aeropyrum pernix. Figure 5.1 shows a sequence alignment of Dim2 from the 
two archaeal species and human and yeast. All three generated models were very 
similar showing an RMSD of 1.1 (Phyre to Phyre 2), 0.5 (Phyre to Swiss-Model), or 
1.3 Å (Phyre 2 to Swiss-Model). Thus, one model, generated by Phyre, was chosen 
for further analysis. 
Phyre generated a model of residues 95-266 from the yeast protein (274 
amino acids in length). As shown in Figure 5.2, the general fold of the modelled 
ScDim2 is very similar to that of the P. horikoshii protein. The locations of the two 
GxxG loops are marked on the figure. In Figure 5.2B only these loops from the 
archaeal structure and the generated model are shown. The conserved loop in the 
KH2 domain fits well into the RNA. However, the degenerated sequence in ScDim2 
KH1 shows large amino acids that do not interact with the RNA in the ideal fashion. 
Further model validation was undertaken, as presented in Figure 5.3. The 
geometry of the side chains was analysed (Figure 5.3A). Multiple outliers were 
found, especially in KH1. However, when these were mapped onto the model 
(Figure 5.3B) it was found that most of them were on the protein surface. Thus, their 
orientations could be readily adapted without disrupting the internal arrangement. 
Finally, a Ramachandran plot was also created (Figure 5.3C) to analyse backbone 
geometry. Only three residues were found to be in non-allowed regions. 
Overall, the model appears to be suitable, particularly for the KH2 domain 
(residues 195-247). The majority of KH1 (99-151) residues also appear to occupy 
plausible orientations. The largest differences are seen towards the end of this 
domain and in the RNA binding loop of KH1 (NSWT instead of GxxG). In the RNA 
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binding loop, while the side chain geometry is allowed in the actual loop, the 
preceding arginine (110) shows side chain angles that are unlikely to occur in nature 
and invades the predicted RNA binding site. Also, the backbone geometry in this 
location is inconsistent with naturally occurring angles, as asparagine 111 (the first 
residue of the loop) is one of the Ramachandran plot outliers. Thus, a eukaryotic 
structure is highly desirable to obtain structural insight into the fold of the Dim2 
protein, particularly in the degenerated domain. This, in turn, might lead to insights 
into its function, as it appears to be unable to bind to RNA in the same fashion as the 
archaeal Dim2 KH1 domain. 
The inability of the eukaryotic KH1 domain to bind rRNA is supported by the 
lack of conservation of the predicted rRNA binding site between eukaryotes and 
archaea. 
 
Figure 5.1: Dim2 sequence alignment using two archaeal sequences and the human and yeast 
proteins. 
The degenerated KH1 domain is marked in a thin blue box while the conserved KH2 domain is in the 
thin black box. The RNA binding loops (GxxG) are shown in the thick black boxes in each domain. 
The KH1 loop in archaea shows the GxxG motif while different sequences are seen in eukaryotes. 





Figure 5.2: Structural comparison of the P. horikoshii (3AEV) structure (PhDim2) to the 
ScDim2 model generated by Phyre. 
A) PhDim2 with and without RNA is shown next to the predicted ScDim2 structure. The proteins are 
coloured from the N-terminus (blue) to the C-terminus (red). The RNA binding loops in each 
domain are shown in black and indicted with arrows on the right. The RNA is shown in green in 
the first image.  
B) A view of the RNA binding loops (blue and yellow) and RNA (green) in the PhDim2 solved 
structure (left) and modelled ScDim2 (right). The RNA and protein fragments are shown as sticks. 
The KH1 loop (blue) in the modelled structure shows larger amino acids that do not fit in the RNA 
groove. The conserved KH2 loop (yellow), in both cases, shows small residues that fit well into 
the RNA. The two glycines (GxxG) allow the short loops to form tight turns in order to be 
incorporated in this manner. 
 




Figure 5.3: Model validation using side chain and backbone geometry. 
A) Geometry analysis of the amino acid side chains in the model. The red bars represent residues that 
are in unsuitable orientations. The taller the bar, the more unlikely the orientation for that amino 
acid is imposed. More of the tall red bars are located in the N-terminal KH-like domain. Overall, 
23 out of 266 residues are red. 
B) The geometric outliers are shown with their side chains as red sticks while the rest of the protein 
backbone is shown as a blue ribbon. The majority of the outliers are pointing out onto the protein 
surface. Thus, their orientations could be changed without disrupting the overall arrangement. 
C) Ramachandran plot for the predicted model. Three residues were found to be in the disallowed 




5.3 Cloning and Expression Trials 
 
 
Multiple constructs for Dim2 were created in order to study its function. 
These are summarised in Table 5.1, which also summarises the results of the 
expression trials performed with these constructs. The tests for the full-length yeast 
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Table 5.1: Summary of the expression results for different constructs created.  
The proteins were expressed as fusions with hexahistidine (His) or glutathione S-transferase (GST) 
tags. The first two constructs were present prior to the start of the project. 
Insert Organism Plasmid Tag Comments 




Expressed, Largely soluble 
Dim2ΔN91 S. cerevisiae pEC-KGC GST Expressed, Some soluble  
Dim2ΔN91 S. cerevisiae pEC-KHC His Expressed, Soluble 
Dim2ΔN51 S. cerevisiae pEC-KHC His Expressed, Soluble 
Dim2ΔN61 S. cerevisiae pEC-KHC His Expressed, Soluble 
Dim2ΔN99 S. cerevisiae pEC-KHC His Not much expressed, 
Insoluble 
Dim2 FL S. cerevisiae pEC-SHT His Expressed, Soluble 
Dim2 FL S. cerevisiae pEC-SGT GST No expression 
Dim2∆N31 H. sapiens pEC-KHC His Expressed, Soluble 




Figure 5.4: Expression trials of full-length (FL) ScDim2 constructs present prior to the start of 
this project. 
The different lanes correspond to the different fractions: uninduced (U), induced (I), soluble (S), 
insoluble/pellet (P), and the nickel/GSH bead-bound (B) fraction. The molecular weight markers (M) 
are also shown on each gel. The band corresponding to the correct size is indicated with an arrow. The 
same labels are used in all following expression trials. 
A) Expression of the full-length GST-tagged protein in different cell lines in 2xTY medium. The 
BL21 (DE3) and BL21 (DE3) pRIPL cell lines show significant soluble expression and 
enrichment in the bead-bound fraction. The BL21 (DE3) strain was chosen for further cultures. 
B) Expression of His-tagged ScDim2 in BL21 (DE3) cells in the 2xTY medium. Less overexpression 
is seen than with the GST-tagged protein. However, the protein is still soluble and enriched on the 
beads. 
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 Additional constructs were also made and tested for expression (Table 5.1). 
The initial truncated construct (ScDim2∆N91) was GST-tagged. However, when the 
GST was removed with 3C protease, the protein precipitated out of solution. The 
presence of the large, soluble tag masked the insolubility of the construct. Thus, the 
majority of constructs made contained His-tagged protein in order to avoid these 
masked solubility issues. Figure 5.5 shows the expression test results for a series of 
His-tagged yeast constructs. ScDim2∆N91 was seen to be mostly soluble with both 
types of tag (the previously performed trials for the GST-tagged protein were not 
repeated). 
 The human GST-tagged Dim2 sequence was obtained from Dr. Nick Watkins 
(University of Newcastle) in the pGEX-6P-1 plasmid. The construct contained a 3C 
cleavage site and the full-length protein. Expression tests were performed and are 
shown in Figure 5.6A. Good, soluble expression was seen. As shown in Table 5.1, 
the protein was re-cloned into the pEC-KHC plasmid containing different N-terminal 
truncations. These two constructs also showed good, soluble expression (Figure 
5.6B). 
Finally, the full-length protein from C. thermophilum was ordered as a codon 
optimised plasmid. Figure 5.7 shows that no soluble expression of this protein was 
obtained. Thus it was not used any further. 
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Figure 5.5: Expression trials for the different ScDim2 constructs created for this project. 
The lane labelling is the same as for the previous figures. 
A) Expression of the His-tagged ∆N91 construct. The protein expresses and is soluble in BL21 (DE3) 
and BL21 (DE3) pRIPL strains. A small amount was also observed using the B834 (DE3) cells. 
B) Expression tests using the three new ∆N mutants (∆N51, 61, and 99). The first two show good 
soluble expression in BL21 (DE3) cells in 2xTY medium. The longest truncation (∆N99), on the 
other hand, shows no soluble expression at all. 
C) Expression of the His-tagged full-length protein from the pEC-SHT plasmid. A small amount of 
expression is seen in BL21 (DE3) in 2xTY medium. The best expression is obtained using the T7 
Express cell line. However, expression from the pEC-KHC plasmid was better.  
D) The GST-tagged protein cloned into pEC-SGT is not expressed at all. Thus, it was not used. 
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Figure 5.6: Expression trials of the human Dim2 (HsDim2) constructs. 
The lane labelling is the same as for the previous figures. 
A) The full-length GST-tagged protein was obtained from Dr. Nick Watkins. The HsDim2 over-
expressed and was soluble in all cell strains used. They all also showed enrichment on the beads. 
The BL21 (DE3) strain was chosen for further cultures. 
B) Expression of the two ∆N mutants created (∆N31 and 42). They both showed soluble expression 





Figure 5.7: Expression trials of the codon optimised CtDim2 in 2xTY medium. 
The lane labelling is the same as for the previous figures. A small amount of induced expression is 
seen in all strains apart from the B834 (DE3) strain. However, all of the protein is seen in the pelleted 
fraction showing that the protein is not soluble. Thus, this construct was not used any further. 
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5.4 Protein Purification 
 
 
5.4.1 Initial trials for ScDim2 – full-length and ∆N91  
 
Previous attempts to purify the full-length ScDim2 (performed by Iva 
Tchasovnikarova) were hampered by co-purification of the protein with ribosomal 
proteins and RNA derived from the expression host. Thus, the truncated version of 
the protein (∆N91) was subjected to purification instead. However, after the first 
affinity step (Figure 5.8A), the protein precipitated upon GST tag cleavage and 
could not be resuspended with addition of salt. Thus, the truncated version only 
seemed to be soluble due to the GST fusion. 
 Going back to the GST-tagged full-length protein, alternative protocols that 
replaced the heparin sepharose step with ion exchange chromatography were tested.  
Neither Mono S nor Mono Q ion exchange columns were able to separate the protein 
from its contaminating RNA (Figure 5.8B and C). 
 To test whether Dim2 could be more easily purified in a complex with Nob1, 
a co-purification strategy was tested. GST-ScDim2 and His-ScNob1 were expressed 
separately and co-lysed. However, both proteins precipitated out of solution upon 
lysis and further purification could not be performed. 
 Finally, the His-ScDim2 construct was subjected to nickel affinity 
purification (Figure 5.9). Afterward, the RNA contamination was digested by 
incubation with Cyanase nuclease. This caused the protein to precipitate, suggesting 
that Dim2 is not stable in the absence of its RNA partner. Alternatively, the protein 
could protect a small portion of the RNA (the binding site) and precipitate due to the 
presence of a shorter nucleic acid. 
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Figure 5.8: Purification trials for ScDim2.  
Absorbance profiles at 280 nm and 260 nm are shown in blue and red (where available) respectively. The protein of interest on the gel is indicated with an arrow.  
A) The GST-tagged ScDim2 ∆N91 was 
affinity-purified using a column packed with 
glutathione resin. The protein was then eluted 
using a buffer containing 20 mM glutathione. 
The corresponding peak was analysed on 
SDS-PAGE (right image). The ScDim2∆N91 
protein co-eluted with E. coli OmpF protein 
(identified with MALDI-ToF mass 
spectrometry analysis). The truncated protein 
precipitated upon GST-tag cleavage and 
purification was discontinued. 
B) GST-tagged full-length ScDim2 was 
purified as above giving the same elution 
profile. The GST-tag was cleaved using 3C 
protease. A Mono S cation exchange column 
was then loaded (result shown here) with the 
protein and eluted with a salt gradient (50 to 
1000 mM). Some ScDim2 remained in the FT 
and the rest co-eluted with the cleaved GST. 
The FT was loaded onto a Mono Q column 
(anion exchange – see below).  
C) Mono Q elution profile for ScDim2 
using the same gradient as for Mono S. The 
column gives good separation but absorbance 
at 260 nm shows a lot of RNA contamination 
(peaks 3 and 4). A small portion appears 
relatively clean (peak 2) but it contains a large 
proportion of uncleaved GST-ScDim2.  




Figure 5.9: Nickel affinity purification of His-tagged ScDim2.  
All the labelling and colour schemes are the same as on previous purification figures.  The elution 
gradient ranged from 20 to 500 mM imidazole. The majority of the protein came in the flowthrough 
(FT) fraction as shown by the high absorbance before the start of the gradient and the SDS-PAGE gel 
on the right. The intense band (marked with an arrow) present in the input is still present in the FT. 
Western blotting (not shown) confirmed that the His tag is present but it appears to be inaccessible. 
Some protein still bound to the column and was eluted in the small peak at the start of the gradient. 
Fractions enveloping the peak were pooled and subjected to incubations with Cyanase nuclease. 
 
 
5.4.2 HsDim2 – full-length 
 
As previously mentioned, the HsDim2 construct was obtained from Dr. Nick 
Watkins. The Watkins lab had also established a single-step purification (GSH resin 
affinity for the GST tag), which included a detergent in the buffer. Two further steps 
were added to the purification in order to obtain pure HsDim2. After elution from the 
GSH resin, the GST tag was cleaved with 3C protease and the protein was dialysed 
into a low salt buffer. Then, the HsDim2 was injected onto a cation exchange column 
(pI of 9.8) and eluted with a salt gradient. Finally, the eluted peak was concentrated 
and injected onto a SEC column. 
Figure 5.10 shows that the three purification steps worked well to give 2 mg 
of pure HsDim2 from 4 litres of culture. The protein eluted as a single peak in SEC 
showing no RNA contamination. The detergent appeared to be important in the first 
step as when it was excluded from the lysis buffer, the HsDim2 precipitated out of 
solution upon dialysis. 
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Figure 5.10: Purification of the GST-
tagged HsDim2. 
All labelling and colours are the same as on 
previous figures. 
A) SDS-PAGE analysis of the elution 
from GSH resin. The protein was incubated 
with the beads and eluted with 20 mM 
glutathione in-batch. Five washes with the 
buffer were performed and all showed 
elution of the correct protein. The first four 
were pooled, dialysed, and used in the 
following steps. 
B) The second step involved binding 
the protein to a Mono S cation exchange 
column and eluting it with a salt gradient 
(100 to 1000 mM KCl). The second peak 
was seen to contain the HsDim2 protein 
while the majority of RNA contamination 
eluted in the first peak. Thus, the second 
peak was pooled and concentrated in 
preparation for SEC. 
C) The SEC profile for HsDim2. A 
single peak containing pure protein is seen. 
A small peak in the void is also seen. 
However, no bands are visible on the gel 
suggesting that it contains nucleic acids or 
other contaminants. Alternatively, the 
amount of protein in this peak is too small 
to be seen. 
 




Since the purification of HsDim2 worked well, the same protocol was used to 
purify the ScDim2∆N51 truncated protein from yeast. However, the first step was 
replaced with nickel affinity as this construct contained a hexahistidine tag. As 
shown in Figure 5.11, 11 mg of pure protein were obtained from 2 litres of culture in 
the same manner as the human construct. However, it was found that the protein 
retained its ability to interact with nickel resin and it did not decrease in size 
observed by SDS-PAGE after incubation with the 3C protease. This suggests that the 
His tag could not be cleaved even though a cleavage site is present. The tag is likely 
to be too close to the folded regions of the protein and the cleavage site is obscured. 
As the new protocol containing the detergent worked well for the human and 
yeast constructs, an attempt was made to go back to the full-length GST-ScDim2 and 
try this alternative purification method. However, when the protein was subjected to 
the second step (cation exchange), it was found to co-elute with the GST tag and 3C 
protease, which normally do not bind to this column (see HsDim2 purification). 
Also, significant RNA contamination was seen (Figure 5.12). 
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Figure 5.11: Purification of the His-
tagged ScDim2∆N51 protein. 
The colours and labels are the same as 
in previous figures. 
A) Nickel affinity purification. 
The protein was eluted with an 
imidazole gradient (20 to 500 mM) and 
was seen as a single peak. The fractions 
containing this peak were pooled and 
dialysed overnight. 
B) Mono S cation exchange 
purification was then performed. Pure 
protein was seen to elute in the second 
peak. An overlapping peak containing 
some of the contaminants was also 
present. The second peak was pooled 
and concentrated for SEC. 
C) The SEC elution profile for 
ScDim2∆N51. A very small peak in the 
void (i.e. FT) is seen. However, all of 
the protein elutes as a single peak. The 
fractions containing this peak were 
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Figure 5.12: Purification of full-length GST-tagged ScDim2 using the protocol established for 
the human protein. 
The labels and colours are the same as on previous figures. The first step using in-batch affinity 
purification with GSH resin looked the same as for HsDim2. The protein was pooled and dialysed 
overnight. Then, it was injected onto a Mono S cation exchange column (chromatogram shown here). 
The results above show that ScDim2 co-elutes with GST and 3C protease, which normally do not bind 
to this column (as seen with HsDim2). This suggests that the protein forms a large 
complex/precipitate with GST and/or 3C protease. Also, the absorbance at 260 nm is relatively high 




5.5 Oligomerisation State of Dim2 Remains in Question 
 
 
Two constructs of Dim2 were successfully purified: the full-length human 
protein and the N-terminally truncated yeast protein. Their elution from the SEC 
column suggests that they both might form dimers (Figure 5.13). However, as stated 
before, SEC profiles depend on the shape as well as size of the protein. Thus, it is 
possible that it forms an elongated monomer instead of a dimer. In order to 
determine which hypothesis is more likely, the hydrodynamic radii (Rh) and radii of 
gyration (Rg) were calculated for existing solved structures using the HYDROPRO 
software (Ortega et al, 2011).  
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Figure 5.13: HsDim2 and 
ScDim2∆N51 SEC results 
compared to size standards.  
The protein standards are 
labelled under the 
chromatogram. Their sizes (in 
kDa) are shown in orange next 
to each peak with the 
corresponding elution volumes 
shown above these in blue or 
green. 
A) Comparison of 
HsDim2 with the size standards. 
HsDim2 appears smaller than 
the BSA monomer but larger 
than the carbonic anhydrase. 
However, the predicted size is 
only 28.3 kDa. 
B) SEC results for 
ScDim2∆N51 compared to the 
standards. This protein is 
slightly smaller than HsDim2 
but still elutes before the 
carbonic anhydrase. The 







For this purpose, the PDB files for the size standards used in SEC and the 
archaeal P. horikoshii Dim2 were used as described in the methods. The results of 
the analysis are summarised in Table 5.2. The hydrodynamic radius is a measure of 
the size of the protein. However, it assumes a spherical shape. The radius of gyration 
is more dependent on the structure as it reflects the root mean square distance from 
the centre of the molecule to each element. The ratio of the two values (Rg/Rh) gives 
an assessment of the globularity of the species. For a spherical protein, this ratio 
should be 0.775 (Burchard et al, 1980; Vandesande & Persoons, 1985). A higher 
ratio corresponds to an elongated protein (Rg is larger than for a spherical protein) 
whereas a lower one shows that the density of the molecule is skewed towards the 
core (Rg is smaller than for a globular species). 
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Table 5.2: Summary of results obtained from HYDROPRO for the different structures and the 
elution volumes obtained from SEC. 
Protein PDB ID MW (kDa) Rh (nm) Rg (nm) Rg/Rh Elution 
Volume (ml) 
BSA monomer 4F5S 66.4 3.60 2.75 0.765 75.0 
Carbonic Anhydrase 1V9E 29.0 2.48 1.84 0.744 88.1 
Archaeal Dim2 2E3U 25.1 2.32 1.82 0.785 - 
ScDim2∆N51 - 27.4 - - - 82.1 
HsDim2 - 28.3 - - - 79.5 
 
The results obtained from HYDROPRO show that while the two size 
standards (BSA and carbonic anhydrase) are dense in the core with a couple of 
extremities (Rg/Rh ratio below 0.775), the solved archaeal Dim2 structure is 
elongated (ratio of 0.785). If the eukaryotic structure is similar to the archaeal one, 
Dim2 should elute marginally earlier in SEC than would be predicted from its 
molecular weight. However, the ratio is still relatively close to that for a globular 
protein and the shape alone cannot explain the large discrepancies in elution 
volumes. For example, HsDim2 elutes closer to BSA than carbonic anhydrase even 
though it is smaller in size than the latter protein. Thus, it is more likely that the 
proteins form a more globular dimer than a largely elongated monomer. 
In the future, SEC-MALS should be performed to determine the true 
oligomerisation state. Then, DLS could be used to experimentally obtain the 
hydrodynamic radii and information about the diffusion of the eukaryotic 
recombinant proteins in solution. 
 
 





In order to determine if the purified HsDim2 protein is stable, thermal 
denaturation was performed. Initially, a trial using different concentrations (1-10 
µM) of HsDim2 was performed. This experiment showed that, unlike Nob1, HsDim2 
is seen to be more stable at higher protein concentrations. The melting temperature 
dropped from 48.7˚C at 10 µM to 43.5˚C at 1 µM. A buffer trial was performed 
using 3 µM HsDim2 (Figure 5.14), as this was the lowest concentration predicted to 
give a good signal-to-noise ratio. 
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Figure 5.14: Thermal denaturation results for HsDim2. 
The experiments were performed in triplicate. The error bars represent the standard deviations. 
A) An example of the raw thermal melt obtained. The increase in relative fluorescence units (RFU) 
was recorded over changes in temperature. A single melt curve is seen. 
B) An example derivative of the thermal melt. The bottom of the peak corresponds to the melting 
temperature (Tm). This value was taken for each of the experiments and averaged over the three 
repeats to obtain the summarised results. 
C) Summary of the effect of protein concentration on protein stability. Higher HsDim2 concentrations 
led to higher melting temperatures suggesting increased stability.  
D) 3 µM protein was used for all the following experiments. Summary of the effect of decreasing pH 
on the melting temperature. The protein appears to be more stable at higher pH. 
E) Effects of glycerol concentration on HsDim2 stability. The Tm increases with glycerol. 
F) KCl concentration has no significant effect on protein stability. 
G) MgCl2 has no significant effect on HsDim2 stability. 
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It was found that the pH of the buffer had a significant effect on the melting 
temperature of HsDim2 (50.3˚C at pH 8.0 to 46.7˚C at pH 6.5). Thus, the protein was 
only stored in buffers at pH 8.0 or 7.5 in later experiments. As with Nob1, it was also 
found that the stability increases with glycerol concentration. Salt and magnesium 
concentrations had no significant effect on the melting temperature suggesting that 
they do not affect protein stability. 
Due to time constraints, the thermal denaturation assay was not performed for 
ScDim2∆N51. However, it should be tested in the future. 
 
 





Since the full-length human Dim2 purified well and was predicted to have 
two domains (the KH and KH-like domains), limited proteolysis was performed to 
see which parts were stably folded. The results, shown in Figure 5.15, suggest that 
the protein is relatively stable as only the highest concentrations of proteases show 
full digestion of the protein. A single band in the GluC 1:10 lane was observed. A 
band of the same size was also seen using 1:10 Elastase (and partially in 1:100 
Trypsin). Thus, these two enzymes were chosen for a time trial (at a 1:100 dilution). 
 
 
Figure 5.15: Limited proteolysis of HsDim2.  
The enzymes used are shown above. Three dilutions per enzyme (of 1 mg/ml stocks) were used. 
Limited proteolysis allowed mapping of stable regions. The band of interest in the 1:10 GluC lane is 
marked with an arrow. The experiment was later scaled up in order to obtain a large amount of the 
truncated protein. 
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Figure 5.16A shows that, after 4 hours, some full-length protein is still 
present. Thus, an overnight incubation was also tested. The long incubation with 
GluC produced, almost exclusively, the band of interest (Figure 5.16B). This 
enzyme and incubation time were chosen for preparative proteolysis. MALDI-ToF 




Figure 5.16: Proteolysis of the HsDim2 protein over time using 1:100 Elastase or GluC. 
A) Time trials using 1:100 Elastase (left) or GluC (left). The protein was incubated with each protease 
for up to 4 hours. Both proteases showed the production of the band of interest. However, the full-
length protein was still visible. Thus, overnight incubation was also performed. 
B) Results of the overnight proteolysis. The Elastase lane still shows a significant amount of the full-
length protein. On the other hand, GluC proteolysed almost all of the protein. Thus, this enzyme 
was chosen for large-scale preparative proteolysis. 
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Figure 5.17: MALDI-ToF analysis results for the full-length and proteolysed HsDim2. 
The band was excised from the gel and subjected to trypsin digestion. The predicted proteolytic sites 
are indicated with the blue arrows. The peptides identified by mass spectroscopy are shown in red.  
A) Results for the full-length protein. Peptides covering almost all of the protein were identified. The 
ones not seen appear to be too short. 
B) Results for the proteolysed fragment of HsDim2. All of the peptides except the N-terminal one 




Preparative proteolysis was performed on fresh HsDim2 purified using the 
first two steps described previously. After cation exchange, the protein was mixed 
with 0.005 mg GluC per 1 mg of HsDim2 and incubated at 4˚C overnight. The 
reaction was then stopped with protease inhibitors and injected onto a SEC column. 
Two overlapping peaks were observed in the elution profile, containing different 
truncation products (Figure 5.18). They were pooled separately and concentrated. 
The longer fragment gave a yield of about 400 µg while the shorter one only 300 µg 
from 4 litres of culture. They were then used for crystallisation screening. No hits 
were obtained using these fragments. 
 




Figure 5.18: Preparative proteolysis and SEC purification of the HsDim2 protein. 
Absorbance at 280 nm is shown in blue while 260 nm is shown in red. Two overlapping peaks were 
eluted from the SEC column. SDS-PAGE analysis of the fractions identified two truncation products. 
They were pooled separately and used for crystallisation screening. Peaks 3 and 4 likely contained the 
excess protease inhibitors. This is supported by the small size of the particles and the high absorbance 




5.8 Testing Interactions with Different Binding Candidates 
 
 
5.8.1 ScNob1 and ScDim2∆N51 do interact  
 
Multiple studies have found that Nob1 and Dim2 interact. To test whether 
this is true for recombinantly purified proteins, semi-analytical SEC was performed 
using the two yeast proteins. The elution profiles looked additive and the individual 
peaks were visible suggesting a lack of interaction (Figure 5.19). However, when the 
experiment was repeated at higher pH (Figure 5.20) or higher salt concentrations 
(Figure 5.21), a shift to an earlier elution volume was observed. Complex formation 
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was confirmed using SDS-PAGE of the fractions. Nevertheless, free proteins are still 
seen along with the complex. 
In the future, other quantitative binding experiments should be performed 
(such as ITC) to obtain more information about the interaction, such as the 





Figure 5.19: Semi-analytical SEC results using ScNob1 and ScDim2∆N51. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown in the top right side. 
A) The SEC profile for ScNob1 only. As before, a single peak is seen. 
B) The chromatogram for ScDim2∆N51 alone.  
C) The SEC result when ScNob1 is mixed with ScDim2∆N51 in a 1:1 ratio. The two peaks remain 
separate, although, as with HsDim2, they overlap making them difficult to define. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The top of the peak 
has shifted slightly to an earlier elution volume suggesting a weak interaction. However, this 
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Figure 5.20: Semi-analytical SEC of ScNob1 and ScDim2∆N51 at high pH (8.5 instead of 7.5). 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only.  
B) The chromatogram for ScDim2∆N51 only. The peak looks the same as at pH 7.5. 
C) The SEC result when ScNob1 is mixed with ScDim2∆N51 in a 1:1 ratio. Separate profiles for the 
two peaks are still seen. However, the larger peak is visibly shifted to an earlier elution volume. 
D) An overlay of the three previous results showing absorbance only at 280 nm. As mentioned above, 
the peak is definitely shifted to the left supporting complex formation. However, a peak for 
ScDim2∆N51 alone is still visible. 
E) Silver stained SDS-PAGE analysis of the fractions from each experiment indicated with an arrow 
in panel D. The distribution of the two proteins changes (to the left) when they are mixed together. 
This suggests that the two protein co-elute supporting that a complex is formed. However, not all 
of the free protein is involved. 
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Figure 5.21: Semi-analytical SEC analysis of ScNob1 binding to ScDim2∆N51 at higher salt 
concentrations (350 mM instead of 150 mM KCl). 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown in the top right corner. 
A) The SEC profile for ScNob1 only.  
B) The chromatogram for ScDim2∆N51 alone.  
C) The SEC result when ScNob1 is mixed with ScDim2∆N51 in a 1:1 ratio. The larger peak is seen to 
shift to an even earlier elution volume although a free ScDim2∆N51 peak is still seen. 
D) An overlay of the three previous results showing absorbance only at 280 nm. As with higher pH, 
higher salt is seen to cause the peak to shift to the left. More of the ScDim2∆N51 peak also 
appears to be incorporated into the other peak. 
E) Coomassie stained SDS-PAGE analysis of the fractions indicated in panel D from each 
experiment. Again, when the two proteins are mixed together, the distribution of protein shifts to 
the left. Thus, a complex is definitely formed. 
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5.8.2 ScNob1 and HsDim2 do not interact 
 
The semi-analytical SEC was then repeated using yeast Nob1 and human 
Dim2. The Dim2 protein is highly conserved between yeast and human, particularly 
in the KH domain (see Figure 1.7). The surface forming interactions with Nob1 
should also be highly conserved to preserve the mechanism of complex formation. 
However, as shown in Figure 5.22, no interaction was observed between the 
recombinant proteins. It is noteworthy that this experiment was only performed using 
the initial conditions. A higher pH or salt concentration could show an interaction 
between these two constructs. 
 
5.8.3 ScDim2∆N51 does not interact with ScDim1 in vitro 
 
A study using co-precipitation from cell extracts has also found that Dim2 
interacts with Dim1 in the pre-ribosome (Vanrobays et al, 2004). Again, this was 
tested with the recombinant proteins in vitro. ScDim1 was previously purified by 
Anees Basha. This was mixed in a 1:1 ratio with ScDim2∆N51 and injected onto a 
semi-analytical SEC column. No interaction was observed in these conditions 
(Figure 5.23).  
As a negative control, the same experiment was repeated with ScNob1 and 
ScDim1. There is no evidence that these two proteins directly interact during 
ribosome biogenesis. The result also looks additive (Figure 5.24), suggesting that 
neither of the proteins interacts with Dim1. However, the ScDim1 protein was kept 
in the freezer as a glycerol stock for a substantial length of time and could have 
deteriorated during storage. Also, the experimental conditions might not have been 
ideal for complex formation. 
 
5.8.4 ScNob1 and ScFap7 do not interact in semi-analytical SEC 
 
Recently, it has been shown that Nob1 can interact with Fap7 in archaea. 
Thus, ScFap7 was purified by Dr. Uma Jayachandran and semi-analytical SEC was 
used to see if these results could be replicated using yeast proteins. However, as 
shown in Figure 5.25, no interaction between the two proteins was seen in the 
conditions tested. 




Figure 5.22: Semi-analytical SEC results for ScNob1 mixed with HsDim2. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the top right. 
A) The SEC profile for ScNob1 only. A single peak is seen. 
B) The chromatogram for HsDim2 alone. Again, a single peak is observed. 
C) The SEC result when ScNob1 is mixed with HsDim2 in a 1:1 ratio. The two peaks appear to be 
separate. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The tops of the two 
peaks are in the same positions on the elution profile suggesting that there is no interaction. A 
slight increase in absorbance can be seen. This is likely due to pipetting or injection variation. 
E) Coomassie stained SDS-PAGE analysis of the fractions containing the peaks (the fractions 
spanned the elution volumes indicated on panel D with the arrow). The two proteins alone and 
mixed together show the same distribution of protein in the peak fractions, supporting that there is 
no interaction. 




Figure 5.23: Semi-analytical SEC using ScDim2∆N51 and ScDim1. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScDim2∆N51 only.  
B) The chromatogram for ScDim1 alone. Two peaks are seen. The more prominent one corresponds 
to the normal elution volume observed for ScDim1. 
C) The SEC result when ScDim2∆N51 is mixed with ScDim1 in a 1:1 ratio. It is impossible to say if 
the peaks remain separate as they overlap. 
D) An overlay of the three previous results showing absorbance only at 280 nm. As the individual 
peaks overlap normally, it is difficult to say if a complex is formed. However, since the left edge 
remains in the same position, no increase in size is evident suggesting that there is no interaction. 
E) Coomassie stained gel of the fractions indicated in panel D from each experiment. The distribution 
of the proteins does not change and they do not co-elute supporting that there is no complex 
formation.




Figure 5.24: Semi-analytical SEC of ScNob1 and ScDim1. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 only. A single peak is seen. 
B) The chromatogram for ScDim1 alone. Two peaks are seen but the one at the correct size is more 
prominent. 
C) The SEC result when ScNob1 is mixed with ScDim1 in a 1:1 ratio. The two peaks remain 
separate. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The tops of the two 
peaks are in the same positions on the elution profile suggesting that there is no interaction. A 
slight increase in absorbance can be seen. This is likely due to pipetting or injection variation. 
 




Figure 5.25: Semi-analytical SEC of ScNob1 and ScFap7. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScNob1 alone. Again, a single peak in the same position as before is seen. 
B) ScFap7 elution profile. A single symmetric peak is seen suggesting the protein is clean. 
C) SEC results for ScNob1 mixed with ScFap7 mixed in a 1:1 ratio. The two peaks remain separate 
and come out at the same elution volumes as they did separately. This suggests that there is no 
interaction between these two proteins in these conditions. 
D) An overlay of the other three results showing absorbance only at 280 nm. Again, the peaks appear 





5.9 Dim2 Interacts with D-site Derived Sequences 
 
 
5.9.1 Dim2 and the D-site tight hairpin do not interact 
 
The Dim2 RNA binding site was predicted based on the archaeal structure in 
complex with bacterial RNA that co-precipitated during purification (GGAUCA 
sequence) (Jia et al, 2010). Different RNA sequences containing this site were 
transcribed as described for Nob1. They were tested for binding to the purified 
human and yeast Dim2 proteins. Initially, the RNA that forms the predicted hairpin 
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was used (DS0). When this sequence was mixed with ScDim2∆N51, no interaction 




Figure 5.26: Semi-analytical SEC using ScDim2∆N51 and yeast DS0 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown in the top right corner. 
A) The SEC profile for ScDim2∆N51 only.  
B) The chromatogram for DS0 RNA alone. Two peaks are seen likely due to the formation of 
secondary structures at 4˚C. 
C) The SEC result when ScDim2∆N51 is mixed with DS0 in a 1:1.2 ratio. The peaks remain separate 
although an overlap is seen. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The peaks overlap to 
some extent. However, they are still visible as separate entities. Also, the absorbance remains the 
same. Thus, this protein and RNA do not make a complex in these conditions. 
 
 
5.9.2 Dim2 and the D-site partial hairpin interact but they precipitate out of 
solution 
 
Since the secondary structure of the D site remains in question, the semi-
analytical SEC was repeated using the yeast DS1 RNA, which contains a shorter 3 
extension and does not form a stable hairpin. The GGAUCA sequence remains 
single-stranded in this RNA. 
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 When this RNA was mixed with either, HsDim2 or ScDim2∆N51, 
precipitation was observed in the tube. This was removed prior to injection onto the 
SEC column. Figures 5.27 and 5.28 show the elution profiles for the two proteins, 
respectively. It appears that the precipitate contained each of the proteins and the 
RNA. This suggests that a complex is formed, but it is insoluble in these conditions.  
 
 
Figure 5.27: Semi-analytical SEC using HsDim2 and yeast DS1 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for HsDim2 only.  
B) The chromatogram for DS1 alone. A couple of peaks are seen suggesting the formation of 
secondary structures. The samples were pre-incubated at room temperature to minimise these. 
C) The SEC result when HsDim2 is mixed with DS1 RNA in a 1:1.2 ratio. Most of the protein peak 
disappeared when the precipitation was removed. 
D) An overlay of the three previous results showing absorbance only at 280 nm. Almost all of the 
protein and some of the RNA were removed with the precipitation prior to the injection. This 
suggests that a complex was formed. 
 
U. McCaughan                                                 Chapter 5: Characterisation of Dim2 and Its Interactions 
 180 
 
Figure 5.28: Semi-analytical SEC using ScDim2∆N51 and yeast DS1 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScDim2∆N51 only.  
B) The chromatogram for DS1 alone. Two large peaks are seen suggesting the presence of several 
species of RNA. This is exacerbated by the pre-incubation being at 4˚C. 
C) The SEC result when ScDim2∆N51 is mixed with DS1 RNA in a 1:1.2 ratio. The precipitated 
particles were removed and the peaks that remain correspond to free RNA. 
D) An overlay of the three previous results showing absorbance only at 280 nm. All of the protein 
appears to have been removed with the precipitation. A large amount of the RNA is also gone. 
This suggests complex formation. 
E) Coomassie stained gel of the precipitated fraction. The precipitate definitely contained the protein. 
It is likely that it also contained RNA its level in the SEC elution profile was lower than expected. 
However, this was not confirmed. 
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An in vitro transcribed human DS1 RNA was also used with HsDim2. No 
interaction was observed (Figure 5.29); however, when the RNA was examined on a 
denaturing gel, multiple species of different lengths were seen (Figure 5.29E), 
suggesting that an incorrect fragment was synthesized. 
In order to negate the precipitation issue, a solubility screen was performed. 
For this purpose, a drop of ScDim2∆N51 was mixed with some DS1 RNA and 
different buffers. Precipitation was monitored under a microscope. It was found that 
the drops remained clear at higher pH (8.5 instead of 7.5) and higher salt (350 mM 
instead of 150 mM KCl). Thus, these two buffer conditions were used for further 
semi-analytical SEC. In both cases, the RNA was no longer able to interact with the 
protein (Figures 5.30 and 5.31 respectively). 
Finally, a Surface Plasmon Resonance (SPR) experiment was designed. In 
this assay, one of the binding partners is immobilised on a chip (ScDim2∆N51) and 
the other one is run over the chip in solution (DS1 RNA). The chip changes mass 
when binding occurs. In turn, this causes a change in the angle of light refracted from 
the chip, allowing the kinetics of the interaction to be observed, including the 
association (when the RNA is added) and dissociation (when the RNA injection is 
stopped) curves. Also, the immobilisation of the protein could prevent precipitation 
when the interaction occurs.  
The experiment involved five injections of increasing amounts of RNA and 
was performed at 4, 10, or 25˚C. Results at 4 and 10˚C were very similar but the 
higher temperature showed less noise. At 25˚C, very little response was seen (Figure 
5.32). Two ways of analysing the results were tested. The kinetic analysis used the 
whole association and dissociation curves fitted to a one-to-one binding model. The 
other method (affinity analysis) averaged the last four seconds of each injection to 
obtain a curve of response vs. the concentration. However, this method requires the 
binding to be saturated. 
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Figure 5.29: Semi-analytical SEC using HsDim2 and in vitro transcribed human DS1 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScDim2∆N51 only.  
B) The chromatogram for DS1 RNA alone. A single peak is seen. 
C) The SEC result when HsDim2 is mixed with DS1 RNA in a 1:1.2 ratio. The two peaks remain 
separate. 
D) An overlay of the three previous results showing absorbance only at 280 nm. Again, it is clear that 
the peaks remain separate suggesting that there is no interaction. 
E) A denaturing gel of the in vitro transcribed yeast and human DS1 RNAs. The human sequence 
shows transcription of other fragments. Although the correctly sized fragment was gel purified, the 
sequence could still be incorrect. 




Figure 5.30: Semi-analytical SEC using ScDim2∆N51 and yeast DS1 RNA at pH 8.5. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScDim2∆N51 only.  
B) The chromatogram for DS1 alone. Again, multiple peaks are seen, likely due to the incubation 
being at 4˚C. 
C) The SEC result when ScDim2∆N51 is mixed with DS1 RNA in a 1:1.2 ratio. Due to the 
complexity of the elution profile of the RNA alone, it is difficult to say if a complex is formed. 
D) An overlay of the three previous results showing absorbance only at 280 nm. The peaks appear to 
be in the same positions; however, the absorbance does increase for some of them. 
E) Silver stained gel of the fractions indicated in panel D. The distribution of the protein does not 
change (the last fraction for the Dim2-only experiment is shown in the left lane). Thus, there 
appears to be no complex formation in these conditions. 




Figure 5.31: Semi-analytical SEC using ScDim2∆N51 and yeast DS1 RNA in 350 mM KCl. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The SEC profile for ScDim2∆N51 only.  
B) The chromatogram for DS1 RNA alone. As before, multiple peaks are seen. 
C) The SEC result when ScDim2∆N51 is mixed with DS1 in a 1:1.2 ratio. It is impossible to say if 
the peaks remain separate as they overlap. 
D) An overlay of the three previous results showing absorbance only at 280 nm. As the individual 
peaks overlap normally, it is impossible to definitely say if a complex is formed. However, since 
the left edge remains in the same position, no increase in size is evident, suggesting that there is no 
interaction. 
E) Coomassie stained gel of the fractions indicated in panel D from each experiment. The distribution 
of the protein does not change supporting that there is no complex formation. 
 




Figure 5.32: The raw sensogram results obtained from the SPR experiments at different 
temperatures. 
The starting response corresponds to the nickel and protein loaded onto the chip. Each experiment 
involved five injections of increasing concentrations of DS1 RNA. 15 µl of each concentration were 
injected followed by a 30 second break. The overall response (Rmax) can be seen in Table 5.3. 
A) The sensogram obtained at 4˚C. The RNA was seen to bind (the rise in response). After the 
injection, there was a fast dissociation (the sudden drop in response) followed by a slower one 
(gradual drop). The binding is seen to be concentration dependent.  
B) The results at 10˚C. The sensogram looks very similar to the one obtained at 4˚C. However, fewer 
buffer mismatches are seen (the vertical lines at the start and end of each injection). 
C) The sensogram obtained with the chip at 25˚C. Some binding is still present and the baseline is 
raised with each injection. However, the association and dissociation curves are difficult to see due 
to noise. Thus, it appears that the most clearly interpretable data was obtained at 10˚C. 
 
 
Kinetic analysis results for the 10˚C experiment, shown in Figure 5.33, 
suggest that an interaction is present. However, the scale of the response seen is 
much lower than predicted. Table 5.3 shows the predicted maximum response and 
the values obtained using the assay at different temperatures. Large bulk 
contributions were observed in the kinetic analysis, which suggests that precipitation 
might still be happening on the surface of the chip. This is supported by the nature of 
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the dissociation curve, which shows two different ‘off’ rates. The faster rate would 
correspond to larger molecules (i.e. precipitate) coming off, while the non-
precipitated individual RNAs dissociating would cause the slower rate.  
The affinity analysis was also performed (Figure 3.33C). However, the 
association curves are not flat at the top showing that the chip was not saturated. 
Thus, the values obtained from this analysis are underestimated and the dissociation 
constants could not be trusted. Overall, a very small portion of the surface appears to 
be active and the RNA precipitates onto it. 
 
Figure 5.33: The analysis results for the SPR experiment performed at 10˚C. 
A) The sensogram is shown again for comparison. 
B) Kinetic analysis of the sensogram data. In pink, the raw data is shown, while the model fitted is 
shown in black. This corresponds to a one-to-one binding model. It does not fit the data as there 
are two on and off rates observed (fast and slow). 
C) Steady state affinity analysis of the sensogram. The last four seconds of each injection were 
averaged for this purpose. Thus, the response could be plotted relative to the DS1 concentration. 
However, as the binding was not saturated (i.e. the top of each peak is not flat) the results are 
inaccurate. 
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Table 5.3: Table of the predicted response for DS1 binding to a chip loaded with ScDim2∆N51. 
The results for each of the three temperatures are shown. The second column lists the response units 
(RU) obtained just from loading the protein onto the chip (it corresponds to the initial RU seen minus 
the RU obtained from loading the chip with nickel). Then, the predicted Rmax is shown. This is the 
maximum response obtained if all of the surface were to bind the RNA. It was calculated using the 
formula: Rmax = (MW of RNA)/(MW of protein) x RUprotein. Finally, the Rmax obtained using the two 











4 597 170 5 15 
10 587 167 10 28 
25 463 132 3 3 
 
 
5.9.3 ScNob1 and HsDim2 compete for the D site RNA 
 
Since it appears that Dim2 and Nob1 interact with overlapping RNA 
sequences, a semi-analytical SEC experiment was performed using both proteins and 
DS1 RNA. It was found that the two proteins (ScNob1 and HsDim2) appear to be 
competing for the nucleic acid (Figure 5.34).  
After all the reactants were mixed, precipitation was observed (as for HsDim2 
and RNA only). The tube was spun down and the precipitation removed prior to 
injection onto the SEC column. The elution profile showed a peak at the same 
volume as for ScNob1 and RNA alone. This suggests that both complexes were 
present in the tube, independently. There was no evidence that a larger complex 
containing all three components was formed. In the future, a silver stained gel of the 
fractions should be included in the analysis to confirm this. 
The lack of an interaction between these two proteins was previously 
observed. However, if they both could bind to the RNA as the same time, a larger 
complex would still be formed. Due to the precipitation issue and because the yeast 
Dim2 protein was obtained in the late stages of the project, the experiment was not 
repeated with ScDim2∆N51. This could be done in the future but, due to the 
precipitation, the results are likely to be the same as with HsDim2. Also, the buffer 
conditions need to keep the pH at 7.5 and salt at 150 mM to preserve the RNA-Dim2 
interaction. The protein-protein interactions would be too weak in these conditions to 
be observed (as seen previously). Thus, it appears that the two proteins cannot 
interact with the RNA at the same time.  




Figure 5.34: Semi-analytical SEC using HsDim2, ScNob1, and the yeast DS1 RNA. 
Absorbance at 280 nm is shown as a solid line whereas absorbance at 260 nm is shown as a dashed 
line. The key for the colours is shown on the right. 
A) The elution profile for ScNob1 alone. 
B) The SEC profile for HsDim2 only.  
C) The chromatogram for DS1 alone. As before, multiple peaks are seen. This is minimised at room 
temperature. 
D) The SEC result when HsDim2 is mixed with ScNob1 and DS1 RNA in a 1:1:1.2 ratio. 
Precipitation was present and removed prior to the injection. The peaks correspond to ScNob1 
alone and the ScNob1-DS1 complex. 
E) An overlay of the three previous results showing absorbance only at 280 nm. Since ScNob1 
remained in solution and HsDim2 precipitated, it appears that both proteins bind to the RNA 
independently and compete for the site. A silver stained gel of the fractions was not run but should 
be included in the future to confirm the results. 
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5.10 Crystallisation Trials 
 
 
Human and truncated yeast Dim2 (∆N51) without RNA were tested in 
crystallisation screens. However, no hits were obtained. The majority of drops 
showed some granular precipitation.  Screening with RNA-protein complexes were 
not performed due to the precipitation issue. In the future, a shorter RNA fragment 
should be tested (e.g. just the GGAUCA sequence) to see if the precipitation can be 
controlled. 
The proteolysed fragments were also tested for crystallisation. However, 
these fragments also produced no hits. The predicted N-terminal truncation could be 
used to re-clone the HsDim2 without these sections. The protein could then be 






5.11.1 ScDim2 modelling based on the archaeal structure 
 
The modelling performed using the archaeal structure showed the predicted 
fold for the KH and KH-like domains. However, the validation of the models showed 
a significant number of outliers. More outliers were present in the degenerated 
domain supporting the idea that it is unable to bind to RNA in the same manner. This 
is further reinforced, as the RNA binding site for this domain is not conserved 
between archaea and eukaryotes (unlike the site for KH2). The GxxG motif of the 
functional KH domain could form the same interactions with the RNA as in the 
archaeal protein as no geometry prohibitions were found. The model provides a good 
starting point but a structure of a eukaryotic protein is still highly desirable, 
especially to understand the structure and function of the first, non-canonical KH 
domain. 
 
5.11.2 Soluble Dim2 was purified 
 
Many different constructs of Dim2 were tested for expression and 
purification. It was found by Iva Tchasovnikarova that the full-length yeast protein 
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eluted with the bacterial ribosome and the purification of this construct was not 
successful during the course of this project. However, directions for future attempts 
have been uncovered. It was found that truncated yeast Dim2 cannot interact with 
RNA at high pH or salt concentrations. Thus, future purification methods could 
incorporate these conditions to try to separate the full-length protein from the 
ribosome. 
N-terminally truncated versions of yeast and human Dim2 were cloned, as 
this portion of the protein was the least conserved (see Figure 1.7). When ScDim2 
was truncated at residue 91 or 100, no soluble protein was obtained. However, 
truncations at residues 51 and 61 showed good overexpression in the small-scale 
trials. The equivalent deletions in the human protein (∆N31 and 42) also showed 
soluble expression. 
ScDim2∆N51 was then expressed in large scale and successfully purified. 
This construct was His-tagged and, thus, purified at pH 8.0 unlike the GST-tagged 
full-length protein (purification attempts at pH 7.5). The higher pH could have 
prevented the interactions with the bacterial ribosome. The full-length GST-tagged 
human protein, which has a shorter N-terminal extension, was also successfully 
purified. Unlike the full-length yeast protein, HsDim2 did not co-purify with the 
bacterial ribosome. It is possible that it forms fewer interactions with the bacterial 
rRNA due to sequence divergence between the two organisms (the two proteins 
show 48.2% sequence identity). 
Finally, the protein from C. thermophilum was tested in expression trials and 
found to be insoluble. Again, N-terminal truncations could have potentially helped. 
However, no further tests with this protein were performed. 
 
5.11.3 Recombinant Dim2 precipitates upon interaction with RNA 
 
Both, the full-length human and the truncated yeast proteins, showed 
precipitation upon interaction with the D site RNA. Thus, co-crystallisation trials 
could not be performed. A solubility screen revealed the lack of precipitation at 
higher pH and higher salt concentrations. However, this was caused by the lack of 
complex formation and not solubilisation of the complex. Nevertheless, this result 
does support that a complex is formed at physiological conditions. 
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The full-length yeast Dim2 could not be easily purified since it co-purified 
with bacterial RNA and ribosomal proteins. However, when it was incubated with an 
RNase, it precipitated. It is possible that the protein bound to RNA equivalent to the 
eukaryotic D site sequence and protected it from digestion. Then, the protein 
precipitated in the same manner as the N-terminal truncation mixed with pre-made 
RNA.  
In order to overcome the solubility issue, ScDim2∆N51 was immobilised 
prior to addition of RNA in an SPR experiment. However, there likely still was 
precipitation on the chip surface as two on and off rates were observed. Also, the 
surface showed a low percentage of activity. This could have been caused by 
precipitation preventing parts of the chip interacting with the RNA or bacterial RNA 
contamination co-purified with the protein. The latter explanation is less likely as the 
absorbance at 260 nm did not show significant RNA contamination during 
purification. 
In the future, shorter RNA sequences (e.g. the GGAUCA sequence only) 
could be used to test for the formation of a soluble complex. Also, if the RNA was 
biotinylated, it could be coupled to the SPR chip (via streptavidin) and the protein 
could be run over in the solvent channels. If the RNA was relatively sparse on the 
chip, this could prevent precipitation onto the surface. 
Interestingly, ScDim2∆N51 interacted with the partially folded D site (DS1) 
but not the tight hairpin (DS0), similar to Nob1. This, again, supports the idea that 
the D site is normally single-stranded or that another factor is involved in unwinding 
it to allow binding. 
The human Dim2 protein was able to interact with the yeast DS1 but not the 
in vitro transcribed human DS1 sequence. However, this is likely due to errors in 
transcription as the gel showed the presence of many different RNA species. Thus, 
for other experiments using this sequence (including the binding assay with ScNob1 
described earlier), the RNA was ordered from IDT as an HPLC purified fragment. 
 
5.11.4 The oligomeric states of Dim2 by itself and in complex remain unknown 
 
SEC data did not provide an accurate determination of the oligomeric state of 
human or yeast Dim2. The proteins appear to be larger than a monomer in SEC. 
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However, as mentioned earlier, the elution volume depends on shape and interaction 
with the matrix as well as the size. HsDim2 should be about 3 kDa larger than 
ScDim2∆N51 and eluted about 2.5 ml earlier in SEC. This suggests that the two 
constructs are a similar shape/size and the N-terminal truncation did not have a 
significant effect on conformation. 
Shape prediction using the archaeal structure and HYDROPRO software 
shows that Dim2 is marginally elongated. However, the elongation would not be 
enough to explain the early elution volumes. It is likely that a more globular dimer is 
formed. Otherwise, the early elution could be caused by proteins interacting 
differently with the SEC matrix. 
SEC-MALS followed by DLS should be performed on the different proteins 
in order to obtain accurate molecular weights and information about the shapes of the 
different species. If a soluble complex between Dim2 and RNA had been obtained, it 
could also have been tested in this manner. Semi-analytical SEC would have been 
performed with differing ratios of protein and RNA (not just 1:1.2 or 1:4). An excess 
of protein would also have been tested in case more than one Dim2 molecule is able 
to bind to each RNA particle. However, due to the solubility problems none of these 
experiments were performed. 
 
5.11.5 Nob1 and Dim2 compete for binding to the D site 
 
The experimentally determined D site RNA binding sequence for Nob1 
(AGGA) appears to overlap with the predicted Dim2 binding site (GGAUCA). 
Although the Dim2 site was predicted from an archaeal structure and not 
experimentally determined, it is conserved from archaea to mammals. Also, the 
Dim2 domain predicted to interact with this site (KH2) is more highly conserved 
than other parts of the protein. Thus, it is likely that eukaryotic Dim2 would interact 
with this site in a similar manner. 
Since the RNA sites for Nob1 and Dim2 overlap, it is likely that the two 
proteins cannot interact with the D site at the same time. This would explain why 
Nob1 is unable to cleave the D site until late stages of 20S pre-rRNA maturation. 
Dim2 might have to be released before Nob1 can perform its function making sure it 
occurs at the right time in the pathway. Semi-analytical SEC results using all three 
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components showed no appearance of a larger complex suggesting that it is not 
formed. In this experiment, the human Dim2 protein was used with yeast Nob1. 
These proteins showed no interactions with each other in the conditions used. It is 
possible that protein-protein interactions are needed to create a stable complex. 
However, they would also mask whether competition for the D site RNA exists (i.e. 
a larger complex could be mediated by protein-protein interactions only and not by 
both proteins binding to the same RNA fragment). Using the two proteins from 
different organisms supports that the competition does exist. Nevertheless, these 
results are inconclusive due to the precipitation of HsDim2 with RNA and further 
tests are needed.  
Previous studies and new cross-linking data have shown that Nob1 and Dim2 
interact with each other as well as the D site RNA. As mentioned above, when 
human Dim2 and yeast Nob1 were mixed and analysed using semi-analytical SEC, 
no change in absorbance or size was seen. This could be due to the small differences 
in sequence between the yeast and human versions of the proteins. Also, the 
interaction could be weak without a long RNA scaffold, incorporating the ITS1 
sequence for Nob1 binding and the D site for Dim2 interactions. Finally, the buffer 
conditions also likely played a part and higher salt and pH should be tested in the 
future to confirm this result. 
When the two yeast proteins are mixed, a shift in elution volume is seen and 
SDS-PAGE analysis of the fractions confirms that Nob1 and Dim2 co-elute. 
However, this only occurred at higher pH and salt concentrations. The profile for the 
Dim2-only peak is still seen suggesting that the free protein is still available. This 
could be caused by the oligomerisation states of the two components and their 
relative ratios. For example, a Nob1 dimer could be binding to a Dim2 monomer. 
SEC-MALS on the complexes would have to be performed in order to obtain 
accurate molecular weights within each peak. Then, the composition would be 
calculated based on the theoretical sizes of the components. The extra free Dim2 
protein would also be present if the interaction is weak without an RNA mediator. 
Alternatively, if the N-terminus of the Dim2 protein is involved in the 
protein-protein interaction, it could be weakened when ScDim2∆N51 is used instead 
of the full-length protein. This is unlikely, as this portion of the protein is not 
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conserved. Finally, if any post-transcriptional modifications were involved, these 
would be missing in the recombinant proteins. For example, phosphorylation might 
be required to separate dimers into monomers, which can then form heterodimers.  
In the future, an SPR experiment containing ScNob1, ScDim2∆N51, and D 
site RNA could be designed. As mentioned earlier, the RNA could be coupled to the 
surface. Then, each of the proteins could be washed over the surface. Competition 
for binding could be observed. If both proteins were able to bind concomitantly, this 
would also be seen. 
 
5.11.6 Previously observed interactions could not be replicated 
 
A recent NMR study has shown that archaeal Nob1 and Fap7 interact with 
each other (Hellmich et al, 2013). An attempt was made to replicate this result with 
the yeast recombinant proteins in a semi-analytical SEC experiment. The two 
proteins did not interact in these conditions. This discrepancy could be explained by 
the increased complexity of the ribosome biogenesis in eukaryotes and the 
eukaryotic protein sequences. It is possible that, in eukaryotes, the two proteins are in 
close proximity and that the interaction is mediated by other proteins or RNA and is 
very weak without the extra components. 
The same result was obtained when the ScDim2∆N51 was tested for an 
interaction with ScDim1. This has also been observed in the past (Vanrobays et al, 
2004). However, no binding was observed with the recombinant proteins. Again, it is 
likely that other components of the ribosome biogenesis pathway are needed to 
mediate the interaction. Otherwise, the N-terminus of Dim2 might be involved in 
complex formation. This is less likely as it is not conserved in sequence between 
organisms but cannot be ruled out at this stage. 
An experiment testing whether Nob1 interacts with Dim1 was also 
performed. There is no previous evidence for a direct interaction between these two 
proteins. However, the negative result acts as a good control for other semi-analytical 
SEC experiments. Comparison between Nob1-Fap7, Dim2-Dim1 and Nob1-Dim1 
results clearly shows that none of these interactions are observed in the conditions 
tested. 
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5.11.7 Crystallisation trials of Dim2 have been unsuccessful to date 
 
Crystallisation screens using either ScDim2∆N51 or HsDim2 were 
unsuccessful. In the future, further screens could be performed. The proteolysed 
HsDim2 fragment appeared to be an N-terminal truncation. The corresponding 
truncation could be cloned, expressed, and purified to remove the variability when 
using proteases. Then, it could be re-screened for crystallisation. Also, multiple 
constructs cloned during the course of the project have not yet been purified. These 
proteins could be tested in crystallisation screens in the future. 
Co-crystallisation of Dim2 and Nob1 has not yet been performed. However, 
the two proteins could be co-purified in order to obtain a stable complex that could 
then be used for crystallisation. Buffer conditions that increase the amount of 




5.12 Concluding remarks 
 
 
Dim2 constructs were successfully purified and were shown to interact with 
single-stranded RNA. However, the proteins precipitated upon interaction with RNA 
and this could not be prevented during the project. It appears that Dim2 and Nob1 
compete for the D site RNA during ribosome biogenesis. At the same time, Nob1 
and Dim2 form protein-protein interactions with each other. Thus, this could form a 
regulatory scaffold that ensures that the D site cleavage occurs in the right place at 
the right time. In this case, Dim2 could recruit Nob1 to the ribosome. Then, Dim2 
would have to leave for Nob1 to bind and cleave the D site. 
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Tsr1 is another ribosome biogenesis factor, which is needed for the late stages 
of small subunit maturation. It shows sequence similarity to several GTP-binding 
proteins (e.g. Bms1) but lacks the regions identified to be involved in the actual 
binding of GTP (Gelperin et al, 2001). Its interactions with rRNA have been mapped 
to a site similar to that bound by a bacterial GTPase, Era (Granneman et al, 2010). 
Although the exact function of Tsr1 remains unknown to date, it is predicted 
to prevent premature assembly of the ribosomal subunits and translation initiation. It 
has been suggested to be involved in the nuclear export of the pre-40S particle as 
well (Campbell & Karbstein, 2011; Gelperin et al, 2001; Schafer et al, 2003; Strunk 
et al, 2011). Its positioning near the D site could also prevent premature cleavage by 
Nob1 (Granneman et al, 2010) while making sure that the 20S pre-rRNA does not 
get degraded before this cleavage occurs (Strunk et al, 2012). 
In order to better understand Tsr1 function, a structure of the eukaryotic 
protein is needed. This chapter reports the initial crystallisation trials for the yeast 
protein. They were successful although, due to time constraints, the full structure has 
not yet been solved. 
 
 
6.2 Native Crystal Optimisation 
 
 
Dr. Uma Jayachandran designed the constructs, purified and characterised 
them, and set up the initial commercial crystallisation screens. Initially, the full-
length protein was purified. However, it did not yield any hits in crystallisation 
screens. Subsequently, it was subjected to limited proteolysis. The assay showed the 
presence of two stable bands. When the assay was scaled up and the products were 
analysed by SEC, it was found that both fragments co-purified together. MALDI-
ToF analysis identified the two fragments as parts from the N- and C-termini. 
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However, the middle portion of the protein was missing. Thus, different constructs 
missing the middle loop were created and characterised (like the loop-out mutants for 
Nob1). The two domains remained connected but by a shorter linker in these 
constructs. 
These new constructs were also cloned, purified, characterised, and screened 
for crystallisation by Dr. Uma Jayachandran. Multiple hits were obtained with 
ScTsr1∆410-476. The three most promising conditions observed are shown in Table 
6.1. 
 
Table 6.1: The three most promising hits obtained using ScTsr1∆410-476 
Condition Buffer Salt Precipitant 
1 50 mM MES pH 6.0 0.2 M Sodium malonate 10% PEG 8000 
2 50 mM MES pH 6.0 0.2 M Magnesium chloride 10% PEG 3350 
3 50 mM MES pH 6.0 0.2 M Calcium acetate 18% PEG 8000 
 
 I further optimised all three conditions in larger 24-well sitting drop plates. 
Only condition 1 showed large crystals. Thus, this condition was chosen for further 
optimisation. Buffers at various pH values were tested and it was found that Tris-HCl 
at pH 8.0 gave more evenly shaped crystals (Figure 6.1).  However, these needles 
stuck to the bottom of the plate and dissolved over time.  
 
Figure 6.1: Sample crystals obtained using ScTsr1∆410-476. 
A) Crystals obtained using the original condition 1 at pH 6.0. Large barrel shaped crystals (about 210 
µm in the longest direction) were observed. However, multiple crystals were stuck together and it 
was impossible to separate them. 
B) Crystals obtained when the pH was raised to 8.0. Single needles, about 330 µm in length, were 
observed. However, they stuck to the bottom of the plate and dissolved over time. 
 
 
U. McCaughan                 Chapter 6: Optimisation of Tsr1 Crystals 
 198 
Nevertheless, the needles were harvested and sent to the Diamond Light 
Source synchrotron in Oxford and tested for diffraction. For this purpose, 4 images 
separated by a 45˚ rotation were collected for each crystal. The best diffraction 
obtained was very weak and extended to about 20 Å in resolution. This was not 
improved when using hanging drops instead of sitting drops (to prevent the crystals 
sticking to the wells). Streak seeding was also performed. However, the diffraction 
did not improve. Finally, additive screens were also undertaken but these showed no 
improvement in crystal appearance or diffraction. 
 Since the N-terminus of Tsr1 is also predicted to be unstructured, further 
constructs without this sequence were designed and tested for crystallisation in 
commercial screens by Dr. Uma Jayachandran. It was found that ScTsr1∆N46∆410-
476 (Figure 6.2) crystallised in these screens. Conditions giving crystals with this 
construct are listed in Table 6.2.  
 
Table 6.2: The hits obtained using ScTsr1∆N46∆410-476. 
Condition Buffer Salt Precipitant 
1 50 mM MES pH 6.0 0.2 M Sodium malonate 10% PEG 8000 
2 50 mM MES pH 6.0 0.08 M Ammonium sulfate 4% MPD 
3 50 mM MES pH 6.0 0.2 M Ammonium acetate 4% MPD 
4 50 mM MES pH 6.0 0.2 M Ammonium sulfate 10% PEG 8000 
5 50 mM MES pH 6.0 0.2 M Ammonium sulfate 18% PEG 8000 
6 50 mM MES pH 6.0 0.2 M Sodium chloride 18% PEG 8000 
7 100 mM Bis-Tris pH 6.5 0.2 M Ammonium acetate 25% PEG 3350 
8 - 0.2 M Ammonium tartrate 
dibasic pH 6.6 
20% PEG 3350 
10 - 0.1 M Sodium malonate pH 6.0 12% PEG 3350 
11 - 0.2 M Ammonium tartrate 
dibasic pH 7.0 
20% PEG 3350 
 
 





Figure 6.2: Sequence alignment of the full-length yeast Tsr1 and the ∆N46∆410-476 mutant. 
The sequences are coloured using the Clustal colour scheme. 
 
I scaled up these screen conditions into 24-well sitting drop plates. The 
crystals obtained were sent to the Diamond Light Source synchrotron and tested for 
diffraction as before. It was found that crystals in condition 10 gave the best 
consistent diffraction (on average to about 8 Å resolution). Examples of the crystals 
can be seen in Figure 6.3. Changing the pH of the well solution did not yield better 
diffracting crystals. 
Since changing the crystallisation conditions did not help, multiple replicates 
of condition 10 were set up and numerous crystals were sent to the Diamond Light 
U. McCaughan                 Chapter 6: Optimisation of Tsr1 Crystals 
 200 
Source (Oxford, UK). The best crystal found diffracted to 3.6 Å. Diffraction data for 
270˚ were collected over 1800 images (0.15˚ rotation and 0.1 second exposure) as 
suggested by EDNA software.  
 
 
Figure 6.3: Crystals obtained using ScTsr1∆N46∆410-476. 
These were obtained using the original condition 10. Even, single crystals were observed (about 160 
µm in length in the longest direction). They were not improved with additives. Some variation in 
diffraction was observed when optimising the salt and precipitant concentrations. The best crystal 
diffracted to 3.6 Å. 
 
 
EDNA indexes and integrates the diffraction spots observed in the initial 4 
images collected in order to obtain the best strategy for full dataset collection. The 
program ensures that the strategy gives the necessary exposure time and transmission 
to obtain a sufficient signal-to-noise ratio. It also estimates the completeness and 
multiplicity predicted to be obtained (Incardona et al, 2009). Thus, it allows 
collection of the best dataset based on the 4 images used to test diffraction. The 
collected dataset was further processed as described in the next section. 
In order to confirm that the correct protein has crystallised, some of the crystals 
were collected and dissolved. They were then analysed on a silver-stained SDS-
PAGE gel. As shown in Figure 6.4, ScTsr1∆46∆410-476 was present in the crystals. 
 




Figure 6.4: Silver-stained SDS-PAGE gel of the ScTsr1∆N46∆410-476 protein and the crystals 
shown in the previous figure. 
As controls, the protein stock from the -80˚C freezer and the whole contents of the drop were also 
analysed. The crystals were rinsed twice in well buffer to remove any protein that was not part of the 
crystal. They were then dissolved in the SEC buffer and separated on SDS-PAGE. As shown, the 
crystals contained, almost exclusively, the correct protein. Contaminants and/or proteolytic cleavage 
products were not seen in the crystals and remained in solution. 
 
 
6.3 Native Data Processing 
 
 
The obtained images for the native protein were processed using the XDS 
software (Kabsch, 2010). In the process, the diffraction spots were indexed and their 
corrected intensities recorded and integrated. Initially, XDS identified orthorhombic 
geometry from the diffraction data (space group 16, P222) based on the angles in 
reciprocal space. This was the highest geometry possible that would still fit the data. 
However, the processing does not differentiate between the chiral space groups 
within the Bravais lattice type (i.e. the screw axes are not determined). These were 
observed in the lattice plane intensity data. Systemic absences (i.e. no intensity) were 
present in the odd reciprocal planes perpendicular to the lattice vectors in all three 
directions (Hahn, 1995). Thus, adjacent molecules in the unit cell were translated as 
well as rotated (a screw axis operation). 
Therefore, after scaling the data with SCALA in the CCP4 suite (Winn et al, 
2011), Cad was utilised to ensure the correct space group was applied (19, P212121). 
The final parameters obtained for this dataset can be seen in Table 6.3. Two out of 
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the three unit cell edges are long, suggesting that the components within are also 
elongated in one direction. This causes additional difficulties in data collection as the 
diffraction spots become very close together at certain angles. 
 
Table 6.3: Summary of the parameters obtained after the initial processing of the diffraction 
data. 
The numbers in brackets correspond to the values for the highest resolution shell. 
Beamline I03  
Energy (eV) 12028.0 
Space group P212121 
Unit Cell a = 65.65, b = 173.90, c = 319.75 
 =  =  = 90˚ 
Resolution 48.77-3.60 (3.79-3.60) Å  
Number of Reflections 437,274 
Unique Reflections 43,821 
Rmeasured (%) 12.7 (92.2) 
Completeness (%) 99.9 (99.5) 
I/I 14.4 (2.9) 
Multiplicity 10.0 (9.9) 
 
 




6.4.1 Molecular replacement (MR) was unsuccessful 
 
As stated in the methods section, solved structures of archaeal eIF5B (PDB 
ID: 1G7R) and SelB (PDB ID: 4ACA) were used as molecular replacement models 
in an attempt to solve the ScTsr1∆N46∆410-476 structure. These two proteins 
contain GTPase domains in their N-termini, which are more conserved than other 
parts of the sequence. A sequence alignment is shown in Figure 6.5. The archaeal 
proteins share 19.0% sequence identity with each other. ScTsr1 shows only 9.1% 
identity to eIF5B and 11.8% identity with SelB. Normally, a sequence identity of at 
least 35% is used for MR (Abergel, 2013). However, although the homology is very 
low in this case, if structural elements look the same in the N-terminal domain, 
useful phases might be obtained. In the alignment, the N-termini do appear to be 
most conserved, supporting that Tsr1 contains a GTPase-like domain. 
Thus, these structures were used as search models in Phaser (McCoy et al, 
2007). Since the GTPase domain is the most likely to be structurally as well as 
sequentially conserved, different C-terminal truncations of the models were tested in 
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Phaser as MR search models. In eIF5B the residues following position 443, 328, or 
225 were deleted from the PDB file. For SelB, the truncations were at 385, 269, and 
178. Also, since the proteins share little sequence identity, the side chains were 
removed from all the amino acids in the models and replaced with alanines. 
 
 
Figure 6.5: Sequence alignment of ScTsr1 and archaeal eIF5B and SelB. 
The N-termini are the most conserved. The rest of the protein shows more variability in sequence. 
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Overall, none of the molecular replacement attempts were successful. The 
solutions obtained showed lower log-likelihood gain (LLG) and Z-score values than 
expected for a true solution (Storoni et al, 2004).  They were very close to those 
predicted for a random model. Also, when the maps were examined in Coot (Emsley 
et al, 2010), no structural elements could be observed in the electron density, which 
showed small and disjointed segments. 
Even though the phasing was unsuccessful, useful information about the 
crystal was obtained from the preliminary analysis carried out in the CCP4 program 
suite. Firstly, the Matthews coefficient (VM) and the likely number of protein 
molecules in the asymmetric unit (ASU) were calculated using the molecular weight 




Molecular Weight × Molecules in ASU × Number of ASUs
    Equation 1 
 
 The VM is related to the amount of solvent present in the crystal (Equation 
2). For most protein crystals it falls between 1.7 and 3.5 Å
3
/Da with the majority 
close to 2.15 Å
3
/Da (Kantardjieff & Rupp, 2003b; Matthews, 1968). Thus, the 
number of molecules in an ASU that gives VM closest to 2.15 Å
3
/Da is usually 
correct.  
Each repeating unit of the crystal (unit cell) is made up of several identical 
symmetry-related ASUs (which can be made up of several non-identical units). A 
crystal with the P212121 space group has to have at least 4 ASUs. Using this number 
in the VM equation, the ScTsr1N46∆410-476 crystal most likely contains 5 protein 
molecules per ASU, giving a VM of 2.33 Å
3
/Da and a solvent content of 47.2% (as 
calculated using Equation 2) (Matthews, 1968). However, as stated above, the VM 
can fall anywhere between 1.7 and 3.5 Å
3
/Da. Thus, although the value using 5 
molecules per ASU is most likely, other numbers would also generate a VM that falls 
in this range (Table 6.4). 
 
Solvent Content = 1 −
1.23
VM
        Equation 2 
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Table 6.4: Numbers of molecules per ASU that give VM values within the accepted range and the 
solvent content they correspond to.  
Molecules per ASU VM (Å
3
/Da) Solvent Content (%) 
4 2.91 57.8 
5 2.33 47.2 
6 1.94 36.7 
 
 More recently, it has been shown that the resolution of the diffraction pattern 
correlates with the VM. Crystals diffracting to a higher resolution have shown lower 
VM values (i.e. they have a lower solvent content) (Kantardjieff & Rupp, 2003a). 
Since the Tsr1 crystals presented here only diffract to 3.6 Å, a larger solvent content 
could be expected than the one predicted from theoretical values. Thus, 4 molecules 
per ASU may actually be more likely than the 5 assumed using the equation. 
Nevertheless, the unit cell appears to contain 16-20 protein molecules. This 
would explain the large dimensions observed. Also, Phaser analysed the intensities 
obtained to determine that there is no twinning evident. If the crystals were twinned, 
there would be unexpected systemic absences and/or the distribution of the 
intensities would be different than expected (e.g. fewer very strong/weak and more 
intermediate intensities). These data can be plotted on a cumulative intensity 
distribution graph and should follow predicted theoretical curves if no twinning is 
present. In this case, no twinning was detected. This analysis supports that the quality 
of the data is good.  
 
6.4.2 Heavy atom soaking did not yield useful derivatives 
 
In order to obtain the phasing information experimentally, some of the 
crystals were picked and soaked in heavy atom solutions as described in the methods 
section. Five heavy compounds were used: thimerosal, gold (I) potassium cyanide, 
lead (II) acetate trihydrate, samarium (III) acetate hydrate, and potassium 
tetranitroplatinate (II). These were chosen as they display a variety of reactivities.  
Samarium and lead form non-covalent bonds with carboxylate groups while 
the others (mercury, gold, and platinum) form covalent bonds with sulphur atoms 
and nitrogen atoms in imidazole moieties (Blundell & Johnson, 1976). The 
ScTsr1∆N46∆410-476 construct consists of 686 residues in total. Out of these, 99 are 
negatively charged (51 aspartates and 48 glutamates) and should interact with 
samarium and lead compounds. The methionines (9), cysteines (5), and histidines 
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(14) should bind the other three metals. In addition, they could form other non-
specific interactions. Thus, the choice of these five metals provides a variety of 
potential interactions upon soaking. 
The soaked crystals were washed (back-soaked), flash-cooled, and sent to the 
synchrotron. Prior to data collection, fluorescence scans were performed in order to 
identify the correct wavelengths to be used for each heavy atom. In this experiment, 
the crystal is exposed to X-rays of different wavelengths. The heavy atoms are able 
to absorb the X-rays at certain energies and emit fluorescence based on which heavy 
atom was used. The energy emission at different wavelengths is measured and the 
ones necessary to obtain the best anomalous diffraction can be identified. Although 
theoretical values exist, the scans were performed to ensure that the chemical 
environment of the heavy atoms was accounted for. 
Several datasets were collected for these crystals (Table 2.10). However, all 
of them showed diffraction to 8 Å or worse. The best the dataset (Hg 1) was 
processed in XDS (in the same manner as the native dataset with the exception that 
Friedel’s law was set to false). This dataset was chosen as it showed diffraction to the 
highest resolution and the most anomalous signal predicted by Fast_dp automatic 
processing (Fast_dp performs XDS and SCALA analysis after every data collection 
using default parameters). 
The parameters obtained following analysis are shown in Table 6.5. The 
dimensions and space group remained the same as for the native dataset. The highest 
resolution used for processing was 8.2 Å. Higher resolution signal was present but 
significantly lowered the completeness of the data when it was included. Also, the 
anomalous signal obtained was very low, particularly in higher resolution shells 
(above 10 Å).  
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Table 6.5: Summary of the parameters obtained after the initial processing of the mercury 
soaked crystal. 
The numbers in brackets correspond to the values for the highest resolution shell. The anomalous 
signal represents the mean difference between the structure factor estimates in numbers of standard 
deviations. 
Beamline I03 
Energy (eV) 12298.5 
Space group P212121 
Unit Cell a = 66.10, b = 174.70, c = 321.70 
 =  =  = 90˚ 
Resolution 49.09-8.24 (8.68-8.24) Å 
Number of Reflections 20,663 
Unique Reflections 3,709 
Rmeasured (%) 5.8 (11.6) 
Completeness (%) 92.5 (52.3) 
I/I 23.1 (6.3) 
Multiplicity 5.6 (2.0) 
Anomalous signal 1.05 (0.65) 
 
Nevertheless, the processed and scaled data was still entered into the 
SHELXC/D/E suite (Sheldrick, 2010) and processed using the default settings. 
SHELXC was used to analyse the initial data and predict the shifts caused by the 
heavy atoms. Then, SHELXD builds a substructure based on the locations of the 
heavy atoms. Finally, SHELXE provides initial phase information based on the 
substructure and improves them. As expected, not enough anomalous signal was 
present to obtain the locations of the heavy atoms. 
 
 
6.5 Purification of Seleno-Methionine labelled Tsr1 
 
 
The heavy atom soaking was initially unsuccessful. Further trails could be 
undertaken changing different parameters (e.g. pH, temperature, atoms used). As an 
alternative approach, purification of seleno-methionine ScTsr1∆N46∆410-476 was 
undertaken. In this case, the heavy atom (selenium) is incorporated directly into the 
protein. There are 9 methionines in the construct and all of them should be replaced 
by the heavy derivative. Thus, the positioning of the atom is more specific than 
soaking and should lead to better crystallisation (if packing is unaffected), as each 
molecule in the crystal should be more homogeneous. In soaking, the binding of the 
atoms is often unspecific and can lead to variability.  
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The protein was expressed in M9 medium supplemented with all the standard 
amino acid with the exception that methionine was replaced with the seleno-
methionine. The expression was performed in B834 (DE3) cells, as they are unable 
to produce their own methionine and would have to use the stock provided. The two-
step purification protocol, developed by Dr. Uma Jayachandran for the native 
protein, was used. As shown in Figure 6.6, pure protein was obtained. 
 
 




Figure 6.6: Purification of the seleno-methionine labelled ScTsr1∆N46∆410-476. 
The labels and colours are the same as in previous purification figures. 
A) Nickel affinity purification was used as the first step. The protein was eluted with a 10-500 mM gradient of imidazole. The fractions containing the peak were 
analysed on SDS-PAGE, pooled and dialysed with 3C protease. 
B) The protein was then concentrated and separated on SEC. A single peak (2) containing the Tsr1 construct was seen. This overlapped with the 3C protease, as shown 
in SDS-PAGE. The fractions containing ScTsr1∆N46∆410-476 and not 3C protease were pooled, concentrated, and used for crystallisation screens. 
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6.6 Optimisation of Seleno-Methionine Crystals 
 
 
Once the heavy atom-labelled protein was purified, it was crystallised in the 
same conditions (based on condition 10 in Table 6.2) as the native protein. The 
crystals looked similar but less even and the edges were not as sharp (Figure 6.7). 
Multiple crystals were sent to the Diamond Light Source (Oxford, UK) to be tested 
for diffraction. A fluorescence scan was performed, in the same manner as for the 
heavy atom soaked crystals, and showed that the selenium was incorporated into the 
crystal (Figure 6.8). This also allowed identification of the best wavelengths for data 
collection. 
Two datasets for the best crystal observed were collected (see Table 2.11 for 
strategies): one at the peak wavelength and one at the inflection energy. The datasets 
were analysed with XDS as for the other crystals. The parameters obtained can be 
seen in Table 6.6. 
 
Table 6.6: Summary of the parameters obtained after the initial processing of the two datasets 
obtained suing the seleno-methionine labelled protein. 
The numbers in brackets correspond to the values for the highest resolution shell. The anomalous 
signal represents the mean difference between the structure factor estimates in numbers of standard 
deviations. 
Dataset Peak Inflection 
Beamline I04 I04 
Energy (eV) 12662.0 12660.0 
Space group P212121 P212121 
Unit Cell a = 65.75, b = 173.91, c = 319.71 
 =  =  = 90˚ 
a = 66.27, b = 175.14, c = 320.40 
 =  =  = 90˚ 
Resolution 49.02-7.92 (8.35-7.92) Å 49.02-8.96 (9.45-8.96) Å 
Number of Reflections 45,158 18,137 
Unique Reflections 4,416 3,087 
Rmeasured (%) 22.7 (58.2) 21.1 (57.5) 
Completeness (%) 98.5 (93.1) 98.1 (92.8) 
I/I 10.4 (3.3) 8.1 (3.5) 
Multiplicity 10.2 (6.1) 5.9 (5.5) 
Anomalous signal 1.06 (0.78) 0.90 (0.76) 
 
 




Figure 6.7: Crystals obtained with the seleno-methionine labelled ScTsr1∆N46∆410-476. 
The crystals are smaller (about 90 µm in length) and the edges are not as sharp. This implies that the 






Figure 6.8: Fluorescence scan results for the seleno-methionine labelled ScTsr1∆N46∆410-476 
crystals. 
The experimental data is shown as a red line. The crystal was exposed to X-rays of different energies 
(x-axis) and the amount of fluorescence released, as the X-rays were absorbed, was recorded (left y-
axis). Then, the peak (f) and inflection (f) energies were calculated. They correspond to the energy 
at which the maximum fluorescence is observed (green) and the point of inflection on the fluorescence 
curve (blue) respectively. The values obtained from the experiment are listed in the table on the right. 
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The lower resolution compared to the native dataset suggests that these 
crystals are less well ordered. Nevertheless, the packing did remain the same as the 
space group and unit cell dimensions did not change significantly. Thus, the data was 
entered into SHELXC/D/E suite (Sheldrick, 2010) and processed using the default 
settings in the same manner as the heavy atom derivatives. Unfortunately, the 
resolution was too low to obtain phase information.  
Thus, optimisation of the labelled crystals was undertaken. The protein was 
re-screened using the Hampton Index and Magic I (Munich crystal platform) screens. 
The two initial hits are shown in Table 6.7. The number of hits significantly 
decreased from the native protein supporting that the crystal formation might be 
affected by the modification. 
 
Table 6.7:The hits obtained using seleno-methionine-labelled ScTsr1∆N46∆410-476 
Condition Buffer Salt Precipitant 
1 50 mM MES pH 6.0 0.2 M Ammonium acetate 4% MPD 
2 50 mM MES pH 6.0 0.2 M Sodium malonate 18% PEG 8000 
 
 The two conditions were taken forward into 24-well sitting drop plates. Some 
crystals have been obtained. They were very small but some of them did diffract. 






6.7.1 Crystallographic data collection for native crystals was successful 
 
The original loop-out construct gave multiple hits in commercial screens. 
However, these did not diffract to a high enough resolution for structure solution. 
Removing the N-terminal portion of the protein aided in the formation of better 
crystals. This could be immediately seen in the commercial screens where more hits 
were obtained. These results support the prediction that this portion of the protein is 
unstructured.  
The best native data obtained from the crystals showed diffraction up to 3.6 Å 
resolution. Data processing showed high completeness (99.6%) and a high signal-to-
noise ratio (I/I), even in the highest resolution shell (I/I = 2.97). The data also 
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displayed a relatively low Rmeas value, which suggests that multiple observations of 
the same data converge well.  
Further data processing would require a solution to the phase problem. 
Equation 3 shows the Fourier transform that needs to be applied to every point in 
order to obtain the electron density (). The F(h k l) values can be calculated from 
the spot intensities (I(h k l) in Equation 4). However, the phases () cannot be 
calculated from the diffraction data and need to be known prior to data analysis. 
Thus, they must either be based on similar solved structures or experimentally 
determined. 
 
𝜌(𝑥, 𝑦, 𝑧) =  
1
V
∑ ∑ ∑ |F(ℎ 𝑘 𝑙)| exp[−2𝜋𝑖(ℎ𝑥 + 𝑘𝑦 + 𝑙𝑧) + 𝑖𝛼(ℎ 𝑘 𝑙)𝑙 ]𝑘ℎ   Equation 3 
 
I(ℎ 𝑘 𝑙) ∝  |F(ℎ 𝑘 𝑙)|2        Equation 4 
 
 
6.7.2 Phasing information has not yet been obtained 
 
Initially, to obtain phasing information, molecular replacement was 
attempted. For this purpose, the solved archaeal structures of eIF5B and SelB were 
used. The eIF5B GTP-binding protein (also known as Fun12) is an initiation factor, 
which aids in the ribosome subunit joining (Kolakofsky et al, 1968) and is involved 
in the translation-like cycle that allows D site cleavage to occur. Its interaction with 
the ribosome is blocked by Tsr1 (Strunk et al, 2011). SelB is a translation elongation 
factor that incorporates seleno-cysteines into forming protein chains (Leibundgut et 
al, 2005). Both proteins display ribosome binding sites in a similar location to that of 
Tsr1 and, thus, might have some structural similarities. 
The two proteins do not share high sequence homology with Tsr1 (about 10% 
sequence identity). They are more similar to each other (19% sequence identity and 
RMSD of 14.6 Å between archaeal eIF5B and SelB structures) and display a similar 
fold, particularly in the N-terminal GTPase domain (Figure 6.9A). The amino acid 
side chains were removed for the modelling and three truncations keeping the 
GTPase domain were created (eIF5B at 443, 328, or 225 and SelB at 385, 269, and 
178) to decrease the potential differences in fold. 
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Figure 6.9: Overlay of the full-length and truncated archaeal eIF5B (PDB: 1G7R) and SelB 
(PDB: 4ACA). 
The proteins are shown in green and blue respectively. 
A) Overlay of the full-length proteins. The N-terminal domain appears to be more similar in structure. 
The structures shown an RMSD of 14.6 Å. 
B) Overlay of the first truncation (at 443 and 385 respectively). The RMSD is decreased to 12.7 Å by 
removing the C-terminal domain. 
C) Overlay of the second truncation (at 328 and 269 respectively). The RMSD is further decreased to 
8.3 Å. 
D) Overlay of the last truncation (225 and 176 respectively). The final RMSD is 5.9 Å 
 
 
None of the molecular replacement trials yielded any usable maps. This could 
be due to the low sequence identity between the proteins. Usually, molecular 
replacement utilises models with at least 35% sequence identity. This translates to an 
average RMSD of 1.5 Å in the main chain carbon atoms (Abergel, 2013). Sequence 
divergence highly affects the structure similarity. For example, the archaeal eIF5B 
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and SelB structures show 19% sequence identity and an RMSD of 14.6 Å. This is 
decreased to 12.7, 8.3, and 5.9 Å aligning each of the truncations respectively 
(Figure 6.9B-D), showing that the more conserved regions display higher structural 
similarities. As Tsr1 only shares about 10% sequence identity with these proteins, 
finding a solution was unlikely. 
Nevertheless, newer structures are being published. Recently, structures of 
the eukaryotic C. thermophilum eIF5B protein in different nucleotide-bound states 
with a variety of conformations have been released (Kuhle & Ficner, 2014). This 
protein shares only about 13% sequence identity with Tsr1 and is unlikely to give a 
solution. However, it is a longer protein than the archaeal variant (over 1092 residues 
vs. 594) and could be more similar in fold to Tsr1. Due to time constraints, molecular 
replacement using these structures has not been attempted but should be performed 
in the future. 
Subsequently, heavy atom soaking was attempted. These atoms, like all 
others in the crystal, would contribute to the diffraction pattern. The contributions 
would be relatively high as heavy atoms are electron dense and have a higher 
scattering power compared to atoms found in polypeptide chains. The changes in 
spot intensities from the native data would allow preliminary phase information to be 
estimated. However, for this method to work, heavy atoms must be incorporated. 
They would have to enter the crystal lattice via the solvent channels and occupy 
uniform spaces in each unit cell. This can prove difficult as the binding is often 
unspecific and depends largely on the soaking conditions.  
Different heavy atom derivatives were used to soak the native crystals (as 
described in the methods section). The crystals were placed in the heavy atom 
solutions and then back-soaked in cryo-protectant. The fluorescence scans showed 
that the atoms were present in the crystal and the optimal wavelengths for data 
collection were identified. Nevertheless, the anomalous signal obtained was very low 
and the maximum resolution was decreased. This suggests that the crystals showed 
more disorder and few atoms were incorporated. The higher disorder was likely 
caused by heterogeneous occupancy. 
Even though useful derivatives were not obtained, this method can be further 
optimised. Relatively few heavy atom salts were screened. Other compounds could 
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be used. Also, the binding of the atoms is highly affected by the reaction dynamics. 
Thus, different buffer pH and temperatures can have large effects (Blundell & 
Johnson, 1976). These could be further screened in the future. 
In the meantime, protein containing the heavy atoms within its sequence was 
purified (seleno-methionine labelled). The construct behaved in the same manner as 
the native protein in purification. It also crystallised in the same conditions. 
However, the crystals did not diffract to the same resolution (highest resolution was 
about 8 Å). This could have been caused by slight differences in the crystal order due 
to the larger atom (selenium) replacing the sulphur. 
Thus, multiple rounds of crystal optimisation were undertaken. Due to time 
constraints, many of these have not been fully optimised. The crystals are still too 
small to give useful diffraction. However, this is a promising path and will likely 
yield results. The advantage of using seleno-methionine labelled protein is that the 
heavy atom is incorporated into the sequence. Therefore, its positioning should be 
uniform within each unit cell. 
 
 
6.8 Concluding remarks 
 
 
Overall, preliminary steps have been taken to solve a eukaryotic Tsr1 
structure. Good native crystallographic data are available. There is a good starting 
point for obtaining experimental phases as a seleno-methionine derivative has been 
created and is in the process of being crystallised. Also, many new protein structures 
are being published and some of them might prove to be good molecular replacement 
search models in the future. Once the structure is obtained, insight into the Tsr1 






Since the initial submission of this thesis in October of 2014, further heavy 
atom soaks were performed. Crystals containing tantalum bromide clusters were 
obtained and initial phases were calculated. The methods and results for this 
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additional work can be seen in Appendix V while the resulting electron density 
cloud is shown below in Figure 6.10. 
 
 
Figure 6.10: A sample image of the electron density obtained using multi-wavelength anomalous 
dispersion (MAD) experimental phasing. 
This is a 2Fo-Fc map where the σ value was set to 1.0. The map shows good connectivity and empty 
space for the solvent channels. The resolution of the derivative crystal (4.2 Å) prevents easy model 
building into the density. In the future, model building and phase extension will be used to improve 
the quality of the map. 
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7.1 Recombinant Ribosome Biogenesis Factors were Successfully 
Purified and Characterised 
 
 
Over the course of the project, three eukaryotic ribosome biogenesis factors 
have been successfully expressed and purified from E. coli strains. The protocols 
were optimised and found to be reproducible. Nob1 (from S. cerevisiae and C. 
thermophilum) and human Dim2 were found to be stable using a thermal 
denaturation assay. Different constructs for each protein were also obtained. The 
protocol for the Tsr1 constructs was optimised by Dr. Uma Jayachandran, who 
showed that these were also stable using thermal denaturation.  
The majority of the experiments performed on Nob1 used the yeast full-
length construct. The recombinant protein was found to have its RNA binding 
activity and to be active in an in vitro D site cleavage assay. However, the RNA 
binding predicted to occur between Nob1 and helix 40 (Granneman et al, 2010) was 
not observed. It is possible that this interaction is mediated by other parts of the pre-
ribosome. Otherwise, the conformations of the artificial rRNA fragments might be 
preventing the interaction from occurring in vitro. Thus, although the zinc ribbon 
domain of the archaeal protein was shown to bind to helix 40 (Veith et al, 2012), it 
remains unclear if this is the case in eukaryotes. 
Instead, the yeast protein was found to interact with a sequence (AGGA) 
immediately upstream of the D site and with one about 100 bases downstream (the 
ITS1 sequence). Previously, rRNA fragments encompassing these sites have been 
identified (Lamanna & Karbstein, 2009) but the specificity was not determined to 
this level of resolution. The two modes of binding appeared distinct in ITC and are 
likely performed independently by the two separate domains. It is possible that the 
PIN domain binds the D site while the ITS1 sequence interacts with the zinc ribbon.  
Further experiments need to be performed in order to determine if both 
sequences can interact with the protein at the same time. For example, a competition 
assay could be performed in ITC. For this purpose, the protein would firstly be 
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saturated with one of the RNAs. Then, the second one would be injected. Its affinity 
should not be changed by the presence of the other RNA if they bind independently. 
If they bind co-operatively, the affinity would be higher and if there were 
competition for the interaction, the affinity would be lower. During these 
experiments, it is important to keep in mind that in archaea, the zinc ribbon domain 
interacts with helix 40. This would add more complexity as it is unclear if and how 
all three interactions would co-exist. 
Dim2 constructs have also been successfully purified. The recombinant 
human and truncated yeast Dim2 proteins appear to be able to interact with RNAs 
containing the predicted binding site (GGAUCA). Both Dim2 constructs were found 
to precipitate upon addition of D site RNA. The precipitation suggests a binding 
event. It was only observed when the RNA was single-stranded supporting that a 
specific interaction is occurring. This also supports the hypothesis that a hairpin is 
not formed at this site during ribosome biogenesis (Lamanna & Karbstein, 2009). 
The interaction was disrupted at higher pH and in higher salt. In the future, the 
binding experiments should be performed with shorter RNA sequences in order to 
prevent precipitation. Also, the sequence requirements for binding should be tested 
by introducing point mutations in the same manner as was done with Nob1. 
The yeast truncated Dim2 protein is also able to interact with Nob1. These 
results support that the recombinant proteins are correctly folded and can perform 
their predicted functions. The full-length yeast protein could not be purified as it was 
heavily contaminated with bacterial rRNA and ribosomal proteins in all protocols 
attempted. 
Finally, S. cerevisiae Tsr1 constructs were designed and purified by Dr. Uma 
Jayachandran. However, the function of this protein remains unknown and a specific 
recognition site has not been mapped. Cross-linking has shown that it is in close 
proximity to long and disparate sequences of the 20S pre-rRNA, including proximal 
sequences to the D site (Granneman et al, 2010). Thus, it is unknown what short 
sequence could be designed for testing of Tsr1 folding. In the future, EMSAs could 
be performed with different parts of the identified sequences in order to pinpoint the 
most important fragment. 
 
 
U. McCaughan                                                                   Chapter 7: Conclusions and Future Prospects 
 220 
7.2 Insight into the 20S pre-rRNA Processing has been Obtained 
 
 
Identification of the Nob1 RNA recognition sequences provides insight into 
the last step of maturation of the small ribosomal subunit. The two distinct binding 
sites (D site and ITS1) with different binding modes suggest a specific order of 
events and interactions that allow the nuclease domain to be positioned correctly.  
Also, the site identified upstream of the cleavage event overlaps the sequence 
predicted for Dim2 binding. Thus, the positioning of the nuclease domain is 
dependent on the other factors in the processing pathway. It is likely that Dim2 needs 
to be released before the Nob1 PIN domain can interact with its target. 
Finally, the yeast Nob1 protein is able to bind to the D site cleavage product 
in the same manner as to the substrate but with a slightly higher affinity. This 
suggests that additional factors are required for the release of the mature particle. 
This may form another checkpoint for the fidelity of the cleavage and a further level 
of control as Nob1 cannot bind to another site and cleave it until it is safely released 
from its previous target.  
All of these data could be added to the proposed translation-like cycle 
(Figure 1.4 in Chapter 1), which shows that the pre-40S subunit has to interact with 
the 60S subunit (mediated by Fun12 GTPase) in order for the small subunit to 
undergo final maturation (Lebaron et al, 2012; Strunk et al, 2012). Figure 7.1 
summarises the steps thought to occur based on the data presented in this thesis.  
The data suggest that Nob1 binds to an ITS1 sequence while Dim2 interacts 
with the D site. The two proteins also interact with each other at this time. Then, 
when the rRNA is determined to be ready for final maturation (possibly through the 
translation-like cycle), Dim2 has to be released by an unknown mechanism. The 
timing of this release with respect to Fun12 and 60S subunit binding is also 
unknown. It is possible that GTP hydrolysis performed by Fun12 and the 
conformational changes associated with it could cause Dim2 to be released. After 
Dim2 is removed, the Nob1 nuclease domain would be able to interact with the D 
site and to cleave it. Then, all the factors, including Nob1, would be released, again 
through an unknown mechanism. 
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Figure 7.1: Model of the D site cleavage combining data obtained in this project and the 
translation-like cycle model previously described (see Figure 1.4). 
The colouring is consistent with the model shown in Figure 1.4. Only the pre-40S subunit is shown 
and it is divided into the head (brown) and body (green) domains. The D site is shown in dark green 
and the ITS1 RNA is shown as a dashed purple line. Nob1 is shown in blue and Dim2 is orange. 
Fun12 (dark blue circle) and the 60S RNA (light blue pentagon) are also indicated. The pre-40S 
subunit (i) is bound by Dim2 near the D site and by Nob1 in the ITS1 (ii). Then, Dim2 is released by 
an unknown mechanism (iii). The Fun12 GTPase and 60S subunit would have to bind to allow the 
translation-like cycle to occur (Lebaron et al, 2012; Strunk et al, 2012). It is unclear if this would 
happen before or after Dim2 release. Nob1 can now bind to the D site with its nuclease domain (iv) 
and perform the cleavage (v). Finally, the Rli1 ATPase separates the ribosomal subunits (Strunk et al, 




7.3 Crystallisation of the Factors has been Successful 
 
 
Loop-out constructs, which removed flexible loops joining two folded 
domains, were created for two proteins (Nob1 and Tsr1) in order to increase the 
chances of obtaining crystals. This method has been used in the past (Derewenda, 
2004) and could prove to be useful for crystallisation of other ribosome biogenesis 
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factors whose structures have not been solved to date. During the course of the 
project, it did allow the yeast Tsr1 to be successfully crystallised. A good dataset has 
been obtained and processed. Although the structure of Tsr1 has not yet been solved, 
the seleno-methionine construct has been purified and heavy atom derivatives have 
been obtained. Structural information would aid in distinguishing the function of this 
protein.  
Future prospects for further Nob1 crystallisation trials have also been 
established. These include co-crystallisation with RNA and/or Dim2 using the loop-
out constructs and different RNA sequences identified in ITC. 
Once a eukaryotic Nob1 structure is obtained, it can be used to further 
understand the D site cleavage. It can also be used to identify potential small 
molecule inhibitors of its function. Cell proliferation in different types of cancer (e.g. 
ovarian, liver, and lung cancers) has been shown to be decreased when Nob1 is 
knocked down (Li et al, 2014; Lin et al, 2011; Lu et al, 2011). Thus, drug molecules 
that target Nob1 function could provide a new cancer treatment with broad 








Previously, an in vitro D site cleavage assay using a long RNA substrate was 
published (Lebaron et al, 2012; Pertschy et al, 2009). Here, this assay was optimised 
and used on shorter substrates successfully. As with the published cleavage, the 
activity of Nob1 was shown to be low in the simplified environment. However, the 
system can be used successfully with recombinant proteins to test for aiding or 
inhibition of the D site cleavage. 
Nob1 and Dim2 were found to interact with overlapping D site RNA 
sequences. However, the sequence requirements for Dim2 were not tested (due to the 
precipitation issue) and the actual positioning is predicted based on the archaeal 
Dim2 structure in complex with bacterial rRNA (Jia et al, 2010). Nevertheless, it is 
likely that the two proteins compete for binding. 
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If a condition giving soluble Dim2-RNA complexes could be found, the 
competition for binding with Nob1 could be observed in ITC (in the same manner as 
described for the RNA competition previously). Then, the D site RNA bound to 
Dim2 could be used in the cleavage assay. It has been shown that Dim2 helps Nob1 
to make rRNA contacts (Woolls et al, 2011). However, this might not be true at the 
D site, as the binding sequences appear to overlap. If Nob1 cleavage becomes more 
efficient in the in vitro system when Dim2 is included, its role in aiding the cleavage 
would be clarified. Otherwise, it could be preventing the cleavage from happening 
until the right moment.  
Also, different types of substrates could be tested. It is possible that the RNA 
sequence and secondary structure have an effect of the efficiency of the Nob1 
cleavage. Thus, different RNAs should be initially probed by primer extension to 
obtain secondary structure information. Then, they could be used in the cleavage 
assay to test for changes in Nob1 activity. Other sequences interacting with the zinc 
ribbon domain, like ITS1, could also affect the PIN domain nuclease function and 
should be included in some experiments. The identified RNA mutation that prevents 
Nob1 binding (AGGA to AAAA) should also be incorporated into some of the 
substrates to see if the interaction is necessary for cleavage.  
Finally, in the future, this assay could also be used to verify any potential 
Nob1 inhibitors identified. The ability of the small molecules to prevent cleavage 
would need to be tested in vitro, as this would provide a very simple system that 
would be easier to analyse than an in vivo system where other factors might obscure 
the relative activity of the inhibitors. 
 
 
7.5 Concluding Remarks 
 
 
Overall, this project was successful in obtaining insight into the late stages of 
small subunit pre-rRNA maturation. The previously identified interaction between 
Nob1 and Dim2 was confirmed using recombinant proteins. However, it was also 
shown that the two proteins might compete for the D site.  Recent cross-linking data 
in growing cells performed by the Tollervey lab (personal communication with Prof. 
Tollervey) suggest that this competition also exists in vivo. The experiments 
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presented in this thesis identified conditions that affect the interaction between Dim2 
and Nob1 or D site rRNA fragments (high salt and pH). This could be useful in the 
future for the formation of stable complexes. 
The initial Nob1 crystals have prospects for optimisation. The structure 
would provide a good starting point for the identification of inhibitors. Then, the 
cleavage assay described in this project could be used to test the effects of these 
inhibitors. The assay could also be expanded to study the effect of Dim2 on Nob1 
nuclease activity. 
Although the function of Tsr1 is unknown, large progress has been made in 
obtaining structural data. A native dataset has been obtained and steps have been 
taken to solve the phase problem. Overall, it is likely that the structure will be solved 
in the near future providing further insight. 
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9.1 Appendix I: Primers 
 
 
Primer Sequences (5-3) 
 
ScNob1 gene amplification for conventional cloning 
(Restriction sites are shown in green and extra two bases are shown in blue) 
 
 ScNob1 forward primer: 
 CCCCCATGGGCACCGAAAACC 
 
 ScNob1 reverse primer: 
 CCCCCTCGAGACTTCTCCTTT 
 
ScDim2 gene amplification for LIC for 3C vectors 
(Overlap with plasmid is shown in red and the extra three bases are shown in blue) 
 
 ScDim2 forward primer: 
 CCAGGGGCCCGACTCGATGGTTGCGCCTACTGCTTTG 
 
ScDim2∆N51 forward primer: 
CCAGGGGCCCGACTCGGCAAAAGAAGAGGTAGAGG 
 
 ScDim2∆N61 forward primer: 
 CCAGGGGCCCGACTCGAGCCGGAAAACGCACG 
 




 ScDim2∆N99 forward primer: 
 CCAGGGGCCCGACTCGATGGTTCCACCACACAGAATG 
   




ScDim2 gene amplification for LIC for TEV vectors 
 




 ScDim2 reverse primer: 













Human proteins into 3C vectors (LIC) 



































HsNob1 (WT and D10N) into pET28α (G-block cloning) 






















Reverse (77 bases): 
TGGTCGGAGTGGCAGGATTC 
 
Reverse (99 bases): 
CCCAAGGGGTTGCCGACAATC  
 
Reverse (109 bases): 
GTTTAGAGGCCCCAAGGGGTT  
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9.2 Appendix II: LIC Vectors 
 
 
The pEC-KHC and pEC-KGC plasmids have kanamycin resistance (K) and a 3C 





The pEC-SHT and pEC-SGT plasmids have streptomycin resistance (S) and a TEV 
protease cleavage site (T) as shown on the next page: 
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9.3 Appendix III: Additional Plasmids 
 
 
The C. thermophilum proteins were ordered as codon optimised plasmids from 
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9.4 Appendix IV: Transcription Sequences 
 
 
In vitro transcription sequences ordered 
(blue – T7 promoter, red – extra bases) 
 
Homo sapiens D site  
 Top: TAATACGACTCACTATAGGGAAGGATCATTAACGGAGCCCG 
 Bottom: CGGGCTCCGTTAATGATCCTTCCCTATAGTGAGTCGTATTA 
Saccharomyces cerevisiae D site 
 Top: TAATACGACTCACTATAGGGAAGGATCATTAAAGAAATTTA 
 Bottom: TAAATTTCTTTAATGATCCTTCCCTATAGTGAGTCGTATTA 
 
In vitro transcription sequences cloned 
 
Saccharomyces cerevisiae H40 (short) 
 TAATACGACTCACTATAGGGATCGGTTTCAAGCCGATCCC 
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9.5 Appendix V: Tsr1 MAD Phasing 
 
 
Materials and Methods 
 
 
 Native crystals were soaked in 1 or 2 mM tantalum bromide for 0.5, 1, 3, 6, 
or 16 hours. This was performed in the same manner as previously described for 
other metals. The back-soaking step was also used. Data was collected remotely on 
the I02 or I03 beamline at the Diamond Light Source synchrotron in Oxford. As with 
the other metals, a fluorescence scan was performed and data collection was 
performed at the peak, inflection, or high remote energy. The best datasets were 
collected from a crystal soaked for 1 hour. The strategies used are listed in Table 
V.I. 
 
Table V.I: Strategies for dataset collection for the best diffracting crystal. 
















Peak I02 9880.9 45˚ 0.15˚ 950 0.1 3.5 15 
Inflection I02 9877.4 45˚ 0.15˚ 950 0.1 3.5 15 
Hrm I02 9890.0 45˚ 0.15˚ 950 0.1 3.5 15 
 
 
The data was then processed in XDS as described earlier for the anomalous 
crystal and the three datasets were scaled together using XSCALE (Kabsch, 2010). 
The heavy atom sites were identified with SHELXC/D/E (Sheldrick, 2010) and 
entered into autoSHARP (Vonrhein et al, 2007) where the phasing was performed 
according to manufacturer’s instructions using default settings for multi-wavelength 






 The parameters obtained for each dataset after processing can be seen in 
Table V.II. A fluorescence scan was performed on the soaked crystals and can be 
seen in Figure V.I. The resulting electron density map is shown in the main text in 
Figure 6.10. 
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Table V.II: Summary of the parameters obtained after the initial processing of the three 
datasets obtained suing the tantalum bromide soaked crystals. 
The numbers in brackets correspond to the values for the highest resolution shell. The anomalous 
signal represents the mean difference between the structure factor estimates in numbers of standard 
deviations. 
Dataset Peak Inflection High Remote 
Beamline I02 I02 I02 
Energy (eV) 9880.9 9877.4 9890.0 
Space group P212121 P212121 P212121 
Unit Cell a = 65.04, b = 175.20, 
c = 319.18 
 =  =  = 90˚ 
a = 65.78, b = 175.37, 
c = 318.01 
 =  =  = 90˚ 
a = 65.54, b = 175.40, 
c = 318.00 







Reflections 143,710 143,704 134,224 
Unique Reflections 27,613 27,756 26,056 
Rmeasured (%) 18.5 (54.3) 18.9 (67.1) 18.1 (62.1) 
Completeness (%) 99.0 (94.4) 99.3 (96.7) 99.2 (92.8) 
I/I 10.3 (3.2) 9.5 (2.7) 9.4 (2.6) 
Multiplicity 5.2 (5.3) 5.2 (5.2) 5.2 (4.9) 







Figure V.I: Fluorescence scan obtained at the L3 edge of tantalum absorption using a soaked 
crystal. 
The experimental data is shown as a red line (as shown before with the seleno-methionine protein). 
The peak (green) and inflection (blue) energies were calculated from the graph. 
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